phenyl acetate has been researched along with Asthma, Bronchial in 845 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (2.01) | 18.7374 |
1990's | 59 (6.98) | 18.2507 |
2000's | 487 (57.63) | 29.6817 |
2010's | 228 (26.98) | 24.3611 |
2020's | 54 (6.39) | 2.80 |
Authors | Studies |
---|---|
Burchard, EG; Carr, F; Chalmers, JD; Espuela-Ortiz, A; Hernandez-Pacheco, N; Herrera-Luis, E; Lassi, G; Maitland-van der Zee, AH; Maroteau, C; Mukhopadhyay, S; Palmer, CNA; Pino-Yanes, M; Platt, A; Srinivasan, S; Tavendale, R; Turner, S; Wilson, K; Young, S | 1 |
Chen, ZM; Hong, JG; Xiang, L; Zhao, DY | 1 |
Cummings, TH; Hardin, JW; Magagnoli, J; Sutton, SS | 1 |
Hong, JG; Lu, J; Qin, Z; Zhou, XJ | 1 |
Feng, XK; Lin, JL; Pei, J; Sun, HY; Zhang, DM | 1 |
Eliseeva, SI; Georas, SN; Hetelekides, S; Rimmer, C; Veazey, JM | 1 |
Feng, X; Liu, L; Zhang, H; Zhang, Y; Zhou, X | 1 |
Akelma, Z; Günbey, S; Özata, E | 1 |
Fox, CW; Gerke, AK; Khaw, CL; Lund, BC | 1 |
Dixon, EG; Hawcutt, DB; King, C; Lilley, A; Sinha, IP | 1 |
Alyasin, S; Babaeian, M; Esmaeilzadeh, H; Far, NM; Hadipour, M; Nabavizadeh, SH | 1 |
D'Andrea, P; Hosoe, M; Matsuo, K; Nakamura, Y; Pethe, A; Sagara, H; Tanaka, Y; Tanase, AM | 1 |
Giallongo, A; Indolfi, C; Leonardi, S; Licari, A; Manti, S; Marseglia, GL; Miraglia Del Giudice, M; Papale, M; Parisi, GF; Salpietro, C | 1 |
Fazel, S; Forton, J; Herttua, K; Luciano, S; Paljarvi, T | 1 |
Conrad, LA; Nandalike, K; Rani, S; Rastogi, D | 1 |
Jun, X; Jun, Z; Ping, Z; Yan, W | 1 |
Huang, Z; Jian, X; Li, J; Li, K; Liang, B | 1 |
Cho, YJ; Choi, BW; Jung, JW; Kim, MH; Kwon, JW; Nam, YH; Park, CS; Park, HJ; Park, JS; Shin, YS; Sohn, KH | 1 |
Chen, Q; Lai, K; Li, H; Liu, B; Luo, W; Peng, W; Tang, J; Yi, F; Zhan, C; Zhou, J | 1 |
Caliendo, G; Camerlingo, R; Cerqua, I; Cirino, G; Costa, SKP; Feitosa, KB; Fiorino, F; Frecentese, F; Granato, E; Muscara, M; Pavese, R; Petti, A; Rea, G; Roviezzo, F; Santagada, V; Severino, B; Soares, AG | 1 |
Can, D; Erdem, SB; Nacaroglu, HT | 1 |
McCarthy, MW | 1 |
Bønnelykke, K; Eklöf, J; Jordan, A; Meteran, H; Sivapalan, P; Stæhr Jensen, JU; Toennesen, LL; Ulrik, CS | 1 |
Chen, F; Chu, F; Liang, L | 1 |
Contreras, E; D'Andrea, P; Jain, M; Kolarz, A; Laki, I; Manga, V; Nell, H; Pak, T; Sekerel, BE; Sen, B; Vaidya, S; Valentin, M | 1 |
Hong, SJ; Kim, HJ; Lee, SH; Lee, SY | 1 |
Bloom, CI; Chan, EWY; Fung, LWY; Lo, CWH; Pathadka, S; Qin, SX; Wong, ICK; Yan, VKC; Yiu, HHE | 1 |
Li, S; Wei, Z | 1 |
Devonshire, AL; Kumar, R | 1 |
Wang, H; Zhang, Y | 1 |
Li, B; Zhang, Y | 1 |
Hao, GX; Jacqz-Aigrain, E; Kan, M; Li, Q; Shi, HY; Su, LQ; Wang, K; Wang, XL; Wu, YE; Yang, XM; Yang, YL; Zhao, W; Zheng, Y; Zhou, J; Zhou, Y | 1 |
Arakawa, M; Hasegawa, T; Hayashi, M; Kikuchi, T; Kimura, Y; Koya, T; Saito, A; Takeuchi, H; Tsukioka, K; Ueno, H; Watanabe, S | 1 |
Bandi, S; Codispoti, CD; Mahdavinia, M; Patel, P | 1 |
Guo, W; Meng, L; Xie, Y; Xu, Z | 1 |
Alonso Charterina, S; Díaz Campos, R; Fernández Crespo, J; Fernández Rodríguez, C; García-Moguel, I | 1 |
Bozek, A; Winterstein, J | 1 |
Bradley, M; Cocoros, NM; Dee, EC; Eworuke, E; Haug, N; Kim, I; Lyons, JG; Ma, Y; Mosholder, A; Pennap, D; Pestine, E; Petrone, AB; Sansing-Foster, V; Toh, S | 1 |
Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y | 1 |
Al-Azzam, N; Elsalem, L | 1 |
Chen, Y; Fang, H; Liu, T; Liu, Y; Shen, K; Wang, X; Wu, B; Wu, E; Wu, P; Xie, J; Zhong, J; Zhou, W | 1 |
Chang, LS; Chien, SJ; Huang, PY; Huang, YH; Kuo, HC; Wang, LJ; Yang, YH | 1 |
Godejohann, M; Helmboldt, H; Karaghiosoff, K; Kolb, C; Müller, HC; Philipp, M; Reiser, A; Schmidt, P | 1 |
Du, C; Li, J; Wang, L; Wang, M; Zhang, Q; Zhao, Q | 1 |
Aksu, F; Aksu, K | 1 |
Han, H; Liu, Q; Liu, X; Luo, H | 1 |
Braciale, T; Gentile, MA; Groote, F; Hernandez, C; Jabbour, SK; Khan, AR; Kim, S; Malhotra, J; Mehnert, J; Michel, C; Misdary, C; Narayanan, N; Radbel, J; Salgame, P; Siddiqui, S; Yegya-Raman, N | 1 |
Andıran, N; Demet Akbaş, E; Razi, CH | 1 |
Deng, L; Fan, L; Kang, Y; Liu, Y; Wang, X; Yang, F | 1 |
Elnazir, B; Nadeem, M; Trayer, J | 1 |
Cao, J; Lei, H; Tang, Q; Wang, J; You, J | 1 |
Carraturo, F; Cermola, F; DellaGreca, M; Galdiero, E; Guida, M; Iesce, MR; Libralato, G; Siciliano, A; Temussi, F | 1 |
Gallo, O; Mangia, PP; Pradelli, L; Ritrovato, D | 1 |
Powell, WS | 1 |
Chen, SJ; Cheng, YD; Huang, KH; Lin, CL; Tsai, WC; Wei, CC | 1 |
Cavero-Carbonell, C; Garne, E; Martos, C; Rabanque-Hernández, MJ; Vinkel-Hansen, A | 1 |
Fujisawa, T; Fukuda, N; Habukawa, C; Ikeda, M; Katsunuma, T; Kitamura, T; Nagao, M | 1 |
Wang, X; Yi, X; Zhao, X; Zhou, J | 1 |
Christiansen, A; Damkier, P; Davidsen, JR; Hallas, J; Henriksen, DP; Laursen, CB; Pottegård, A | 1 |
Asae, KH; Koizumi, Y; Kojima, Y; Nagase, H; Ohta, K; Ro, S; Sugimoto, N; Ujino, M; Yamashita, N | 1 |
Akerman, M; DeVoti, J; Elera, C; Farzan, S; Khan, S; Tsang, J | 1 |
Brodlie, M; Haq, I; Harris, C; McKean, MC; Taylor, J | 1 |
Ernst, G; Ernst, P | 1 |
Bastien, V; Benard, B; Ducharme, FM; Krajinovic, M; Vinet, B; Yang, R | 1 |
Bateman, ED; Brockhaus, F; Guerreros, AG; Holzhauer, B; Kay, RA; Pethe, A; Townley, RG | 1 |
Haribabu, B | 1 |
Urdaneta, E | 1 |
Bénard, B; Ducharme, FM | 1 |
Harding, AG; Harding, TW | 1 |
Ding, D; Han, X; Li, H; Liu, B; Lu, B; Wang, L; Wang, X; Zhang, Y | 1 |
Cobos-Carrascosa, E; Eiros, JM; Fernández-Puentes, V; Guarino-Narváez, J; Luque-Pérez, S; Sánchez-Porto, A | 1 |
Gao, F; Li, Z; Liu, J; Tian, Z; Wang, X; Zhang, X | 1 |
Anzures-Cabrera, J; Governale, L; Holweg, CTJ; Kerwin, E; Korenblat, P; Leshchenko, I; Martin, C; Matthews, JG; Olsson, J; Putnam, WS; Yen, K | 1 |
Christiansen, A; Damkier, P; Farah, RI; Henriksen, DP | 1 |
Begueret, H; Berger, P; Debelleix, S; Fayon, M; Kamaev, A; Marthan, R; Ousova, O; Siao-Him Fa, V | 1 |
Akhbari, M; Harris, KM; Kneale, D; Pike, KC | 2 |
Bood, J; Dahlén, B; Dahlén, SE; Davis, A; Gomez, C; Gyllfors, P; Kolmert, J; Lantz, AS; Lazarinis, N; Wheelock, CE | 1 |
Divac Rankov, A; Dragicevic, S; Korosec, P; Kosnik, M; Milosevic, K; Nikolic, A; Rijavec, M; Skerbinjek Kavalar, M | 1 |
Jawhari, N; Strauss, RA | 1 |
Bateman, ED; Ivanov, S; Luke, S; O'Brien, C; Rugman, P; Uddin, M | 1 |
Ciółkowski, J; Hydzik, P; Mazurek, E; Mazurek, H; Stasiowska, B | 1 |
Chang, YS; Cho, YJ; Cho, YS; Choi, BW; Chung, JH; Jee, YK; Jo, EJ; Jung, J; Kim, HK; Kim, MK; Kim, SH; Lee, BJ; Lee, JM; Lee, SK; Lee, SY; Park, CS; Park, HS; Park, HW; Park, JW; Yoo, KH; Yoon, HJ | 1 |
Gupta, D; Gupta, N; Gupta, S; Nanavati, J; Sachdev, A | 1 |
Wang, XP; Yang, LD; Zhou, JF | 1 |
Damkier, P; Hallas, J; Henriksen, DP; Winkel, JS | 1 |
Castro-Rodriguez, JA; Ducharme, FM; Rodriguez-Martinez, CE | 1 |
Anzivino, R; Autilio, C; Baroni, S; De Corso, E; De Vita, C; Di Nardo, W; Galli, J; Mele, D; Mullol, J; Paludetti, G; Salvati, A; Settimi, S | 1 |
Kulkarni, GT; Kumar, Y; Singh, N | 1 |
Liao, JY; Zhang, T | 1 |
Yang, LD; Zhang, YF | 1 |
Choi, Y; Nguyen, TVT; Park, HS; Shin, YS; Suh, DH; Trinh, HKT | 1 |
Dokuni, R; Funada, Y; Kawa, Y; Kobayashi, K; Kotani, Y; Miwa, N; Nagano, T; Nakajima, T; Nishimura, Y; Nishiuma, T; Ohnishi, H; Shirotani, T; Takenaka, K | 1 |
Chen, D; Guo, Q; Kang, P; Shen, ZB; Sun, XM | 1 |
Feldman, LY; Finkelstein, Y; Glockler-Lauf, SD; To, T; Zhu, J | 1 |
Liu, HY; Sun, W | 1 |
Dai, JH; Tu, JW; Zhu, XH | 1 |
Akcaboy, M; Altinel Acoglu, E; Gurkan, A; Sari, E; Senel, S; Yazilitas, F | 1 |
Akers, WS; Arnold, DH; Bowman, N; Hartert, TV; Reiss, TF; Seger, DL | 1 |
Kovesi, T | 1 |
Finkelstein, Y; To, T | 1 |
Lavorini, F; Matucci, A; Pistolesi, M; Rossi, O | 1 |
Friedman, HS; Hong, SH; Navaratnam, P; Oh, SJ; Park, SW; Petigara, T; Shin, J; Tunceli, K; Urdaneta, E | 1 |
Li, CC; Zhang, WX | 1 |
Awan, S; Haque, AS; Husain, SJ; Khan, JA; Khawaja, A; Rao, N; Salahuddin, N; Shah, AA; Zubairi, AB | 1 |
Inoue, H; Ito, I; Iwata, T; Kanemitsu, Y; Matsumoto, H; Mishima, M; Nagasaki, T; Nakaji, H; Niimi, A; Oguma, T; Petrova, G; Tajiri, T | 1 |
Li, M; Shang, YX; Wei, B; Zhang, H | 1 |
Holme, H; Winckworth, LC | 1 |
Niimi, A | 1 |
Ameratunga, R; Anderson, BJ; Dalziel, S; Randall, N | 1 |
Cai, F; Gao, JM; Ma, Y; Peng, M; Wang, B | 1 |
Adner, M; Dahlén, SE; Fuchs, B; Karlsson, L; Nilsson, GP; Rao, NL; Riley, JP; Sjöberg, L | 1 |
Devouassoux, G; Freymond, N; Pacheco, Y | 1 |
Ding, Y; Hammad, TA; Iyasu, S; Kaplan, S; Moeny, D; Mosholder, A; Wu, Y; Zhou, EH | 1 |
Fuchimoto, Y; Ikeda, G; Kanehiro, A; Kataoka, M; Koga, H; Kurimoto, E; Miyahara, N; Taniguchi, A; Tanimoto, M; Tanimoto, Y; Waseda, K | 1 |
Aydogan, M; Aydogmus, CY; Bulan, K; Siraneci, R | 1 |
Gulcan Oksuz, B; Igde, M; Islek, I; Kocyigit, A; Uzun, F; Yarar, F | 1 |
García, L; Leimgruber, C; Maldonado, CA; Quintar, AA; Roth, FD; Torres, AI; Uribe Echevarría, EM | 1 |
Devereux, GS; Miller, D; Scaife, A; Spiteri-Cornish, D; Turner, SW; Walsh, GM | 1 |
Bacharier, LB; Covar, R; Guilbert, TW; Lemanske, RF; Malka, J; Mauger, DT; Morgan, WJ; Rabinovitch, N; Reisdorph, N; Szefler, SJ; Zeiger, RS | 1 |
Ben Salah, R; Chauhan, BF; Ducharme, FM | 1 |
Battaglia, S; Bellia, V; Benfante, A; Scichilone, N | 1 |
Jeon, WY; Lee, MY; Shin, HK; Shin, IS | 1 |
Chang, TS; Fitzpatrick, AM; Gangnon, RE; Jackson, DJ; Lemanske, RF; Mauger, DT; Page, CD; Sorkness, CA; Szefler, SJ | 1 |
Baker, JW; Carlsson, LG; Szefler, SJ; Uryniak, T | 1 |
Albertson, TE; Chan, AL; Gidwani, N; Juarez, MM | 1 |
Ibarra-Barrueta, O; Mayo-Suarez, J; Mora-Atorrasagasti, O; Palacios-Zabalza, I | 1 |
Kohno, S; Matsuse, H | 1 |
Chang, C; Wade, A | 1 |
An, JY; Gao, Y; Guan, WJ; Guo, E; Jiang, CY; Liu, QX; Liu, WT; Shi, X; Xie, YQ; Yu, XX; Zheng, JP; Zhong, NS; Zhu, Z | 1 |
Brand, PL; Bush, A; Caudri, D; Eber, E; Gaillard, EA; Garcia-Marcos, L; Hedlin, G; Henderson, J; Kuehni, CE; Merkus, PJ; Pedersen, S; Valiulis, A; Wennergren, G | 1 |
Dave, J; Gohil, J; Khapekar, S; Shah, MB | 1 |
Dozor, AJ; Gill, R; Krishnan, S | 1 |
Ilango, K; Nageswari, AD; Rajanandh, MG | 2 |
Endo, T; Hizawa, N; Iijima, H; Ito, YM; Kaneko, N; Kokubu, F; Konno, S; Makita, H; Ninomiya, H; Nishimura, M; Saito, T; Sakamoto, T; Shimizu, K | 1 |
Guo, YS; Li, J; Ma, C; Zai, J; Zhang, J; Zou, YX | 1 |
Covar, R; Lemanske, RF; Malka, J; Mauger, DT; Morgan, WJ; Rabinovitch, N; Spahn, JD; Strunk, RC; Szefler, SJ; Zeiger, RS | 1 |
Chelakkot-Govindalayathila, AL; D'Alessandro-Gabazza, CN; Fujisawa, T; Gabazza, EC; Harada, E; Hosoki, K; Kainuma, K; Nagao, M; Roeen, Z; Toda, M | 1 |
Farmer, K; Harrison, D; Keast, SL; Nesser, N; Smith, M; Thompson, D | 1 |
Patil-Gadhe, A; Pokharkar, V | 1 |
Ahsan, F; Gupta, N; Patel, B | 1 |
Anderson, R; Feldman, C; Gravett, CM; Steel, HC; Theron, AJ; Tintinger, GR | 1 |
Barchuk, W; Barnathan, ES; Bertelsen, K; Fourie, A; Fuhr, R; Jiang, JZ; Lambert, J; Liu, X; Silkoff, PE; Thurmond, R | 1 |
Hon, KL; Leung, AK; Leung, TF | 1 |
Bacharier, LB; Bernstein, D; Blessing-Moore, J; Dinakar, C; Kercsmar, CM; Khan, D; Lang, D; Li, J; Nicklas, R; Oppenheimer, J; Portnoy, J; Randolph, C; Schuller, D; Spector, S; Tilles, SA; Wallace, D | 1 |
Calapai, F; Calapai, G; Casciaro, M; Gangemi, S; Miroddi, M; Navarra, M | 1 |
Brugha, R; Dickson, I; Eldridge, S; Griffiths, CJ; Grigg, J; Holloway, JW; Koh, L; Nwokoro, C; Pandya, H; Price, D; Rutterford, C; Sanak, M; Turner, S; Vulliamy, T | 1 |
Becker, AB; Paré, PD | 1 |
Vora, AC | 1 |
Bush, A | 1 |
Anna, J; Jerzynska, J; Majak, P; Ożarek-Hanc, A; Smejda, K; Stelmach, I; Stelmach, W; Zaczeniuk, M | 1 |
Ali, MM; Cleves, MA; Martin, BC; O'Brien, CE | 1 |
Aono, Y; Azuma, M; Fujikawa, T; Goto, H; Hanibuchi, M; Itai, A; Nishioka, Y; Ogawa, H; Tezuka, T; Uehara, H; Yamaguchi, Y | 1 |
Amrani, Y; Brightling, C; Chachi, L; Gavrila, A; Tliba, O | 1 |
Belhassen, M; Brouard, J; Chanut-Vogel, C; de Blic, J; de Pouvourville, G; Fauroux, B; Laforest, L; Laigle, V; Lamezec, L; Van Ganse, E | 1 |
Binková, I; Doubková, M; Foret, F; Greguš, M; Kindlová, D; Kubáň, P; Merta, Z; Plutinský, M; Pokojová, E; Skřičková, J | 1 |
Liang, M; Xu, G; Xu, R | 1 |
Dahlin, A; Irvin, CG; Kubo, M; Lima, JJ; Litonjua, A; Peters, SP; Tamari, M; Tantisira, KG | 2 |
Chevalier, N; Gibson, PG; Macia, L; Mackay, CR; Mariño, E; Mason, LJ; Mattes, J; McConville, MJ; McKenzie, CI; Moore, RJ; Murphy, VE; Robert, R; Roberts, LK; Shen, S; Shim, R; Stanley, D; Tan, JK; Thorburn, AN; Tull, DL; Wong, CH; Wong, L; Wood, LG | 1 |
Balfour-Lynn, IM; Turnbull, A | 1 |
Cakir, E; Dilek, F; Gedik, AH; Kesgin, S; Kocyigit, A; Ozkaya, E; Yazici, M | 1 |
Aubier, M; Bateman, ED; Bousquet, J; Bredenbröker, D; O'Byrne, PM | 1 |
Akkerman-Nijland, AM; Diamant, Z; Driessen, JM; Kersten, ET; Thio, BJ | 1 |
Chapman, SC; Heller, MK; Horne, R | 1 |
Dilek, F; Dundaroz, MR; Guler, EM; Kocyigit, A; Ozkaya, E; Yazici, M | 1 |
Gelves, CR; Holmes, TW; Johnson, CM; Kountakis, SE; Yelverton, JC | 1 |
Antoniazzi, S; Carnovale, C; Clementi, E; Gentili, M; Radice, S | 1 |
Bateman, ED; Goehring, UM; Richard, F; Watz, H | 1 |
Borodin, EA; Kolosov, AV; Kolosov, VP; Mal'tseva, TA; Perel'Man, YM; Pirogov, AB; Prikhod'ko, AG; Semenova, GV | 1 |
Everard, ML; Giezek, H; Hartert, TV; Knorr, B; Lu, S; Mehta, A; Nelsen, L; Patel, H; Reiss, TF | 1 |
Can, D; Erdem, SB; Karaman, S; Nacaroglu, HT; Unsal Karkıner, CS; Yazıcı, S | 1 |
Ciółkowski, J; Hydzik, P; Mazurek, H; Stasiowska, B | 1 |
Alavidze, N; Ekaladze, E; Gamkrelidze, S; Pkhakadze, I | 1 |
Du, H; Shi, Y; Sun, W; Wang, Y; Yu, J; Zhang, Y | 1 |
Hattab, S; Jaradat, N; Kittana, N; Zaid, AN; Ziyadeh-Isleem, A | 1 |
Bjermer, L; Kuna, P; Tornling, G | 1 |
Azzali, A; Boner, A; Chinellato, I; Peroni, D; Piacentini, G; Piazza, M; Sandri, M; Tenero, L | 1 |
Petigara, T; Rasouliyan, L; Tobe, K; Tunceli, K; Whalley, D | 1 |
Bates, JH; Dixon, AE; Irvin, CG; Kaminsky, DA; Peters, S; Shade, DM; Thamrin, C; Wang, LL; Wise, RA | 1 |
Li, DS; Liu, JJ; Wei, Y; Zhang, J; Zhao, HE | 1 |
Chen, J; Li, L; Li, M; Lou, CY; Zhang, JB | 1 |
Endo, T; Hizawa, N; Iijima, H; Inui, T; Kanazawa, J; Kaneko, N; Kokubu, F; Konno, S; Makita, H; Masuko, H; Ninomiya, H; Nishimura, M; Saito, T; Sakamoto, T; Shimizu, K; Yamada, H; Yatagai, Y | 1 |
Chan, CH; Chan, EY; Chan, JY; Chan, KY; Chan, PH; Chow, PY; Leung, SY; Li, H; Liu, PL; Ng, DK; Ng, JP; To, CY; Zhang, X | 1 |
Ahsan, F; Patel, B; Rashid, J | 1 |
Bian, FF; Diao, M; Gong, L; Guo, F; Liu, R; Min, J; Xu, L; Zhang, CL | 1 |
Ahsan, F; Gupta, N; Patel, B; Rashid, J | 1 |
Latorre, M; Milanese, M; Novelli, F; Olivieri, C; Paggiaro, P; Perrella, A; Scalese, M; Scichilone, N; Sposato, B | 1 |
Baraldi, E; Boner, A; de Benedictis, FM | 1 |
Amirav, I | 1 |
Dass, SB; Wahn, U | 1 |
de Vries, TW; Duiverman, EJ; Kooi, EM; Marike Boezen, H; Schokker, S; Vaessen-Verberne, AA; van der Molen, T | 1 |
Harik-Khan, R; Holbrook, JT | 1 |
Anderton, S; Chan, R; Cuevas, F; Guerra, F; Gutierrez, JP; Maspero, J; Mechali, D; Pedersen, S; Soto-Ramos, M | 1 |
Chapman, KR; Fritscher, LG; Rodrigues, MT; Zamel, N | 1 |
Dorinsky, P; Koenig, SM; Ostrom, N; Pearlman, D; Prillaman, BA; Waitkus-Edwards, K; Yancey, S | 1 |
Bacharier, LB; Chinchilli, VM; Covar, R; Guilbert, T; Krawiec, M; Larsen, G; Lemanske, RF; Martinez, FD; Mauger, DT; Morgan, WJ; Paul, IM; Phillips, BR; Sorkness, CA; Strunk, RC; Szefler, SJ; Taussig, LM; Zeiger, RS | 1 |
Currie, GP; Kerr, KM; McKinlay, L | 1 |
Bacharier, LB; Boehmer, SJ; Chinchilli, VM; Guilbert, TW; Heldt, GP; Larsen, GL; Lemanske, RF; Martinez, F; Mauger, DT; Morgan, W; Radford, S; Sorkness, CA; Strunk, RC; Szefler, SJ; Taussig, LM; Zeiger, RS | 1 |
Geng, YM; Liu, CT; Wang, K; Wu, YH | 1 |
Chen, AH; Sun, LH; Zhang, Y | 1 |
Bisgaard, H; Knorr, B; Swern, AS; Tozzi, CA | 1 |
Bacharier, LB; Boehmer, SJ; Knuffman, JE; Lemanske, RF; Martinez, FD; Mauger, DT; Sorkness, CA; Strunk, RC; Szefler, SJ; Taussig, LM; Zeiger, RS | 1 |
Cevirme, L; Eskitütüncü, B; Hatipoğlu, ON; Kurtar, N; Ozdemir, L; Ozlen, B; Soy, M | 1 |
Chan, Y; Hsu, CH; Hu, CM; Ku, MS; Lue, KH; Sheu, JN; Sun, HL | 1 |
Akamatsu, K; Hirano, T; Ichikawa, T; Ichinose, M; Koarai, A; Matsunaga, K; Minakata, Y; Sugiura, H; Yanagisawa, S | 1 |
Boulet, LP; Cockcroft, DW; Davis, BE; Deschesnes, F; Gauvreau, GM; Illamperuma, C; O'Byrne, PM; Watson, RM | 1 |
Dramaix, M; Herbots, E; Korn, D; Peché, R; Potvin, E; Van den Brande, P | 1 |
Klanderman, B; Lima, J; Sylvia, J; Tantisira, KG; Weiss, ST | 1 |
He, XY; Hu, Y; Jin, YJ; Qian, XB; Song, ZY; Wang, XY | 1 |
Barnes, NC; Gizycki, M; Jeffery, PK; Ramsay, CF; Reiss, TF; Sullivan, P; Swern, AS; Wang, D | 1 |
Gerard, A; Harkisoon, S | 1 |
Blinder, MA; DeBaun, MR; Field, JJ; Knight-Perry, JE; Strunk, RC; Townsend, RR | 1 |
Borderias, L; Dal Negro, RW; Fan, T; Guilera, M; Sazonov, V; Taylor, SD; Zhang, Q | 1 |
Andea, AA; Black, JG; Bonner, JR; Boulware, D | 1 |
Bisgaard, H; Boza, ML; Knorr, B; Newcomb, K; Noonan, G; Reiss, TF; Skoner, D; Tozzi, CA | 1 |
Dzubak, P; Hajduch, M; Kopriva, F; Potesil, J | 1 |
Giezek, H; Papadopoulos, NG; Philip, G; Polos, PG; Smugar, SS; Watkins, M | 1 |
Abraham, WM; Arimura, A; Deguchi, M; Hirano, Y; Shichijo, M; Suzuki, N; Yasui, K | 1 |
Dass, SB; Liu, N; Lu, S; Reiss, TF | 1 |
Bousquet, J; Demoly, P; Humbert, M | 1 |
Guan, JT; Ma, JY; Su, Y; Wang, L; Yang, HS; Yang, W | 1 |
Bloomberg, GR; Brown, M; Busse, WW; Calatroni, A; Chmiel, JF; David, G; Gergen, PJ; Gruchalla, RS; Kumar, R; Lamm, C; Liu, AH; Matsui, E; Sampson, HA; Smartt, E; Sorkness, CA; Steinbach, SF; Stone, KD; Szefler, SJ | 1 |
Bartlett, SJ; Brown, ED; Castro, M; Cohen, R; Holbrook, JT; Irvin, CG; Rand, CS; Sockrider, MM; Sugar, EA; Wise, RA | 1 |
Coates, A; Dick, PT; Schuh, S; Stephens, D; Willan, AR | 1 |
Kaliterna, DM; Perković, D; Radić, M | 1 |
He, S; Zhu, ML | 1 |
Ikeda, Y; Imbe, S; Iwanaga, T; Muraki, M; Sato, R; Tohda, Y; Yamagata, S | 1 |
Avgil, M; Berkovich, M; De Santis, M; Diav-Citrin, O; Einarson, A; Kalra, S; Koren, G; Lavigne, SV; Sarkar, M; Smorlesi, C; Ying, A | 1 |
Busse, WW; Lemanske, RF | 1 |
Leuppi, JD; Price, DB; Spertini, F; Steurer-Stey, C; Taegtmeyer, AB; Wildhaber, JH | 1 |
Abdullah, VJ; Au, CT; Chan, IH; Chan, MH; Lam, CW; Lam, HS; Leung, AW; Li, AM; Ng, PC; So, HK; Tsen, CS | 1 |
Gulmann, C; Ho, WL; Jennings, L; Murphy, GM | 1 |
Dass, SB; Lai, E; Liu, N; Loeys, T; Philip, G; Reiss, TF; van Adelsberg, J; Wong, P | 1 |
Ezekowitz, A; Hustad, C; Knorr, B; Malice, MP; Noonan, G; Philip, G; Reiss, TF | 1 |
Kelsay, K | 1 |
Ezekowitz, A; Hustad, CM; Knorr, B; Malice, MP; Noonan, G; Philip, G; Reiss, TF | 1 |
Bloomberg, GR | 1 |
Drotar, D; Kercsmar, C; McNally, KA; Redline, S; Riekert, KA; Rohan, J; Schluchter, M; Schmidt, A; Vavrek, P | 1 |
Castro-Rodriguez, JA; Rodrigo, GJ | 1 |
Arakawa, M; Hasegawa, T; Hayashi, M; Kagamu, H; Kawakami, H; Koya, T; Narita, I; Suzuki, E; Tanaka, J | 1 |
Christmann, M; Dogan-Yildiz, G; Kloska, M; Lieb, A; Rose, MA; Rosewich, M; Schubert, R; Schulze, J; Zielen, S | 1 |
Ljungblad, L; Mehta, A; Mitfessel, H; Virchow, JC | 2 |
Alawi, F; Ciarrocca, KN; DeRossi, SS | 1 |
Aigner, K; Forche, G; Kneussl, M; Pfeiffer, KP; Pohl, W; Schlick, W; Zwick, H | 1 |
Emuzyte, R; Firantiene, R; Petraityte, R; Sasnauskas, K | 1 |
Andersson, K; Makeeva, N; Roomans, GM; Servetnyk, Z; Shebani, EB | 1 |
Boulet, LP; Busse, WW; Camargo, CA; Emmett, AH; Ferro, TJ; Ortega, HG; Sutherland, ER; Yancey, SW | 1 |
Anlar, FY; Igde, M | 1 |
Camarasa, A; Chiner, E; Llombart, M; Sancho-Chust, JN | 1 |
Diamant, Z; Ulrik, CS | 1 |
Kusama, K; Nonaka, M; Ogihara, N; Sakanushi, A; Yagi, T | 1 |
Camargo, CA; Chapela, R; Dass, SB; Fabbri, LM; Green, SA; Gurner, DM; Knorr, BA; Legrand, C; Malice, MP; Reiss, TF; Smithline, HA | 1 |
Droszcz, W | 1 |
Drazen, JM; von Mutius, E | 1 |
Bacharier, LB; Boehmer, SJ; Covar, RA; Guilbert, TW; Jackson, DJ; Larsen, G; Lemanske, RF; Martinez, FD; Mauger, DT; Morgan, WJ; Moss, MH; Sorkness, CA; Spahn, JD; Strunk, RC; Szefler, SJ; Taussig, LM; Zeiger, RS | 1 |
Bobrowska-Korzeniowska, M; Brzozowska, A; Jerzynska, J; Majak, P; Olszowiec-Chlebna, M; Stelmach, I | 1 |
Chen, CC; Dai, ZK; Tsai, CW; Tsai, TC; Wu, JR; Wu, WF; Yang, CY | 1 |
Fujimura, M; Ishiura, Y; Kita, T; Myou, S; Nakao, S; Nakatsumi, Y; Nomura, S; Ogawa, H | 1 |
Becker, AB; Green, SA; Gurner, DM; Massaad, R; Morris, CR; Piñieiro, A; Smugar, SS | 1 |
Bratke, K; Grosse-Thie, C; Julius, P; Kuepper, M; Virchow, JC | 1 |
Agnieszka, B; Bobrowska-Korzeniowska, M; Błauz, A; Kuna, P; Majak, P; Pułaski, L; Rychlik, B; Stelmach, I | 1 |
Berra, D; Canonica, GW; Chiodini, E; Colombo, F; Marogna, M; Massolo, A; Passalacqua, G; Spadolini, I; Zanon, P | 1 |
Contrafatto, MR; Crimi, C; Crimi, N; Mastruzzo, C; Palermo, F; Vancheri, C | 1 |
Kabra, SK; Lodha, R; Todi, VK | 1 |
Anderson, SD; Brannan, JD; Caillaud, C; Perry, CP; Seale, JP | 1 |
Bianchi, M; Bonati, M; Clavenna, A | 1 |
Aristizabal, G; Fogel, RB; Gaile, S; Loeys, T; Noonan, G; Polos, PG; Rosario, N; Smugar, SS | 1 |
Kanda, T; Nishihara, H; Nogaki, F; Ono, T; Tanio, H; Wu, C | 1 |
Edelman, JM; Gern, JE; Grant, EN; Jia, G; Johnston, NW; Jones, CA; Sears, MR; Smugar, SS; Watkins, MW; Weiss, KB | 1 |
Bleecker, ER; Davis, WB; Djukanović, R; Doherty, DE; Dorinsky, PM; Edwards, LD; Israel, E; Jarjour, NN; Kavuru, MS; Kleerup, E; Koenig, SM; Laviolette, M; Moore, WC; Olivenstein, R; Reilly, DS; Stauffer, JL; Wilson, SJ; Yancey, SW | 1 |
Câmara, NO; Hiyane, MI; Landgraf, MA; Landgraf, RG; Pacheco-Silva, A; Silva, RC | 1 |
Bacharier, LB; Chinchilli, VM; Graber, NJ; Martinez, FD; Rabinovitch, N; Sorkness, CA; Strunk, RC; Szefler, SJ; Zeiger, RS | 1 |
Einarson, A; Koren, G; Sarkar, M | 1 |
Vaughn, MP | 1 |
Kuz'mina, LP; Petrykina, MV; Sorkina, NS | 1 |
Korenblat, PE; Pedinoff, A; Philip, G; Reiss, TF; Smugar, SS; Tymofyeyev, Y; Vandormael, K | 1 |
Mildenhall, S; Pearson, D; Ramsay, CF; Wilson, AM | 1 |
Lang, JE; Lima, JJ; Mougey, EB; Wen, X | 1 |
Capsomidis, A; Tighe, M | 1 |
Anselmo, M | 1 |
Bunga, S; Israel, E; Kazani, S; Sadeh, J; Wechsler, ME | 1 |
Anderson, R; Feldman, C; Theron, AJ; Tintinger, GR | 1 |
Hollenbeak, CS; Lemanske, RF; Martinez, FD; Mauger, DT; Paul, IM; Sorkness, CA; Strunk, RC; Szefler, SJ; Taussig, LM; Wang, L; Zeiger, RS | 1 |
Grzelewski, T; Jerzynska, J; Majak, P; Olszowiec-Chlebna, M; Stelmach, I; Stelmach, W | 1 |
Jolobe, OM | 1 |
Rosenberg, JL | 1 |
Choi, WA; Hong, SJ; Kang, MJ; Kim, BJ; Kwon, JW; Shin, YJ; Yu, J | 1 |
Budelsky, AL; Chen, JJ | 1 |
Amlani, S; McIvor, RA | 1 |
Bork, JA; DeMore, JP; Evans, MD; Gaworski, KL; Gern, JE; Kloepfer, KM; Swenson, CA; Vrtis, RF | 1 |
Ewert, R; Felix, SB; Gläser, S; Gustavus, B; Koch, B; Kunkel, G; Noga, O; Schäper, C | 1 |
Gonda, H; Hasegawa, Y; Hiramatsu, T; Iwata, M; Iwata, S; Kishi, R; Kondo, M; Kotani, H; Kume, H; Mouri, A; Nishiyama, O; Niwa, T; Noda, Y; Sashio, T; Shindo, J; Shiraki, A; Suzuki, R; Taniguchi, H | 1 |
Lenney, W; Perry, S; Price, D | 1 |
Coulet, A; Devignes, MD; Napoli, A; Smaïl-Tabbone, M | 1 |
Philip, G; Reiss, TF; Shah, SR; Smugar, SS; Vandormael, K; Villarán, C | 1 |
Boza, ML; Gurner, DM; Knorr, BA; Nelsen, LM; Philip, G; Reiss, TF; Robertson, CF; Smugar, SS; Valovirta, E; Verbruggen, N | 1 |
Imbe, S; Iwanaga, T; Muraki, M; Sano, H; Santo, H; Sato, R; Tohda, Y | 1 |
Cai, C; Chen, CS; Li, YP; Zhou, MX | 1 |
Blanc, FX | 1 |
Bellecoste, V; Devouassoux, G; Pacheco, Y | 1 |
Amlani, S; McIvor, RA; Nadarajah, T | 1 |
Aoki, A; Maldonado, CA; Uribe Echevarría, AM; Uribe Echevarría, EM | 1 |
Chirdjirapong, V; Jirapongsananuruk, O; Komoltri, C; Pajarn, P; Santadilog, S; Vichyanon, P; Visitsunthorn, N | 1 |
Kroegel, C | 1 |
Bamshad, MJ; Cunningham, ML; Eng, PM; Gould, AL; Nelsen, LM; Philip, G; Shields, KE; Smugar, SS; Stoler, JM | 1 |
Anar, C; Halilçolar, H; Ozanturk, ME; Ünsal, I; Yucel, N | 1 |
Castro, M; Drummond, MB; Holbrook, JT; Irvin, CG; Peters, SP; Smith, LJ; Sugar, EA; Wise, RA | 1 |
Allen-Ramey, FC; Blais, L; Ducharme, FM; Gingras, J; Maiese, EM; Noya, FJ | 1 |
Chin, K; Jinnai, M; Matsumoto, H; Matsuoka, H; Mishima, M; Niimi, A; Takemura, M; Ueda, T; Yamaguchi, M | 1 |
Stiefelhagen, P | 1 |
Dong, WF; Hong, JG; Zhou, XJ | 1 |
Cheng, LH; Chu, YH; Kao, CH; Wang, CH; Wang, HW; Wang, JY | 1 |
Pettipher, R; Whittaker, M | 1 |
Bäck, M; Ingelsson, E; Yin, L | 1 |
Chang, LS; Chung, YH; Kao, SL; Kuo, HC; Liang, CD; Tsui, KY; Wu, CC; Yang, KD; Yu, HR | 1 |
Greenberg, S; Kaur, A; Knorr, BA; Lakshminarayanan, M; Liu, N; Nelsen, LM; Noonan, G; Reiss, TF; Smugar, SS; Zhou, Y | 1 |
Abdel Aziz, RR; Gameil, NM; Helaly, NY; Zalata, KR | 1 |
Blake, KV; Chen, C; Lima, JJ; Mougey, EB; Peters, SP; Tantisira, KG; Weiss, ST; Wise, RA | 1 |
Daubeuf, F; De Bosscher, K; De Cauwer, L; Frossard, N; Gerlo, S; Haegeman, G; Lambrecht, BN; Plantinga, M; Reber, LL; Tavernier, J; Van Calenbergh, S; Waelput, W | 1 |
Furukawa, T; Gelfand, EW; Hasegawa, T; Kagamu, H; Kawakami, H; Kimura, Y; Koya, T; Matsumoto, K; Nakayama, M; Narita, I; Sakagami, T; Sakai, Y; Suzuki, E; Yamabayashi, C | 1 |
Balantic, M; Korosec, P; Kosnik, M; Rijavec, M; Silar, M; Skerbinjek Kavalar, M; Suskovic, S | 1 |
Bozek, A; Filipowska-Gronska, A; Jarzab, J; Warkocka-Szoltysek, B | 1 |
Bakır, K; Bayram, N; Dikensoy, Ö; Elbek, O; Kibar, Y; Uyar, M | 1 |
Admyre, C; Eklund, A; Esser, J; Gabrielsson, S; Grönneberg, R; Grunewald, J; Lukic, A; Nord, M; Rådmark, O; Rahman, QK; Scheynius, A; Torregrosa Paredes, P | 1 |
De Stefano, S; Di Giorgio, A; Maglione, M; Manna, A; Montella, S; Santamaria, F | 1 |
Adachi, M; Hisada, S; Ishine, T; Sano, Y; Smugar, SS; Taniguchi, H; Tohda, Y | 1 |
Adamko, DJ; Ilarraza, R; Wu, Y | 1 |
Alonso-Lebrero, E; Callero-Viera, A; Fuentes-Aparicio, V; Infante, S; Zapatero, L | 1 |
Basu, K; Donald, HP; Lipworth, BJ; Macgregor, DF; Mukhopadhyay, S; Ogston, SA; Palmer, CN; Tavendale, R | 1 |
Assendelft, WJ; Bakker, MJ; Kaptein, AA; Snoeck-Stroband, JB; Sont, JK; Taube, C; Thoonen, BP; van Bodegom-Vos, L; van der Meer, V; van Gaalen, JL | 1 |
Ahmed, S; Atia, NN | 1 |
James, M; Lenney, W; McKay, AJ; Price, D; Tudur Smith, C; Williamson, PR | 1 |
Bjermer, L; Lu, S; Mehta, A; Petrovic, R; Philip, G; Polos, PG; Popov, TA; Price, D; Strus, JD; Vandormael, K | 1 |
Blake, K; Cury, JD; Hossain, J; Lima, J; Mougey, E; Tantisira, K; Wang, J | 1 |
Boner, AL; De Gasperi, W; Loiacono, A; Micciolo, R; Peroni, DG; Piacentini, GL; Pietrobelli, A; Sabbion, A | 1 |
Droste, G; Köhler, D; Lauter, H; Riffelmann, FW | 1 |
Fujimura, M; Igarashi, T; Nakajima, S; Takagi, K; Takahashi, K; Taniguchi, H; Tohda, Y; Yasuhara, H | 1 |
Gal, AA; Morris, RJ; Pine, JR; Spraker, MK | 1 |
Baraldi, E; Ghiro, L; Pasquale, MF; Piovan, V; Rampon, O; Zanconato, S | 1 |
Becler, K; Håkansson, L; Rak, S | 1 |
Fee, WH | 1 |
Borker, R; Dorinsky, P; Emmett, A; Rickard, K; Sheth, K | 1 |
Inman, MD; Leigh, R; O'Byrne, PM; Rerecich, T; Vethanayagam, D; Watson, RM; Yoshida, M | 1 |
Eschenhagen, T; Mühlhäuser, U; Münzel, F | 1 |
Böhme, S; Jörres, RA; Kanniess, F; Magnussen, H; Richter, K | 1 |
Janicki, S; Jörres, RA; Kanniess, F; Magnussen, H; Richter, K; Schleiss, MB | 1 |
Camargo, CA; Green, SA; Malice, MP; Reiss, TF; Smithline, HA | 1 |
Bates, CE; Currie, GP; Haggart, K; Lee, DK; Lipworth, BJ | 1 |
Korenblat, PE; Strunk, RC | 1 |
Bird, SR; Chervinsky, PS; Edelman, JM; Friedman, B; Ghannam, AF; Israel, E; Skalky, CS; Van Bavel, J | 1 |
Akveld, M; Burke, CM; O'Sullivan, S; Poulter, LW | 1 |
Bailey, B; Carrière, B; Chabot, G; Lebel, D | 1 |
Berger, ML; Edelman, JM; Markson, LE; Narayanan, S | 1 |
Kulus, M | 1 |
Graff, GR; Smith, AL; Weber, A; Wessler-Starman, D | 1 |
Bazan-Socha, S; Bestynska-Krypel, A; Cmiel, A; Mastalerz, L; Mejza, F; Nizankowska, E; Pierzchalska, M; Sanak, M; Szczeklik, A | 1 |
Lachman, A; Malonne, H; Van den Brande, P | 1 |
Angner, R; Baumgartner, RA; Bernstein, M; Bird, S; Dass, SB; Edelman, JM; Lu, S; Martinez, G; Polis, A; Reiss, TF; Rodriguez Gomez, GG | 1 |
FitzGerald, JM | 1 |
Melo, RE; Naspitz, CK; Solé, D | 1 |
Bates, CE; Currie, GP; Lee, DK; Lipworth, BJ | 1 |
Casan, P; Castillo, J; Gonzalez-Esteban, J; Perpiña, M; Picado, C; Sanchis, J; Sobradillo, V; Valencia, A; Vaquerizo, MJ; Verea, H; Viejo, JL; Villasante, C | 1 |
Beeh, KM; Fiterman, J; Gilles, L; Hernandez, D; James, IG; Konstantopoulos, S; Leff, JA; Magyar, P; Pons, M; Price, DB; Rojas, R; van Noord, JA | 1 |
Chan, AW; Chik, SC; Li, W; Li, Z; Tsang, KW; Wu, AY | 1 |
Crouch, MA; Stiegler, KA; Yunker, NS | 1 |
Akveld, M; Bateman, ED; Eliraz, A; Mulder, PG; Pruzinec, R; Ringdal, N; Weber, HH | 1 |
Valacer, DJ | 1 |
D'Orazio, N; Guagnano, MT; Riccioni, G; Sensi, S; Vecchia, RD | 1 |
Arduino, JM; Bisgaard, H; Knorr, BA; Meyer, KA; Santanello, NC | 1 |
Caduff, P; Iselin, HU; Meier, D; Reichen, J; Russmann, S; Simon, HU; Zimmermann, A | 1 |
Cýllý, A; Gülkesen, KH; Kara, A; Oğüş, C; Ozdemir, T | 1 |
Brandis, M; Ihorst, G; Kuehr, J; Moske, O; Storm Van's Gravesande, K; Strauch, E; Thoma, S | 1 |
Baena-Cagnani, CE; Berger, WE; Danzig, M; DuBuske, LM; Gurné, SE; Lorber, R; Stryszak, P | 1 |
Bonini, S; Bruscolini, A; Coassin, M; Lambiase, A; Rasi, G | 1 |
Beck, R; Bentur, L; Gavriely, N; Naveh, T; Shinawi, M | 1 |
Stempel, DA | 3 |
Bernstein, A; Bukstein, DA; Luskin, AT | 1 |
Anderson, SD; Brannan, JD; Currie, GP; Fowler, SJ; Haggart, K; Lee, DK; Lipworth, BJ; Wilson, AM | 1 |
Tang, MB; Yosipovitch, G | 1 |
Cowan, LM; Currie, GP; Dempsey, OJ; Fowler, SJ; Lee, DK; Lipworth, BJ | 1 |
Jackson, CM; Lipworth, BJ; Sims, EJ | 1 |
Bacci, E; Dente, FL; Di Franco, A; Giannini, D; Paggiaro, PL; Taccola, M; Tonelli, M; Vagaggini, B; Zingoni, M | 1 |
Arvin-Berod, C; Paganin, F; Poubeau, P; Yvin, JL | 1 |
Cronin, B; Downes, SJ; Eller, TJ; Greene, C; Irani, AM; Phipatanakul, W; Schneider, LC | 1 |
Büyüköztürk, S; Cevikbaş, A; Gürbüz, B; Gürer, US; Palandüz, S | 1 |
Michael, AB; Murphy, D | 1 |
Allen-Ramey, FC; Duong, PT; Goodman, DC; Markson, L; Nelsen, LM; Sajjan, SG | 1 |
Keogh, KA; Specks, U | 1 |
GROSS, A | 1 |
PRICKMAN, LE; WAKAI, CS | 1 |
GREENE, CT; NELSON, TL; STROUP, G | 1 |
KERR, JW | 1 |
KUMKOVA, EP | 1 |
Stone, KD | 1 |
Braunstein, GL | 1 |
Blake, K; Duckworth, LJ; Kissoon, N; Lima, JJ; Sylvester, JE; Wang, J; Whelan, GJ | 1 |
Jung, A | 1 |
Bird, SR; Bratton, DL; Bukstein, DA; Edelman, JM; Estojak, J; Firriolo, KM; Hustad, CM | 1 |
Bisgaard, H; Buchvald, F | 1 |
Chapman, KR; Ferreira, IM; Gutierrez, C; Jardim, JR; Sandrini, A; Zamel, N | 1 |
Bibi, H; Eliraz, A; Madar, Z; Offer, S; Shoseyov, D | 1 |
Bisgaard, H; Bjermer, L; Bousquet, J; Dass, SB; Fabbri, LM; Greening, AP; Haahtela, T; Holgate, ST; Leff, JA; Menten, J; Picado, C; Polos, PG | 1 |
Liu, CT; Luo, FM; Wang, ZL; Xian, LW | 1 |
Avital, A; Bardach, E; Berkman, N; Breuer, R; Godfrey, S; Springer, C | 1 |
Chernichovski, T; Fireman, E; Iaina, A; Kivity, S; Sade, K; Schwartz, D; Schwartz, I; Wolman, Y | 1 |
Eren, A; Sipit, T; Taci, N; Yurdakul, AS | 1 |
Jalba, MS | 1 |
Nathan, R | 1 |
Humbert, M | 1 |
Magnan, A | 1 |
Lipworth, B | 1 |
Cerruti, JL; Delannay, B; Desfougères, JL; Grosclaude, M; Hérent, M; Spilthooren, F | 1 |
Rodrigo, C; Rodrigo, GJ | 1 |
Kemp, JP | 2 |
Muijsers, RB; Noble, S | 2 |
Fernandes, FT; Kasahara, DI; Kay, FU; Leick-Maldonado, EA; Leonhardt, MC; Martins, MA; Prado, CM; Tibério, IF | 1 |
Green, SA; Malice, MP; Reiss, TF; Tanaka, W; Tozzi, CA | 1 |
Carranza Rosenzweig, JR; Meyer, J; Stanford, RH; Stempel, DA; Stoloff, SW | 1 |
Dal Negro, RW; Micheletto, C; Pomari, C; Tognella, S; Trevisan, F; Visconti, M | 1 |
Apter, AJ; Szefler, SJ | 1 |
Nayak, A | 1 |
Campos, MA; Hurtado, A; Mendes, ES; Wanner, A | 1 |
Baraldi, E; Bonetto, G; Carraro, S; Pasquale, F; Zanconat, S | 1 |
de Blic, J; Le Bourgeois, M; Pham Thi, TN; Scheinmann, P | 1 |
Blanc, PD; Eisner, MD; Katz, PP; Snyder, L; Yelin, EH | 1 |
Boccagni, C; Colombi, S; Mittino, D; Monaco, F; Naldi, P; Terazzi, E; Tesser, F; Zoppis, E | 1 |
Ciprandi, G; Milanese, M; Ricca, V; Schenone, G; Tosca, MA | 1 |
Anoia, J; Black, M; Goldstein, MF | 1 |
Haggart, K; Jackson, CM; Lee, DK; Lipworth, BJ | 1 |
Barabra, H; Beate, U; Heinz, L; Oberndorfer, S; Peter, H; Sabine, U; Wolfgang, G | 1 |
Deutsch, P; Hartford, A; Kearns, GL; Knorr, B; Migoya, E; Tozzi, CA; van Adelsberg, J; Zhao, J | 1 |
Lei, S; Li, FY; Liu, CT; Mao, H; Wang, ZL; Yin, KS; Zhang, XL | 1 |
Deng, YL; Liu, CT; Mao, H; Wang, ZL; Yin, KS; Yu, YH | 1 |
Abgrall, JF; Arnaud, B; Blouch, MT; Duchemin, J; Lion, F; Nicot, C | 1 |
Bayram, H; Bulbul, Y; Ozlu, T; Yildirim, Z | 1 |
Barnes, N; Pearson, M; Simnett, S; Tate, H; Thomas, M | 1 |
Crown, WH; Kamal, K; Limpa-Amara, S; Orsini, L; Stanford, RH | 1 |
Aberle, N; Ajduk, J; Dekaris, D; Gagro, A; Jelacić, J; Rabatić, S | 1 |
Athavale, A; Avasthi, R; Kale, M; Singh, NP; Sireesha, K; Souza, GA; Taneja, A | 1 |
Bird, SR; Edelman, JM; Friedman, B; Hustad, CM; Ilowite, J; Kerwin, E; Webb, R | 1 |
Lack, G; Levi-Schaffer, F; Puxeddu, I; Smith, SJ | 1 |
Ishii, Y; Kimura, T; Kodama, T; Morishima, Y; Nomura, A; Sakamoto, T; Sekizawa, K | 1 |
Borker, R; Dorinsky, P; Emmett, A; Jhingran, P; Nelson, H; O'Connor, RD; Rickard, K | 1 |
Jerzynska, J; Kuna, P; Majak, P; Stelmach, I; Stelmach, W | 1 |
Haggart, K; Lee, DK; Lipworth, BJ; Robb, FM | 1 |
Baker, JW; Bird, S; Edelman, J; Hustad, C; Kaplan, MS; Pearlman, DS; Schatz, M; Zeiger, RS | 1 |
Bubendorf, L; Conen, D; Hauser, T; Leuppi, J; Ronsdorf, A; Tamm, M | 1 |
Hoogsteden, HC; Leman, K; Mulder, PG; O'Sullivan, S; Overbeek, SE; Prins, JB | 1 |
Bai, JW; Deng, WW; Wu, HC | 1 |
Aggarwal, KK; Ghosh, G; Kukreja, S; Moharana, A; Sanjay, S | 1 |
Mintz, M | 1 |
Shen, HH; Wang, SB; Wei, EQ; Zhang, L; Zhang, YJ | 1 |
Berger, WE; Dass, SB; Leynadier, F; Nayak, AS; Philip, G; Reiss, TF; Vrijens, F | 1 |
Becker, A; Knorr, B; Reiss, T; Swern, A; Tozzi, CA; Yu, Q | 1 |
Abe, M; Hayashi, Y; Katsuragi, T; Murai, A; Sakata, N; Tanaka, K | 1 |
Caiaffa, MF; Haeggström, JZ; Macchia, L; Ramires, R; Tursi, A | 1 |
Spector, SL; Tan, RA | 1 |
Boner, AL; Caramella, D; De Marco, E; Pietrobelli, A; Pifferi, M; Ragazzo, V | 1 |
Green, RJ; Weinberg, EG | 1 |
Fardon, EJ; Fardon, TC; Hodge, MR; Lipworth, BJ | 1 |
Allen-Ramey, FC; Duong, PT; Markson, LE; Riedel, AA; Weiss, KB | 1 |
Bisgaard, H; Garcia-Garcia, ML; Gilles, L; Johnston, SL; Menten, J; Polos, P; Tozzi, CA; Zielen, S | 1 |
Conover-Walker, MK; Corren, J; Dass, SB; Kim, EH; Malice, MP; Massaad, R; Perry, TT; Philip, G; Reiss, TF; Wood, RA | 1 |
Arvidsson, P; Bruce, C; Lötvall, J; Palmqvist, M; Sjöstrand, M | 1 |
Liang, Z; Liu, C; Xian, L | 1 |
Crim, C; Dorinsky, P; Edwards, L; O'Connor, RD; Rickard, KA; Stanford, R; Yancey, SW | 1 |
Hong, SJ; Hong, TJ; Kim, BS; Kim, HB; Kim, JH; Lee, SY; Shim, JY | 1 |
Barnes, N; Price, D; Tate, H; Thomas, M | 1 |
Kósa, L; Novák, Z; Zsigmond, G | 1 |
Bratton, DL; Dasbach, EJ; Davies, GM; Knorr, BA; Santanello, NC | 1 |
Duong, M; Efthimiadis, A; Hargreave, FE; Jayaram, L; Kamada, D; Pizzichini, E; Pizzichini, MM | 1 |
Baraldi, E; Bodini, A; Boner, AL; Loiacono, A; Miraglia Del Giudice, M; Peroni, D; Piacentini, G | 1 |
Keeley, D; McKean, M | 1 |
Bachert, C; Petro, W | 1 |
Cartier, A; Hargreave, FE; Jayaram, L; Lemière, C; Man, SF; Pizzichini, E; Pizzichini, MM | 1 |
Hall, GL; Hamacher, J; Minocchieri, S; Moeller, A; Sennhauser, FH; Straub, DA; Wildhaber, JH | 1 |
Bacharier, LB; Bloomberg, GR; Chinchilli, VM; Guilbert, TW; Heldt, G; Larsen, G; Lemanske, RF; Martinez, FD; Morgan, WJ; Moss, MH; Phillips, BR; Sorkness, CA; Spahn, JD; Strunk, RC; Szefler, SJ; Taussig, LM; Zeiger, RS | 1 |
Wu, YQ; Zhang, HQ; Zhou, CH | 1 |
Hamacher, J; Minocchieri, S; Moeller, A; Straub, DA; Wildhaber, JH | 1 |
Jerzynska, J; Kuna, P; Majak, P; Stelmach, I | 1 |
Balkrishnan, R; Kulkarni, AS; Nelsen, LM; Pleasants, RA; Schechter, MS; Whitmire, JT | 1 |
Bowton, DL; Dmitrienko, AA; Israel, E; Sides, GD; Zeiher, BG | 1 |
Crimi, N; Lisitano, N; Mastruzzo, C; Pagano, C; Palermo, F; Vancheri, C | 1 |
Pieters, WR; Smith, HC; Sondhi, S; Tamminga, JJ; Wilson, KK | 1 |
Bird, SR; Edelman, JM; Hustad, CM; Kaplan, MS; Orav, EJ; Pearlman, DS; Schatz, M; Zeiger, RS | 1 |
Dong, L | 1 |
Bobrowska-Korzeniowska, M; Kuna, P; Majak, P; Stelmach, I; Stelmach, W | 1 |
Hsu, PC; Hua, YM; Hung, CH; Lai, YS; Li, CY; Yang, KD | 1 |
Aitken, ML; Hallstrand, TS; Henderson, WR; Moody, MW; Schwartz, LB; Wurfel, MM | 1 |
Ammori, BJ; Farooq, A | 1 |
Bjermer, L; Bousquet, J; Gaugris, S; Kocevar, VS; Polos, PG; Yin, DD; Zhang, Q | 1 |
Dramaix, M; Dupont, L; Gusman, J; Korn, D; Lachman, A; Peché, R; Potvin, E | 1 |
Knorr, B; Moy, J; Reiss, TF; Tozzi, CA; van Adelsberg, J; Wei, LX | 1 |
Anderson, WJ; Currie, GP; Lee, DK | 1 |
Beduneau, G; Berard, H; Calvet, P; Dominique, S; Nouvet, G; Picard, C | 1 |
Jenkins, CR; Reddel, HK; Thien, FC; Wheatley, JR | 1 |
Berti, I; Longo, G; Visintin, S | 1 |
Lyseng-Williamson, KA; Reynolds, NA; Wiseman, LR | 1 |
Garcia Garcia, ML; Gilles, L; Polos, P; Swern, A; Tozzi, CA; Wahn, U | 1 |
Goodman, DC | 1 |
Crimi, N; Mastruzzo, C; Vancheri, C | 1 |
Castronuovo, M; D'Orazio, N; Di Ilio, C; Riccioni, G; Vecchia, RD | 1 |
Carranza Rosenzweig, JR; Crim, C; Decotiis, BA; Edwards, LD; Hanson, KM; Lincourt, WR; Ostrom, NK | 1 |
Barberà, JA; Casas, A; Dahlén, B; Dahlén, SE; Gómez, FP; Roca, J; Rodríguez-Roisin, R | 1 |
Bukstein, D; Kocevar, VS; Luskin, A; Yin, DD | 1 |
Borker, R; Dorinsky, P; Emmett, A; Jhingran, P; Rickard, K | 1 |
Carranza Rosenzweig, JR; Legorreta, AP; Ryskina, KL; Stanford, RH; Stempel, DA; Stoloff, SW | 1 |
Weinberger, M | 1 |
Sveum, RJ | 1 |
Campos, MG; Fernandez, J; Jankowski, C; Oropeza, M; Ponce, H; Reyes, R; Vancalsteren, MR | 1 |
Cockcroft, DW; Davis, BE; Todd, DC | 1 |
Dorinsky, PM; Nathan, RA; Nelson, HS; Philpot, E; Prillaman, BA; Stauffer, JL; Waitkus-Edwards, K; Yancey, SW | 1 |
Barnes, PJ; Biernacka, HM; Biernacki, WA; Kharitonov, SA | 1 |
Allayee, H; Barnes, K; Grant, A; Holbrook, J; Lima, JJ; Shao, L; Sylvester, J; Tantisira, KG; Wang, J; Weiss, ST; Wise, R; Zhang, S | 1 |
Allen-Ramey, FC; Anstatt, DT; Markson, LE; Sajjan, SG | 1 |
Caballero, L; Mazon, A; Medina, A; Nieto, A; Oliver, F; Pamies, R | 1 |
Chen, CJ; Hung, CH; Lai, YS; Lee, MY; Yang, KD | 1 |
Fireman, E; Kivity, S; Sade, K; Schwartz, Y | 1 |
Bacharier, LB; Bloomberg, GR; Chinchilli, VM; Guilbert, TW; Heldt, G; Larsen, G; Lemanske, RF; Martinez, FD; Morgan, WJ; Moss, MH; Phillips, BR; Schatz, M; Sorkness, CA; Spahn, JD; Strunk, RC; Szefler, SJ; Taussig, LM; Zeiger, RS | 1 |
Chi, EY; Chiang, GK; Henderson, WR; Tien, YT | 1 |
Shah, AR; Shah, KV; Sharples, LD; Solanki, RN | 1 |
Beg-Zec, Z; Jakopović, M; Kukulj, S; Pavicić, F; Popović-Grle, S; Samarzija, M | 1 |
Bird, SR; Busse, WW; Casale, TB; Dykewicz, MS; Edelman, JM; Grant, E; Hustad, CM; Meltzer, EO; Zeldin, RK | 1 |
Balatsouras, DG; Eliopoulos, P; Ferekidis, E; Korres, S; Rallis, E; Sterpi, P | 1 |
Plavec, D; Turkalj, M | 1 |
King, GG; Salome, CM | 1 |
Elashoff, R; Goldin, JG; Kim, HJ; Kleerup, EC; Liu, W; Sayre, JW; Simmons, MD; Tashkin, DP; Truong, DA; Zeidler, MR | 1 |
Brightling, CE; Green, RH; Hall, IP; Hargadon, B; McKenna, S; Neale, N; Parker, D; Pavord, ID; Ruse, C | 1 |
Carter, K; Currie, GP | 1 |
Bird, SS; Edelman, JM; Grant, E; Hustad, CM; Peters-Golden, M; Swern, A | 1 |
Dahlén, SE | 1 |
Gilmore, AS; Jhingran, PM; Legorreta, AP; Manjunath, R; O'Connor, RD; Stanford, RH | 1 |
Barnes, PJ; Bush, A; Kharitonov, SA; Lex, C; Nicholson, AG; Payne, DN; Wilson, NM; Zacharasiewicz, A | 1 |
Ngamphaiboon, J | 1 |
Bachert, C; Virchow, JC | 1 |
Ahn, K; Joung, H; Kim, DY; Kim, JH; Kwon, OK; Lee, HK; Lee, J; Lee, MY; Lee, S; Oh, SR; Park, BY | 1 |
Bulut, Y; Deveci, F; Ilhan, N; Muz, MH; Turgut, T; Yekeler, H | 1 |
Philip, G; Polos, P; Price, DB; Swern, A; Tozzi, CA | 1 |
Covar, RA; Gelfand, EW; Gleason, M; Jain, N; Shimamoto, R; Spahn, JD; Szefler, SJ | 1 |
Bakirtas, A; Degim, T; Harmanci, K; Turktas, I | 1 |
Allen-Ramey, FC; Bukstein, D; Luskin, A; Markson, LE; Sajjan, SG | 1 |
Crownover, BK | 1 |
Curtiss, FR | 1 |
Becker, AB; Dass, SB; Knorr, BA; Kuznetsova, O; Reiss, TF; Soto-Quiros, ME; Vermeulen, J; Young, B | 1 |
Kabra, SK; Lodha, R; Walia, M | 1 |
Currie, GP; Lee, DK; Lipworth, BJ; Menzies, D | 1 |
Allen-Ramey, FC; Markson, LE; Riedel, AA; Sajjan, S; Weiss, KB | 1 |
Barnes, PJ; Ciabattoni, G; Koch, P; Mondino, C; Montuschi, P | 1 |
Fedor, ME; Rubinstein, A | 1 |
Li, S; Tao, J; Wu, Y; Zhou, C | 1 |
Chipps, B | 1 |
Allayee, H; Cohen, RI; Dixon, AE; Holbrook, JT; Irvin, CG; Lima, JJ; Shade, DM; Skloot, GS; Smith, LJ; Wise, RA | 1 |
Gelfand, EW; Rabinovitch, N; Zhang, L | 1 |
Kabra, SK; Lodha, R | 1 |
Boulet, LP; Chakir, J; Gauldie, J; Kelly, MM; Laviolette, M; O'Byrne, PM; Vethanayagam, D | 1 |
Polos, PG | 1 |
Boushey, HA; Chinchilli, VM; Craig, TJ; Deykin, A; DiMango, E; Fahy, JV; Israel, E; Kraft, M; Kunselman, SJ; Lazarus, SC; Lemanske, RF; Leone, F; Martin, RJ; Pesola, GR; Peters, SP; Sorkness, CA; Szefler, SJ; Wechsler, ME | 1 |
Wechsler, ME | 1 |
Akazawa, M; Stempel, DA | 1 |
Mustafa, SJ; Nadeem, A; Obiefuna, PC; Wilson, CN | 1 |
Anderson, WH; Baitinger, LA; Bleecker, ER; Dorinsky, PM; Edwards, LD; Klotsman, M; Yancey, SW | 1 |
Ghosh, G; Manglik, AK; Roy, S | 1 |
Jat, GC; Mathew, JL; Singh, M | 1 |
Bolgos, GL; Kim, J; McKinley, L; Remick, DG; Siddiqui, J | 1 |
Bobrowska-Korzeniowska, M; Grzelewski, T; Kuna, P; Stelmach, I; Stelmach, P | 1 |
Katsunuma, T; Kondo, N; Morikawa, A; Odajima, Y | 1 |
Carranza Rosenzweig, JR; McLaughlin, TP; Stanford, RH; Stempel, DA | 1 |
Pan, MM; Sun, TY; Zhang, HS | 1 |
Fitzgerald, D; Glasgow, N; Henry, R; Lee, AJ; Mellis, C; Price, D; Robertson, CF; Sant, M; Turner, J | 1 |
Price, D; Sazonov Kocevar, V; Thomas, M; Wisniewski, T; Zhang, Q | 1 |
Bacharier, LB; Bloomberg, GR; Boehmer, SJ; Chinchilli, VM; Covar, RA; Guilbert, TW; Heldt, G; Larsen, G; Lemanske, RF; Martinez, FD; Mauger, DT; Mellon, MH; Morgan, WJ; Moss, MH; Sorkness, CA; Spahn, JD; Strunk, RC; Szefler, SJ; Taussig, LM; Zeiger, RS | 1 |
Frimurer, TM; Gerlach, LO; Grimstrup, M; Högberg, T; Kostenis, E; Mathiesen, JM; Receveur, JM; Rist, Ø; Uller, L; Ulven, T | 1 |
Barnes, ML; Burns, P; Fardon, TC; Lipworth, BJ; Menzies, D; Wilson, AM | 1 |
Actis, GC; Bugianesi, E; Ottobrelli, A; Rizzetto, M | 1 |
Hajduch, M; Janostáková, A; Jarmila, S; Kopriva, F; Zápalka, M | 1 |
Ludington, E; Mehra, P; Simon, RA; Stevenson, DD; White, A | 1 |
Cairns, CB; Ellison, MC; Irvin, C; Kraft, M; Pak, J; Wenzel, S | 1 |
Ambrosio, M; Capra, V; Riccioni, G; Rovati, GE | 1 |
Boushey, HA; Cherniack, R; Chinchilli, VM; Craig, TJ; Deykin, A; DiMango, E; Fahy, JV; Fish, JE; Ford, JG; Israel, E; Kiley, J; Kraft, M; Lazarus, SC; Lemanske, RF; Leone, FT; Martin, RJ; Pesola, GR; Peters, SP; Rollings, NJ; Sorkness, CA; Szefler, SJ; Wechsler, ME | 1 |
Adler, A; Bentur, L; Hakim, F; Livnat, G; Tal, A; Vilozni, D | 1 |
Dickerson, KS; Luttermoser, GK; Scow, DT | 1 |
Kruzikas, DT; Manjunath, R; Stempel, DA | 1 |
Grönke, L; Janicki, S; Jörres, RA; Magnussen, H; Maus, J; Richter, K | 1 |
Chang, HC; Hua, YM; Hung, CH; Jong, YJ; Lai, YS; Li, CY; Yang, KD | 1 |
Eickmeier, O; Kitz, R; Rose, MA; Rosewich, M; Travaci, M; Zielen, S | 1 |
Bakhireva, LN; Chambers, CD; Johnson, D; Jones, KL; Klonoff-Cohen, HS; Schatz, M; Slymen, DJ | 1 |
Bilderback, A; Edelman, JM; Hustad, CM; Rand, C; Schiller, K; Zeiger, RS | 1 |
Fujimura, M; Nakao, S; Nishitsuji, M; Oribe, Y | 1 |
Guillevin, L; Guilpain, P; Lhote, F; Mouthon, L; Pagnoux, C | 1 |
Badia, X; Borderias, L; Guilera, M; Mincewicz, G; Paggiaro, PL; Sazonov Kocevar, V; Taylor, SD | 1 |
Boner, AL; Capasso, M; Capristo, AF; Capristo, C; Maiello, N; Miraglia del Giudice, M; Piacentini, GL | 1 |
Asai, K; Kanazawa, H; Nomura, S | 1 |
Langdon, RB; Nayak, A | 1 |
Culp, JA; Steinke, JW | 1 |
Anderson, WH; Klotsman, M; Pillai, SG; Sharma, SS; van den Oord, EJ; Vargas-Irwin, C; York, TP | 1 |
Alluri, R; Currie, GP; Nair, A | 1 |
Allen, D; Barnes, N; Corris, P; Flood-Page, P; Hargreave, F; Laviolette, M; O'Connor, B; Parker, D; Pavord, I; Tate, H | 1 |
Anthonisen, N; Castro, M; Holbrook, JT; Irvin, CG; Peters, SP; Smith, LJ; Wise, RA | 1 |
Hopkinson, P; Lipworth, BJ; McFarlane, L; Menzies, D; Nair, A | 1 |
Kabra, SK; Kumar, V; Lodha, R; Pandey, RM; Ramesh, P | 1 |
Badia, X; Dal Negro, R; Guilera, M; Piskorz, P; Sazonov Kocevar, V; Vives, R | 1 |
Allayee, H; Conti, DV; Hartiala, J; Irvin, CG; Lee, W; Lima, JJ; Mehrabian, M | 1 |
Agertoft, L; Dass, SB; Knorr, B; Kuznetsova, O; Pedersen, S; Reiss, TF; Williams-Herman, D; Wolthers, OD | 1 |
Storms, W | 1 |
Dai, J; Duncan, JM; Greene, JM; Johnston, NW; Lambert, K; Mandhane, PJ; Sears, MR | 1 |
Parker, D; Pavord, I; Rice, L; Woodcock, A | 1 |
Brantly, ML; Eden, E; Holbrook, JT; Turino, GM; Wise, RA | 1 |
Grzelewski, T; Jerzynska, J; Kuna, P; Majak, P; Stelmach, I; Stelmach, W | 1 |
Baker, JW; Goldman, M; Silkoff, PE; Szefler, SJ; Uryniak, T | 1 |
Chuang, SS; Hsu, SH; Hua, YM; Hung, CH; Jong, YJ; Lin, CS; Tien, CH; Yang, KD | 1 |
Abo, H; Ichikawa, T; Inomata, M; Izumi, S; Taniguchi, H | 1 |
Barnes, PJ; Baviera, G; Ciabattoni, G; Koch, P; Mondino, C; Montuschi, P | 1 |
Albisetti, M; Johannes, W; Knauer, N; Lehmann, A; Moeller, A; Rochat, M | 1 |
Jaffe, DM; Nelson, KA; Smith, SR; Trinkaus, K | 1 |
Jartti, T | 1 |
Gustafsson, P; Wickman, M | 1 |
Abo, H; Imanishi, S; Izumi, S; Kanbara, K; Taniguchi, H | 1 |
Coste, J; Gross, WL; Guillevin, L; Hauser, T; Hellmich, B; Mahr, A; Metzler, C; Sommerstein, R | 1 |
Ahmed, T; Kearns, GL; Knorr, B; Li, XS; Lu, S; Maganti, L; Migoya, E; Reiss, TF | 1 |
Bisgaard, H; Bønnelykke, K | 1 |
Armentia, A; Blanco-Quiros, A; Diez, I; Fernandez-Carvajal, I; Jesus Alonso, M; Telleria, JJ; Varillas, D | 1 |
Abadoglu, O; Misirligil, Z; Mungan, D; Pasaoglu, G | 1 |
Bonanno, A; Bonsignore, MR; Cibella, F; Cuttitta, G; Interrante, A; La Grutta, S; Marchese, M; Morici, G; Profita, M; Scichilone, N; Veca, M; Virzi', M | 1 |
Gielen, CL; van't Wout, JW | 1 |
Mastronarde, JG; Olopade, CO; Scharf, SM; Shade, DM; Wise, RA | 1 |
Baba, K; Kawai, S; Matsubara, A; Okada, T; Shiono, H; Yamaguchi, E | 1 |
Gelfand, EW; Rabinovitch, N; Strand, M; Stuhlman, K | 1 |
Amiot, N; Courville, P; Cuvelier, A; Girszyn, N; Lahaxe, L; Marie, I | 1 |
Grouven, U; Joos, S; Kaiser, T; Miksch, A; Schneider, A; Szecsenyi, J; Wieseler, B | 1 |
Aizawa, Y; Ei, K; Gejyo, F; Gotoh, H; Hanai, I; Hanai, J; Hirasawa, Y; Horiuchi, T | 1 |
Cho, SW; Jeong, SW; Kim, HT; Kim, YH; Lee, SM; Lee, SY; Park, CS; Park, TE; Uh, S | 1 |
Kuroume, T; Maeda, S; Mochizuki, H; Morikawa, A; Shimizu, T; Tokuyama, K | 1 |
Kuroume, T; Mochizuki, H; Morikawa, A; Shimizu, T | 1 |
Fireman, E; Kivity, S; Lerman, Y | 1 |
Mochizuki, H; Morikawa, A; Shimizu, T; Tokuyama, K | 1 |
Altman, LC; Bewtra, A; Chervinsky, P; Kundu, S; Noonan, GP; Reiss, TF; Stricker, WE; Zhang, J | 1 |
Botto, A; De Lepeleire, I; Decramer, M; Kundu, S; Reiss, TF; Rochette, F; Zhang, J | 1 |
Botto, A; Busse, WW; Kundu, S; Reiss, TF; Sorkness, CA; Stricker, W; Zhang, J | 1 |
Massie, RJ | 1 |
Tan, RA | 1 |
Becker, A; Bernstein, JA; Knorr, B; Matz, J; Nguyen, H; Reiss, TF; Seidenberg, BC | 1 |
Chervinsky, P; Dockhorn, RJ; Edwards, TB; Reiss, TF; Seidenberg, B; Shingo, S | 1 |
Aharony, D | 1 |
Brandon, M; Chervinsky, P; Kundu, S; McBurney, J; Noonan, MJ; Reiss, TF; Zhang, J | 1 |
Breznay, JB; Ellsworth, A | 1 |
Altman, LC; Munk, Z; Noonan, N; Reiss, TF; Seltzer, J; Shingo, S; Zhang, J | 1 |
Faulds, D; Markham, A | 1 |
Dockhorn, RJ; Kemp, JP; Knorr, B; Nguyen, HH; Reiss, TF; Seidenberg, BC; Shapiro, GG | 1 |
Lawyer, C | 1 |
Adelman, A | 1 |
Lane, SJ | 1 |
Jébrak, G | 1 |
Lipworth, BJ | 2 |
De Smet, M; Diamant, Z; Grootendorst, DC; Leff, JA; Peszek, I; Seidenberg, BC; Sterk, PJ; Timmers, MC; Veselic-Charvat, M; Zwinderman, AH | 1 |
Rosenwasser, LJ | 1 |
Guerra, J; Malmstrom, K; Piñeiro, A; Reiss, TF; Rodriguez-Gomez, G; Seidenberg, BC; Villaran, C; Wei, LX | 1 |
Artés, MJ; Franco, J | 1 |
Mallet, JP | 1 |
Jones, TR; Rodger, IW | 1 |
Capizzi, T; Finn, AF; Godard, P; Israel, E; Kundu, S; Leff, JA; Löfdahl, CG; Noonan, MJ; Reiss, TF; Seidenberg, BC | 1 |
Matthys, H; Virchow, JC | 1 |
Richardson, CR | 1 |
Amin, RD; Blake, K; Chervinsky, P; Freeman, A; Gertz, BJ; Haesen, R; Holland, S; Knorr, B; Larson, P; Michiels, N; Nguyen, HH; Noonan, G; Reiss, TF; Rogers, JD; Seidenberg, BC; Spielberg, S; van Nispen, CH; Xu, X; Zhao, J | 1 |
Boulet, LP; Efthimiadis, AE; Hargreave, FE; Hendeles, L; Leff, JA; Pizzichini, E; Reiss, TF; Wei, LX; Zhang, J | 1 |
Barber, BL; Reiss, TF; Santanello, NC; Seidenberg, B; Zhang, J | 1 |
Bisgaard, H; Loland, L; Oj, JA | 1 |
Anderson, P | 1 |
Drazen, JM; Pauwels, R; Wechsler, ME | 1 |
Bratton, DL; Lanz, MJ; Miyazawa, N; Silkoff, PE; White, CW | 1 |
Chervinsky, P; Laviolette, M; Lu, S; Malmstrom, K; Peszek, I; Pujet, JC; Reiss, TF; Zhang, J | 1 |
Blau, H; Gil-Ad, I; Nussinovitch, M; Shtaif, B; Tabachnik, E; Varsano, I; Volovitz, B; Weizman, A | 1 |
Thien, FC | 1 |
Kuna, P; Kupczyk, M | 1 |
Hampson, NB | 1 |
Blake, KV | 1 |
Barker, A; Drazen, JM; Finn, D; Gunawardena, D; Haranath, SP; Kips, JC; Pauwels, RA; Wechsler, ME; Westlake, R | 1 |
Barnes, NC; Kuitert, LM | 1 |
Baumgartner, RA; Dockhorn, RJ; Leff, JA; Noonan, M; Reiss, TF; Stricker, W; Vandormael, K; Weinland, DE | 1 |
Becker, A | 2 |
Price, D | 1 |
Coutinho, SV; Geller, M; Melo, LR | 1 |
Dempsey, OJ; Lipworth, BJ; Mistry, C; Sims, EJ; Wilson, AM | 1 |
Chapman, KR; D'Urzo, AD | 1 |
Jarvis, B; Markham, A | 1 |
Stey, C | 1 |
Geller, M | 1 |
Dellaripa, PF; Drazen, J; Roth, ME; Wechsler, ME | 1 |
Bisgaard, H; Nielsen, KG | 1 |
Bisgaard, H; Bjermer, L; Bousquet, J; Fabbri, LM; Greening, A; Haahtela, T; Holgate, ST; Leff, JA; Picado, C | 1 |
Hosker, HS; Tuggey, JM | 2 |
Szefler, SJ | 1 |
Finn, AF; Geissler, L; Nguyen, H; Peszek, I; Reicin, A; Seidenberg, BC; Weinstein, SF; White, R | 1 |
Holland, S; Knorr, B; Nguyen, HH; Reiss, TF; Rogers, JD | 1 |
Dempsey, OJ; Lipworth, BJ | 1 |
Dempsey, OJ; Lipworth, BJ; Orr, LC; Sims, EJ; Wilson, AM | 1 |
Stempel, DA; Stoloff, S | 1 |
Dempsey, OJ | 1 |
Mehta, PN | 1 |
Busse, WW; Church, N; Emmett, A; Kerwin, E; Knobil, K; Nelson, HS; Rickard, K | 1 |
Christiansen, SC; Mathison, DA; Simon, RA; Stevenson, DD | 1 |
Bisgaard, H | 1 |
Knorr, B; Michele, TM; Noonan, G; Reiss, TF; Shapiro, G; Shingo, S; Storms, W; Zhang, J | 1 |
Heyse, JF; Stine, RA | 1 |
Anderson, KR; Clark, KW; Gong, H; Linn, WS; Terrell, SL | 1 |
Donohue, JF | 1 |
Pereiro Alonso, ME; Sala Félix, J; Salas Antón, C | 1 |
Ben-Joseph, RH; Price, DB; Zhang, Q | 1 |
Busse, W; Edwards, L; Galant, S; Goode-Sellers, S; Kalberg, C; Raphael, GD; Rickard, K; Srebro, S | 1 |
Lipworth, BJ; Wilson, AM | 1 |
Aziz, I; Kastelik, JA; Morice, AH | 1 |
Bold, T; Gruer, P; Vilardo, L | 1 |
Mauskopf, J; McLaughlin, T; Stanford, RH; Stempel, DA; Yazdani, C | 1 |
Artuso, A; Cerqua, N; Di Rienzo, L | 1 |
Bayram, NG; Dikensoy, O; Filiz, A | 1 |
Dempsey, OJ; Lipworth, BJ; Sims, EJ; Wilson, AM | 2 |
Reiss, TF; Shingo, S; Zhang, J | 1 |
Krawiec, ME; Wenzel, SE | 1 |
García-Marcos, L; Schuster, A | 1 |
Al-Ahmadi, W; Al-Gazlan, S; Al-Rawithi, S; Alshowaier, IA; Raines, DA; Yusuf, A | 1 |
Aristizabal, G; Laessig, W; Lee, BW; Leff, JA; Lyttle, B; Menten, J; Perez-Frias, J; Schuster, A; Sekerel, BE; Simons, FE; Teper, AM; Villa, JR | 1 |
Anderson, SD; Brannan, JD; Chan, HK; Gomes, K; King, GG; Seale, JP | 1 |
Barnes, N; Edelman, JM; Leff, JA; Reiss, TF; Shingo, S; Wei, LX; Yu, C | 1 |
Bukstein, D; O'Brien, K | 1 |
Boza, ML; Kearns, GL; Knorr, B; Larson, P; Nguyen, HH; Reiss, TF; Rogers, JD; Spielberg, S; Villaran, C; Zhang, J | 1 |
Busse, WW | 1 |
Bock, S; Faehndrich, S; Luttmann, W; Matthys, H; Nassenstein, C; Virchow, JC | 1 |
Guerra, J; Knorr, B; Matz, J; Noonan, G; Reiss, TF; White, R; Williams, B | 1 |
Spector, SL | 1 |
Angner, R; Knorr, B; Lu, S; Noonan, GP; Reiss, TF; Williams, B | 1 |
Green, RH; Pavord, ID | 1 |
Barnes, PJ; Campbell, D; Robinson, DS | 1 |
Liebke, C; Niggemann, B; Sommerfeld, C; Wahn, U | 1 |
Skoner, D | 1 |
Louis, R | 1 |
Boone, R; Emmett, A; Fish, JE; Israel, E; Murray, JJ; Rickard, KA; Yancey, SW | 1 |
Bisgaard, H; Bratton, DL; Franchi, LM; Knorr, B; LeSouef, P; Michele, TM; Nguyen, HH; Reiss, TF; Santanello, N; Vermeulen, JH | 1 |
Calhoun, WJ; Dorinsky, P; Emmett, A; Kalberg, C; Nathan, RA; Nelson, HS; Pepsin, PJ; Rickard, KA | 1 |
Saenghirunvattana, S | 1 |
Bukstein, DA; Henk, HJ; Luskin, AT | 1 |
Darby, YC; Parikh, A; Ragab, S; Scadding, GK | 1 |
Grundmann, T; Töpfner, M | 1 |
Blonski, J; Cash, R | 1 |
Adachi, M; Minoguchi, K | 1 |
Coutie, WJ; Gardiner, Q; Lipworth, BJ; Orr, LC; Sims, EJ; White, PS; Wilson, AM | 1 |
Morice, AH | 1 |
Currie, G; Fowler, S; Lipworth, BJ | 1 |
Mastalerz, L; Nizankowska, E; Sanak, M; Szczeklik, A | 1 |
Białoruska, B; Cichocka-Jarosz, E; Głodzik, I; Lis, G; Szczerbiński, T | 1 |
Amrani, Y; Hoffman, R; Moore, PE; Panettieri, RA; Shore, SA | 1 |
González-Crespo, F; Jiménez-Alonso, J; Sabio, JM | 1 |
Dueñas-Meza, E; Kosa, L; Leff, JA; Maspero, JF; Pinacho Daza, C; Volovitz, B; Vrijens, F | 1 |
Hayden, ML | 1 |
Bobrowska, M; Grzelewski, T; Jerzyńska, J; Kuna, P; Majak, J; Majak, P; Stelmach, I | 1 |
Chesrown, S; Hendeles, L; Hutson, A; Patel, P; Sherman, J | 1 |
Young, RN | 1 |
Bousquet, J; Dahlén, B; Dahlén, SE; Holgate, ST; Kowalski, M; Kuna, P; Lumry, WR; Malmström, K; Nizankowska, E; Pauwels, R; Picado, C; Reiss, TF; Shahane, A; Stevenson, DD; Szczeklik, A; Zhang, J | 1 |
Chi, EY; Chiang, GK; Chu, SJ; Henderson, WR; Jonas, M; Jones, F; Pae, C; Tang, LO; Tsao, SM; Wang, H | 1 |
Dempsey, OJ; Kennedy, G; Lipworth, BJ | 1 |
Berisa, F; Cortés, CM; Mateo, ML | 1 |
Bosch, JA; Orriols, R; Selva, A; Solans, R; Vilardell, M | 1 |
Koziol, JA; Mathison, DA | 1 |
Hendeles, L; Segal, R | 1 |
Davis, EA; Pathak, DS; Stanford, RH | 1 |
Frew, AJ | 1 |
Jerzynska, J; Kuna, P; Stelmach, I | 2 |
Bowers, B; Dorinsky, P; Emmett, A; Kalberg, C; Lieberman, AK; Pearlman, DS; Pepsin, PJ; Rickard, KA; White, MV | 1 |
Adachi, M; Kihara, N; Kohno, Y; Minoguchi, H; Minoguchi, K; Sano, Y; Yasuhara, H | 1 |
Meyer, JW; O'Donnell, JC; Stempel, DA | 1 |
Wiebicke, W | 1 |
Arshad, H; Holgate, ST; Jeffs, JA; Jennison, S; Rorke, S; Sampson, AP | 1 |
Abbott, CL; Cobb, DB; Fernández, MC; Watson, WA | 1 |
Ilowite, J | 1 |
Jackson, CM; Lipworth, BJ | 1 |
Aukrust, P; Frøland, SS; Hammer, HB | 1 |
Wilson, AM | 1 |
Janson, S; Lazarus, SC | 1 |
Eggleston, PA; Kesavan, J; Nowak-Wegrzyn, A; Phipatanakul, W; Schuberth, K; Van Natta, M; Wood, RA | 1 |
Dadas, E; Jung, A; Kalicki, B; Straz-Zebrowska, E; Zuber, J | 1 |
Górski, P; Grzelewski, T; Jerzyńska, J; Kuna, P; Majak, P; Stelmach, I; Stelmach, W | 2 |
Martínez González, A; Mendia, JL; Naberan Toña, KX | 1 |
Bodini, A; Boner, AL; Costella, S; Del Giudice, MM; Peroni, DG; Piacentini, GL; Vicentini, L | 1 |
Edwards, L; Friedman, BF; Goode-Sellers, S; Kalberg, C; Lockey, RF; Meltzer, EO; Rickard, K; Srebro, S | 1 |
Addis, A; Buzzetti, R; D'Amico, R | 1 |
Cohen, P; Guillevin, L; Guilpain, P; Kambouchner, M; Lagarde, P; Pellegrin, JL; Viallard, JF | 1 |
Noonan, G; Reiss, TF; Yu, C; Zhang, J | 1 |
Parra Arrondo, A; Pérez de Llano, LA; Veres Racamonde, A | 1 |
Virchow, JC | 1 |
Fowler, SJ; Hall, IP; Lipworth, BJ; Wheatley, AP; Wilson, AM | 1 |
Aizawa, Y; Ei, K; Gejyo, F; Hirasawa, Y; Ikeda, T; Shibata, A | 1 |
Demoulin, S; Dorsch, W; Gropp, M; Ring, J; Stuppner, H; Wagner, H | 1 |
Kern, DG | 1 |
Korri, UM; Salaspuro, M | 1 |
Kimura, S; Kuroume, T; Mochizuki, H; Morikawa, A; Shigeta, M; Tajima, K; Tateno, K; Tokuyama, K | 1 |
Kuroume, T; Mitsuhashi, M; Mochizuki, H; Morikawa, A; Tokuyama, K | 1 |
Mitchell, RG; Richardson, JE; Thom, H | 2 |
Ackerman, SJ; Brooks, SM; Sullivan, I; Thrasher, K; Werk, EE | 1 |
Aubert, J; Boutin, C; Charpin, J; Ohresser, P | 1 |
Farr, RS; Hawkins, D; Pinckard, RN | 1 |
Loscialpo Ramundo, D | 1 |
Beck, S; Gollmer, D; Mosebach, KO | 1 |
109 review(s) available for phenyl acetate and Asthma, Bronchial
Article | Year |
---|---|
Efficacy and safety of salmeterol/fluticasone compared with montelukast alone (or add-on therapy to fluticasone) in the treatment of bronchial asthma in children and adolescents: a systematic review and meta-analysis.
Topics: Acetates; Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Albuterol; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Drug Therapy, Combination; Fluticasone; Humans; Quinolines; Salmeterol Xinafoate; Sulfides | 2021 |
Deprescribing montelukast in children with asthma: a systematic review.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cyclopropanes; Deprescriptions; Forced Expiratory Volume; Humans; Infant; Infant, Newborn; Quinolines; Sulfides | 2022 |
Montelukast as a potential treatment for COVID-19.
Topics: Acetates; Asthma; COVID-19; Cyclopropanes; Double-Blind Method; Humans; Leukotriene Antagonists; Quinolines; Randomized Controlled Trials as Topic; SARS-CoV-2; Sulfides | 2023 |
Neuropsychiatric events associated with montelukast in patients with asthma: a systematic review.
Topics: Acetates; Aged; Animals; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Humans; Quinolines | 2023 |
An efficacy and safety evaluation of montelukast + fluticasone propionate vs. fluticasone propionate in the treatment of cough variant asthma in children: a meta-analysis.
Topics: Acetates; Androstadienes; Anti-Asthmatic Agents; Asthma; Child; Cough; Cyclopropanes; Fluticasone; Humans; Quinolines | 2023 |
Pediatric asthma: Principles and treatment.
Topics: Acetates; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cough; Cyclopropanes; Humans; Inflammation; Pediatrics; Quinolines; Respiratory Sounds; Sulfides | 2019 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Leukotriene D
Topics: Acetates; Airway Remodeling; Animals; Anti-Asthmatic Agents; Asthma; Bronchial Hyperreactivity; Cyclopropanes; Cysteine; Gene Expression; Humans; Hypersensitivity; Indoles; Inflammation Mediators; Leukotriene Antagonists; Leukotriene D4; Leukotrienes; Phenylcarbamates; Quinolines; Receptors, Leukotriene; Sulfides; Sulfonamides; Tosyl Compounds | 2020 |
Eicosanoid receptors as therapeutic targets for asthma.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Benzoquinones; Biomarkers; Cyclopropanes; Heptanoic Acids; Humans; Lung; Mice; Quinolines; Receptors, Eicosanoid; Sulfides | 2021 |
Interventions for autumn exacerbations of asthma in children.
Topics: Acetates; Adrenal Cortex Hormones; Anti-Allergic Agents; Anti-Asthmatic Agents; Asthma; Behavior Therapy; Child; Chromones; Cyclopropanes; Disease Progression; Humans; Leukotriene Antagonists; Omalizumab; Quinolines; Randomized Controlled Trials as Topic; Seasons; Sulfides | 2018 |
Interventions for autumn exacerbations of asthma in children.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Disease Progression; Humans; Omalizumab; Quinolines; Seasons; Sulfides | 2018 |
Daily inhaled corticosteroids or montelukast for preschoolers with asthma or recurrent wheezing: A systematic review.
Topics: Acetates; Administration, Inhalation; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Child, Preschool; Cyclopropanes; Drug Therapy, Combination; Hospitalization; Humans; Infant; Leukotriene Antagonists; Prospective Studies; Quinolines; Recurrence; Respiratory Sounds; Sulfides | 2018 |
[Leukotriene and respiratory syncytial virus].
Topics: Acetates; Asthma; Bronchiolitis, Viral; Cyclopropanes; Cysteine; Humans; Infant; Infant, Newborn; Leukotriene Antagonists; Leukotrienes; Nasopharynx; Quinolines; Respiratory Syncytial Virus Infections; Risk Factors; Sulfides | 2013 |
Cough, asthma, and cysteinyl-leukotrienes.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Antitussive Agents; Asthma; Cough; Cyclopropanes; Cysteine; Glucocorticoids; Humans; Leukotriene Antagonists; Leukotrienes; Quinolines; Sputum; Sulfides | 2013 |
Impact of montelukast on asthma associated with rhinitis, and other triggers and co-morbidities.
Topics: Acetates; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Comorbidity; Cyclopropanes; Humans; Leukotriene Antagonists; Quinolines; Rhinitis; Sulfides | 2014 |
Addition of anti-leukotriene agents to inhaled corticosteroids in children with persistent asthma.
Topics: Acetates; Adolescent; Asthma; Child; Cyclopropanes; Drug Therapy, Combination; Humans; Leukotriene Antagonists; Quinolines; Randomized Controlled Trials as Topic; Sulfides | 2013 |
Safety and efficacy of montelukast as adjunctive therapy for treatment of asthma in elderly patients.
Topics: Acetates; Aged; Aged, 80 and over; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Female; Humans; Male; Middle Aged; Quinolines; Sulfides | 2013 |
Management of critical asthma syndrome during pregnancy.
Topics: Abortion, Spontaneous; Acetates; Adrenal Cortex Hormones; Animals; Asthma; Bronchodilator Agents; Contraindications; Critical Illness; Cyclopropanes; Epinephrine; Female; Humans; Intensive Care Units; Medication Adherence; Pregnancy; Pregnancy Complications; Quinolines; Sulfides; Syndrome | 2015 |
Leukotriene receptor antagonists pranlukast and montelukast for treating asthma.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Asthma; Chromones; Cyclopropanes; Cysteine; Humans; Leukotriene Antagonists; Leukotrienes; Quinolines; Sulfides | 2014 |
Evaluation and treatment of critical asthma syndrome in children.
Topics: Acetates; Animals; Asthma; Caregivers; Child; Critical Illness; Cyclopropanes; Humans; Hyperbaric Oxygenation; Immunoglobulins, Intravenous; Patient Compliance; Patient Education as Topic; Practice Guidelines as Topic; Quinolines; Respiration, Artificial; Sulfides; Syndrome | 2015 |
Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Acetates; Anti-Asthmatic Agents; Arachidonate 5-Lipoxygenase; Asthma; Chromones; Cyclopropanes; Gene Expression Regulation; Humans; Immunity, Innate; Immunologic Factors; Indoles; Leukotriene Antagonists; Monocytes; Neutrophils; NF-kappa B; Phenylcarbamates; Quinolines; Receptors, Leukotriene; Sulfides; Sulfonamides; Tosyl Compounds | 2014 |
Clinical effectiveness and safety of montelukast in asthma. What are the conclusions from clinical trials and meta-analyses?
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Child; Clinical Trials as Topic; Cyclopropanes; Glucocorticoids; Humans; Medication Adherence; Quality of Life; Quinolines; Sulfides | 2014 |
Montelukast-induced adverse drug reactions: a review of case reports in the literature.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Humans; Leukotriene Antagonists; Quinolines; Risk Factors; Sulfides | 2014 |
Montelukast in paediatric asthma: where we are now and what still needs to be done?
Topics: Acetates; Administration, Inhalation; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cyclopropanes; Glucocorticoids; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 2015 |
[Recent advances in allergic rhinitis].
Topics: Acetates; Allergens; Anti-Inflammatory Agents; Asthma; Child; Cyclopropanes; Humans; Hypersensitivity, Immediate; Immunoglobulin E; Immunotherapy; Inflammation; Leukotriene Antagonists; Prevalence; Quinolines; Rhinitis, Allergic; Sulfides | 2015 |
Recent advances in paediatric respiratory medicine.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Bronchopulmonary Dysplasia; Ciliary Motility Disorders; Cyclopropanes; Humans; Lung Diseases, Interstitial; Medication Adherence; Pediatrics; Pulmonary Medicine; Quinolines; Saline Solution, Hypertonic; Sleep Apnea, Obstructive; Sulfides | 2016 |
Montelukast-induced metamorphopsia in a pediatric patient: A case report and a pharmacovigilance database analysis.
Topics: Acetates; Asthma; Child; Cyclopropanes; Databases, Factual; Evidence-Based Medicine; Female; Humans; Immunosuppressive Agents; Pharmacovigilance; Quinolines; Sulfides; Vision Disorders; Withholding Treatment | 2016 |
[Therapeutic effect and safety of montelukast sodium combined with budesonide in children with cough variant asthma: a Meta analysis].
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Budesonide; Child; Cough; Cyclopropanes; Drug Therapy, Combination; Humans; Quinolines; Sulfides | 2016 |
Review of recent results of montelukast use as a monotherapy in children with mild asthma.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Anti-Asthmatic Agents; Asthma; Asthma, Exercise-Induced; Bronchoconstriction; Child; Child, Preschool; Cyclopropanes; Glucocorticoids; Humans; Hypersensitivity, Immediate; Leukotriene Antagonists; Patient Compliance; Quinolines; Randomized Controlled Trials as Topic; Sulfides | 2008 |
Montelukast and emotional well-being as a marker for depression: results from 3 randomized, double-masked clinical trials.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Depression; Double-Blind Method; Emotions; Female; Humans; Male; Multicenter Studies as Topic; Quality of Life; Quinolines; Randomized Controlled Trials as Topic; Suicide; Sulfides | 2008 |
Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cyclopropanes; Humans; Infant; Quinolines; Rhinitis, Allergic, Perennial; Sulfides | 2009 |
Montelukast in guidelines and beyond.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Humans; Leukotriene Antagonists; Practice Guidelines as Topic; Quinolines; Rhinitis, Allergic, Seasonal; Sulfides | 2009 |
Recurrent wheezing illness in preschool-aged children: assessment and management in primary care practice.
Topics: Acetates; Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Anti-Asthmatic Agents; Asthma; Causality; Child; Child, Preschool; Comorbidity; Cyclopropanes; Diagnosis, Differential; Europe; Female; Humans; Hypersensitivity; Infant; Infant, Newborn; Male; Predictive Value of Tests; Prednisolone; Primary Health Care; Quinolines; Recurrence; Respiratory Sounds; Risk Assessment; Sulfides; Terminology as Topic; United States | 2009 |
The role of inhaled corticosteroids and montelukast in children with mild-moderate asthma: results of a systematic review with meta-analysis.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cyclopropanes; Drug Therapy, Combination; Forced Expiratory Volume; Glucocorticoids; Humans; Peak Expiratory Flow Rate; Quinolines; Randomized Controlled Trials as Topic; Sulfides; Treatment Outcome | 2010 |
Human rhinoviruses, allergy, and asthma: a clinical approach.
Topics: Acetates; Adult; Allergens; Antiviral Agents; Asthma; Child; Child, Preschool; Consensus; Cyclopropanes; Disease Susceptibility; Follow-Up Studies; Humans; Infant; Interferons; Picornaviridae Infections; Prevalence; Quinolines; Randomized Controlled Trials as Topic; Recurrence; Respiratory Hypersensitivity; Respiratory Sounds; Rhinovirus; Sulfides; Time Factors | 2009 |
Body mass index and response to asthma therapy: fluticasone propionate/salmeterol versus montelukast.
Topics: Acetates; Adult; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Body Mass Index; Cyclopropanes; Double-Blind Method; Drug Combinations; Female; Fluticasone-Salmeterol Drug Combination; Forced Expiratory Volume; Humans; Male; Middle Aged; Multicenter Studies as Topic; Obesity; Overweight; Quinolines; Randomized Controlled Trials as Topic; Sulfides; Time Factors; Treatment Outcome | 2010 |
[Antileukotrienes in asthma - critical view].
Topics: Acetates; Adrenal Cortex Hormones; Adult; Adverse Drug Reaction Reporting Systems; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Child; Churg-Strauss Syndrome; Drug Interactions; Humans; Leukotriene Antagonists; Leukotrienes; Practice Guidelines as Topic; Risk Assessment | 2010 |
Inter-country variations in anti-asthmatic drug prescriptions for children. Systematic review of studies published during the 2000-2009 period.
Topics: Acetates; Adolescent; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Beclomethasone; Budesonide; Canada; Child; Cromolyn Sodium; Cyclopropanes; Drug Prescriptions; Ethanolamines; Europe; Fluocinolone Acetonide; Fluticasone; Humans; Italy; Prevalence; Quinolines; Salmeterol Xinafoate; Sulfides; United States | 2010 |
Archimedes. Question 2. Is oral montelukast beneficial in treating acute asthma exacerbations in children?
Topics: Acetates; Acute Disease; Administration, Oral; Anti-Asthmatic Agents; Asthma; Child, Preschool; Cyclopropanes; Evidence-Based Medicine; Female; Humans; Quinolines; Sulfides | 2010 |
Pediatric asthma controller therapy.
Topics: Acetates; Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adult; Age Factors; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cyclopropanes; Glucocorticoids; Humans; Practice Guidelines as Topic; Quinolines; Sulfides | 2011 |
Montelukast: more than a cysteinyl leukotriene receptor antagonist?
Topics: Acetates; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Cyclopropanes; Humans; Leukotriene Antagonists; Neutrophils; Pulmonary Disease, Chronic Obstructive; Quinolines; Receptors, Leukotriene; Sulfides | 2010 |
[Montelukast in the treatment of mild to moderate persistent asthma].
Topics: Acetates; Adrenal Cortex Hormones; Adult; Airway Remodeling; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Child; Cyclopropanes; Cytokines; Drug Therapy, Combination; France; Humans; Inflammation; Leukotriene Antagonists; Leukotrienes; Models, Biological; Practice Guidelines as Topic; Prevalence; Quinolines; Randomized Controlled Trials as Topic; Receptors, Leukotriene; Sulfides | 2011 |
Montelukast for the treatment of asthma in the adult population.
Topics: Acetates; Adult; Animals; Anti-Inflammatory Agents; Asthma; Clinical Trials as Topic; Cyclopropanes; Humans; Quinolines; Randomized Controlled Trials as Topic; Sulfides | 2011 |
[What helps for persistent symptoms of asthma during inhalative steroid therapy?].
Topics: Acetates; Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Adult; Albuterol; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Child; Cyclopropanes; Drug Therapy, Combination; Ethanolamines; Formoterol Fumarate; Humans; Hydroxyurea; Leukotriene Antagonists; Quality of Life; Quinolines; Randomized Controlled Trials as Topic; Respiratory Function Tests; Salmeterol Xinafoate; Sulfides; Treatment Failure | 2011 |
Clinical effectiveness of inhaled corticosteroids versus montelukast in children with asthma: prescription patterns and patient adherence as key factors.
Topics: Acetates; Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cyclopropanes; Female; Follow-Up Studies; Hospitalization; Humans; Male; Patient Compliance; Practice Patterns, Physicians'; Quinolines; Risk Factors; Sulfides; Treatment Outcome | 2012 |
Update on the development of antagonists of chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2). From lead optimization to clinical proof-of-concept in asthma and allergic rhinitis.
Topics: Acetates; Animals; Asthma; Aza Compounds; Carbazoles; Clinical Trials as Topic; Humans; Indoleacetic Acids; Pyrazoles; Pyrimidines; Pyrroles; Receptors, Immunologic; Receptors, Prostaglandin; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sulfonamides; Th2 Cells; Thiazoles | 2012 |
Airway obstruction lability helps distinguish levels of disease activity in asthma.
Topics: Acetates; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Anti-Asthmatic Agents; Asthma; Beclomethasone; Circadian Rhythm; Clinical Trials, Phase III as Topic; Cyclopropanes; Drug Administration Schedule; Female; Forced Expiratory Volume; Glucocorticoids; Humans; Leukotriene Antagonists; Male; Middle Aged; Peak Expiratory Flow Rate; Quinolines; Randomized Controlled Trials as Topic; Severity of Illness Index; Sulfides; Treatment Outcome; Young Adult | 2012 |
Update on leukotriene receptor antagonists in preschool children wheezing disorders.
Topics: Acetates; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Child, Preschool; Cyclopropanes; Humans; Leukotriene Antagonists; Practice Guidelines as Topic; Quinolines; Respiratory Sounds; Sulfides | 2012 |
[Leukotriene antagonist drugs].
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 2002 |
New treatments for asthma: the role of leukotriene modifier agents.
Topics: Acetates; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Asthma, Exercise-Induced; Cyclopropanes; Drug Evaluation; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds; Treatment Outcome | 1999 |
Atopic diseases of childhood.
Topics: Acetates; Adrenergic beta-Agonists; Animals; Asthma; Child; Cyclopropanes; Dermatitis, Atopic; Environmental Exposure; Feces; Genetic Predisposition to Disease; Hepatitis A Virus Cellular Receptor 1; Hepatitis A Virus Cellular Receptor 2; Humans; Hypersensitivity, Immediate; Immunosuppressive Agents; Leukotriene Antagonists; Membrane Proteins; Mice; Quinolines; Receptors, Virus; Skin; Sulfides; T-Lymphocytes; Tacrolimus | 2003 |
[Anti-leukotrienes in allergic diseases in children].
Topics: Acetates; Asthma; Child; Cyclopropanes; Humans; Hydroxyurea; Leukotriene Antagonists; Leukotrienes; Membrane Proteins; Quinolines; Receptors, Leukotriene; Sulfides | 2003 |
Recent advances in the management of asthma using leukotriene modifiers.
Topics: Acetates; Administration, Inhalation; Adolescent; Adult; Asthma; Child; Child, Preschool; Chromones; Controlled Clinical Trials as Topic; Cyclopropanes; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxyurea; Leukotriene Antagonists; Male; Middle Aged; Peak Expiratory Flow Rate; Quinolines; Respiratory Function Tests; Severity of Illness Index; Sulfides; Treatment Outcome | 2003 |
Spotlight on montelukast in asthma in children 2 to 14 years of age.
Topics: Acetates; Administration, Oral; Adolescent; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cyclopropanes; Drug Administration Schedule; Drug Therapy, Combination; Humans; Quinolines; Randomized Controlled Trials as Topic; Sulfides | 2002 |
Advances in adult and pediatric asthma.
Topics: Acetates; ADAM Proteins; Administration, Inhalation; Adrenal Cortex Hormones; Adult; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Female; Humans; Male; Metalloendopeptidases; Osteoporosis; Pregnancy; Pregnancy Complications; Quinolines; Respiratory System; Sulfides; United States | 2004 |
A review of montelukast in the treatment of asthma and allergic rhinitis.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Humans; Leukotriene Antagonists; Membrane Proteins; Quinolines; Randomized Controlled Trials as Topic; Receptors, Leukotriene; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sulfides | 2004 |
Problems in the management of asthma in young children--a potential role for montelukast.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cyclopropanes; Humans; Infant; Patient Compliance; Quality of Life; Quinolines; Sulfides; Treatment Outcome | 2004 |
Asthma and other wheezing disorders in infants and children.
Topics: Acetates; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cromolyn Sodium; Cyclopropanes; Drug Therapy, Combination; Humans; Infant; Ipratropium; Nebulizers and Vaporizers; Nedocromil; Quinolines; Respiratory Sounds; Sulfides; Theophylline | 2004 |
[Mechanisms of action of cysteinyl leukotriene receptor antagonist and progresses in relevant studies in children with asthma].
Topics: Acetates; Animals; Asthma; Cyclopropanes; Humans; Leukotriene Antagonists; Quinolines; Receptors, Leukotriene; Sulfides | 2005 |
Inhaled salmeterol/fluticasone propionate: a review of its use in asthma.
Topics: Acetates; Administration, Inhalation; Albuterol; Androstadienes; Asthma; Asthma, Exercise-Induced; Bronchodilator Agents; Budesonide; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Economics, Pharmaceutical; Ethanolamines; Fluticasone; Fluticasone-Salmeterol Drug Combination; Formoterol Fumarate; Humans; Quinolines; Salmeterol Xinafoate; Sulfides; Therapeutic Equivalency | 2005 |
Childhood asthma. Balancing efficacy and adherence for optimum management.
Topics: Acetates; Adolescent; Adult; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cyclopropanes; Humans; Indoles; Infant; Leukotriene Antagonists; Phenylcarbamates; Practice Guidelines as Topic; Quinolines; Severity of Illness Index; Sulfides; Sulfonamides; Tosyl Compounds | 2005 |
Leukotriene receptor antagonists--an update.
Topics: Acetates; Administration, Inhalation; Adolescent; Adult; Asthma; Child; Child, Preschool; Cyclopropanes; Delayed-Action Preparations; Humans; Indoles; Infant; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Rhinitis, Allergic, Seasonal; Sulfides; Sulfonamides; Tosyl Compounds; Treatment Outcome | 2005 |
Treatment of asthma with antileukotrienes: first line or last resort therapy?
Topics: Acetates; Animals; Asthma; Clinical Trials as Topic; Cyclopropanes; Humans; Hydroxyurea; Leukotriene Antagonists; Leukotriene C4; Leukotriene D4; Leukotriene E4; Lipoxygenase Inhibitors; Membrane Proteins; Quinolines; Receptors, Leukotriene; Respiratory System; Rhinitis; Sulfides | 2006 |
Montelukast in pediatric asthma management.
Topics: Acetates; Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Asthma; Bronchial Diseases; Child; Constriction, Pathologic; Cyclopropanes; Humans; Infant; Leukotriene Antagonists; Practice Guidelines as Topic; Quinolines; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Seasonal; Sulfides | 2006 |
Managing asthma in the 21st century: role of pharmacogenetics.
Topics: Acetates; Adrenergic beta-Agonists; Anti-Asthmatic Agents; Asthma; Beclomethasone; Cyclopropanes; Genotype; Humans; Pharmacogenetics; Polymorphism, Single Nucleotide; Quinolines; Receptors, Adrenergic, beta; Sulfides | 2006 |
Single-inhaler combination therapy for asthma: a review of cost effectiveness.
Topics: Acetates; Androstadienes; Anti-Asthmatic Agents; Asthma; Budesonide; Clinical Trials as Topic; Cost-Benefit Analysis; Cyclopropanes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethanolamines; Fluticasone; Formoterol Fumarate; Humans; Nebulizers and Vaporizers; Quinolines; Sulfides | 2006 |
Cysteinyl-leukotriene receptor antagonists: present situation and future opportunities.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Humans; Leukotriene Antagonists; Membrane Proteins; Quinolines; Receptors, Leukotriene; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sulfides; Treatment Outcome | 2006 |
Leukotriene inhibitors in the treatment of allergy and asthma.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Asthma, Exercise-Induced; Cyclopropanes; Dermatitis, Atopic; Humans; Hydroxyurea; Hypersensitivity; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sulfides; Sulfonamides; Tosyl Compounds | 2007 |
[Antileukotrienes and Churg-Strauss syndrome].
Topics: Acetates; Adult; Anti-Asthmatic Agents; Antibodies, Antineutrophil Cytoplasmic; Asthma; Chromones; Churg-Strauss Syndrome; Cohort Studies; Cyclopropanes; Humans; Incidence; Indoles; Leukotriene Antagonists; Leukotrienes; Phenylcarbamates; Quinolines; Retrospective Studies; Sulfides; Sulfonamides; Tosyl Compounds | 2007 |
Montelukast in the treatment of allergic rhinitis: an evidence-based review.
Topics: Acetates; Asthma; Child; Cyclopropanes; Drug Administration Schedule; Evidence-Based Medicine; Humans; Leukotriene Antagonists; Placebo Effect; Quinolines; Receptors, Leukotriene; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sulfides | 2007 |
Leukotriene synthesis inhibitors versus antagonists: the pros and cons.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Arachidonate 5-Lipoxygenase; Asthma; Chromones; Cyclopropanes; Humans; Hypersensitivity; Indoles; Inflammation Mediators; Leukotriene Antagonists; Leukotrienes; Lipoxygenase Inhibitors; Phenylcarbamates; Quinolines; Receptors, Leukotriene; Sulfides; Sulfonamides; Tosyl Compounds | 2007 |
Update on montelukast and its role in the treatment of asthma, allergic rhinitis and exercise-induced bronchoconstriction.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Asthma; Asthma, Exercise-Induced; Bronchoconstriction; Cyclopropanes; Humans; Leukotriene Antagonists; Quinolines; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sulfides | 2007 |
Inhaled corticosteroids or montelukast as the preferred primary long-term treatment for pediatric asthma?
Topics: Acetates; Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Androstadienes; Asthma; Bronchodilator Agents; Child; Child, Preschool; Cyclopropanes; Fluticasone; Humans; Infant; Leukotriene Antagonists; Quinolines; Randomized Controlled Trials as Topic; Sulfides; Treatment Outcome | 2008 |
Churg-Strauss syndrome associated with montelukast therapy.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Drug Eruptions; Female; Humans; Middle Aged; Quinolines; Respiratory Function Tests; Sulfides; Treatment Outcome | 2008 |
Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review.
Topics: Acetates; Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Albuterol; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Drug Therapy, Combination; Female; Humans; Male; Quinolines; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Sulfides | 2008 |
The role of antileukotrienes in asthma management.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Asthma; Chromones; Cyclopropanes; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Lipoxygenase Inhibitors; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 1998 |
Pharmacology of leukotriene receptor antagonists.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Asthma; Bronchoconstriction; Cyclopropanes; Dicarboxylic Acids; Disease Models, Animal; Humans; In Vitro Techniques; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 1998 |
Montelukast.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Drug Tolerance; Humans; Quinolines; Sulfides | 1998 |
Leukotriene antagonism in asthma and rhinitis.
Topics: Acetates; Asthma; Bronchi; Cyclopropanes; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Leukotriene D4; Lipoxygenase Inhibitors; Membrane Proteins; Phenylcarbamates; Quinolines; Receptors, Leukotriene; Rhinitis; Sinusitis; Sulfides; Sulfonamides; Tosyl Compounds | 1998 |
Leukotriene-receptor antagonists.
Topics: Acetates; Adolescent; Adult; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Drug Administration Schedule; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Perennial; Sulfides; Sulfonamides; Tosyl Compounds | 1999 |
Montelukast and zafirlukast in asthma.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Asthma, Exercise-Induced; Child; Cyclopropanes; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Randomized Controlled Trials as Topic; Sulfides; Sulfonamides; Tosyl Compounds | 1998 |
[Leukotriene antagonists].
Topics: Acetates; Administration, Inhalation; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 1999 |
Role of leukotrienes and leukotriene receptor antagonists in asthma.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 1999 |
[The role of leukotrienes in inflammation and leukotriene inhibitors].
Topics: Acetates; Arachidonate 5-Lipoxygenase; Asthma; Cyclopropanes; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Leukotrienes; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 1999 |
Montelukast: data from clinical trials in the management of asthma.
Topics: Acetates; Adult; Animals; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Humans; Quinolines; Sulfides | 1999 |
Clinical evidence with montelukast in the management of chronic childhood asthma.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Child; Chronic Disease; Cyclopropanes; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 2000 |
Tolerability of montelukast.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Child; Churg-Strauss Syndrome; Controlled Clinical Trials as Topic; Cyclopropanes; Humans; Leukotriene Antagonists; Product Surveillance, Postmarketing; Quinolines; Sulfides | 2000 |
Leukotriene-receptor antagonists. Role in asthma management.
Topics: Acetates; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Bronchial Spasm; Chronic Disease; Cyclopropanes; Double-Blind Method; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Randomized Controlled Trials as Topic; Respiratory Therapy; Sulfides; Sulfonamides; Time Factors; Tosyl Compounds | 2000 |
Montelukast: a review of its therapeutic potential in persistent asthma.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Humans; Quinolines; Sulfides | 2000 |
[Leukotriene antagonists--do they have a value?].
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds; Treatment Outcome | 2000 |
Asthma: the new advances.
Topics: Acetates; Administration, Inhalation; Adult; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Glucocorticoids; Humans; Leukotriene Antagonists; Pulmonary Ventilation; Quinolines; Risk Factors; Severity of Illness Index; Sulfides; Theophylline | 2000 |
Montelukast adult (10-mg film-coated tablet) and pediatric (5-mg chewable tablet) dose selections.
Topics: Acetates; Adult; Asthma; Child; Child, Preschool; Cyclopropanes; Dose-Response Relationship, Drug; Humans; Leukotriene Antagonists; Quinolines; Sulfides; Tablets | 2000 |
Leukotriene receptor antagonist therapy.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Asthma, Exercise-Induced; Chronic Disease; Cyclopropanes; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 2000 |
Leukotriene modifiers in pediatric asthma management.
Topics: Acetates; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Leukotrienes; Membrane Proteins; Phenylcarbamates; Quinolines; Receptors, Leukotriene; Sulfides; Sulfonamides; Tosyl Compounds | 2001 |
Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged > or = 6 years.
Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Asthma; Child; Chronic Disease; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclopropanes; Double-Blind Method; Female; Humans; Leukotriene Antagonists; Male; Middle Aged; Multicenter Studies as Topic; Quinolines; Randomized Controlled Trials as Topic; Sulfides; Treatment Outcome | 2001 |
[Treatment of asthma with antileukotrienes and Churg-Strauss syndrome].
Topics: Acetates; Adult; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfides | 2001 |
Leukotriene inhibitors and non-steroidal therapies in the treatment of asthma.
Topics: Acetates; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Asthma; Bronchoconstriction; Child; Clinical Trials as Topic; Cyclopropanes; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Phenylcarbamates; Phosphodiesterase Inhibitors; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds; Treatment Outcome | 2001 |
Antileukotrienes in asthma: present situation.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Chromones; Clinical Trials as Topic; Cyclopropanes; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Leukotrienes; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 2001 |
Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function.
Topics: Acetates; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Analysis of Variance; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Eosinophils; Female; Forced Expiratory Volume; Humans; Leukocyte Count; Male; Middle Aged; Quinolines; Randomized Controlled Trials as Topic; Severity of Illness Index; Sulfides; Treatment Outcome | 2001 |
Use of oral montelukast in the treatment of asthma.
Topics: Acetates; Administration, Oral; Adult; Anti-Asthmatic Agents; Asthma; Bronchoconstriction; Child; Clinical Trials as Topic; Cyclopropanes; Drug Interactions; Exercise; Humans; Inflammation Mediators; Quinolines; Sulfides | 2001 |
Montelukast in 2- to 5-year-old children with asthma.
Topics: Acetates; Administration, Oral; Asthma; Child, Preschool; Cyclopropanes; Female; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfides | 2001 |
[Leukotriene modifiers].
Topics: Acetates; Asthma; Chromones; Cyclopropanes; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Leukotrienes; Lipoxygenase Inhibitors; Membrane Proteins; Phenylcarbamates; Practice Guidelines as Topic; Quinolines; Receptors, Leukotriene; Sulfides; Sulfonamides; Tosyl Compounds | 2001 |
Leukotriene modifiers. Expanded role may be on horizon.
Topics: Acetates; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Forced Expiratory Volume; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Lipoxygenase Inhibitors; Patient Compliance; Phenylcarbamates; Quinolines; Safety; Steroids; Sulfides; Sulfonamides; Tosyl Compounds; Treatment Outcome | 2000 |
Discovery of montelukast: a once-a-day oral antagonist of leukotriene D4 for the treatment of chronic asthma.
Topics: Acetates; Administration, Oral; Animals; Asthma; Chromones; Chronic Disease; Cyclopropanes; Humans; Leukotriene Antagonists; Leukotriene D4; Lung; Quinolines; Sulfides | 2001 |
Montelukast: a review of its therapeutic potential in asthma in children 2 to 14 years of age.
Topics: Acetates; Adolescent; Asthma; Bronchoconstriction; Child; Child, Preschool; Cyclopropanes; Humans; Leukotriene Antagonists; Membrane Proteins; Quinolines; Randomized Controlled Trials as Topic; Receptors, Leukotriene; Sulfides; Treatment Outcome | 2002 |
Are antihistamines useful in managing asthma?
Topics: Acetates; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Bronchospirometry; Cetirizine; Cyclopropanes; Drug Therapy, Combination; Histamine H1 Antagonists; Humans; Loratadine; Mannitol; Quinolines; Rhinitis; Sulfides; Terfenadine | 2002 |
Where do leukotriene modifiers fit in asthma management?
Topics: Acetates; Asthma; Child; Churg-Strauss Syndrome; Cyclopropanes; Forced Expiratory Volume; Humans; Indoles; Leukotriene Antagonists; Leukotrienes; Phenylcarbamates; Quinolines; Severity of Illness Index; Sulfides; Sulfonamides; Tosyl Compounds | 2002 |
[Reflections on antileukotrienes].
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 2002 |
Churg-Strauss syndrome in two patients receiving montelukast.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Churg-Strauss Syndrome; Cyclophosphamide; Cyclopropanes; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosuppressive Agents; Leukotriene Antagonists; Male; Middle Aged; Quinolines; Sulfides | 2002 |
320 trial(s) available for phenyl acetate and Asthma, Bronchial
Article | Year |
---|---|
A Comparative Study of Montelukast and Azelastine add on Therapy in Moderate to Severe Allergic Rhinitis Treatment: A Double-Blind Randomized Clinical Trial.
Topics: Acetates; Administration, Intranasal; Adolescent; Adrenal Cortex Hormones; Adult; Asthma; Budesonide; Cyclopropanes; Double-Blind Method; Histamine Antagonists; Histamine H1 Antagonists; Humans; Nasal Sprays; Phthalazines; Quality of Life; Quinolines; Rhinitis, Allergic; Sulfides; Treatment Outcome; Young Adult | 2022 |
Long-term safety of once-daily indacaterol acetate/glycopyrronium bromide/mometasone furoate high-dose, and indacaterol acetate/mometasone furoate high-dose, in Japanese patients with inadequately controlled asthma: Results from two open-label, 52-week st
Topics: Acetates; Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adult; Asthma; Bronchodilator Agents; Drug Combinations; East Asian People; Glycopyrrolate; Humans; Mometasone Furoate; Treatment Outcome | 2023 |
Addition of a nutraceutical to montelukast or inhaled steroid in the treatment of wheezing during COVID-19 pandemic: a multicenter, open-label, randomized controlled trial.
Topics: Acetates; Administration, Inhalation; Anti-Asthmatic Agents; Asthma; Child; Communicable Disease Control; COVID-19; Cyclopropanes; Dietary Supplements; Humans; Pandemics; Quinolines; Respiratory Sounds; Steroids; Sulfides | 2022 |
Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma.
Topics: Acetates; Administration, Inhalation; Adrenal Cortex Hormones; Antitussive Agents; Asthma; Budesonide; Budesonide, Formoterol Fumarate Drug Combination; Capsaicin; Cough; Cyclopropanes; Formoterol Fumarate; Humans; Inflammation; Leukotriene Antagonists; Quinolines; Sulfides | 2022 |
Effect of budesonide combined with montelukast sodium on pulmonary function parameters and immunoglobulin levels in children with bronchial asthma.
Topics: Acetates; Administration, Inhalation; Anti-Asthmatic Agents; Asthma; Budesonide; Child; Humans; Quinolines | 2023 |
Efficacy, Safety, and Systemic Exposure of Once-Daily Indacaterol Acetate in Pediatric Asthma: A Randomized, Double-Blind, Controlled Dose-Finding Study.
Topics: Acetates; Asthma; Child; Double-Blind Method; Forced Expiratory Volume; Humans | 2023 |
Efficacy of montelukast sodium chewable tablets combined with inhaled budesonide in treating pediatric asthma and its effect on inflammatory factors.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Anti-Asthmatic Agents; Asthma; Budesonide; Child; Child, Preschool; Cyclopropanes; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Inflammation; Male; Quinolines; Respiratory Function Tests; Sulfides; Tablets; Treatment Outcome | 2019 |
Developmental Pharmacogenetics of SLCO2B1 on Montelukast Pharmacokinetics in Chinese Children.
Topics: Acetates; Asthma; Child; Child, Preschool; China; Cyclopropanes; Female; Genotype; Humans; Infant; Leukotriene Antagonists; Male; Organic Anion Transporters; Pharmacogenetics; Prospective Studies; Quinolines; Receptors, Leukotriene; Sulfides | 2019 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Effects of using montelukast during acute wheezing attack in hospitalized preschool children on the discharge rate and the clinical asthma score.
Topics: Acetates; Asthma; Child; Child, Preschool; Cyclopropanes; Double-Blind Method; Humans; Infant; Leukotriene Antagonists; Patient Discharge; Quinolines; Respiratory Sounds; Sulfides | 2021 |
Early control treatment with montelukast in preschool children with asthma: A randomized controlled trial.
Topics: Acetates; Adrenergic beta-2 Receptor Agonists; Asthma; Child, Preschool; Cyclopropanes; Female; Humans; Infant; Japan; Male; Quinolines; Registries; Sulfides | 2018 |
Montelukast Treatment of Acute Asthma Exacerbations in Children Aged 2 to 5 Years: A Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Child, Preschool; China; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Quinolines; Sulfides; Treatment Outcome | 2018 |
Effectiveness of montelukast in overweight and obese atopic asthmatics.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Double-Blind Method; Female; Humans; Male; Obesity; Overweight; Prospective Studies; Quinolines; Sulfides | 2017 |
Fevipiprant, an oral prostaglandin DP
Topics: Acetates; Adult; Airway Management; Anti-Asthmatic Agents; Asthma; Budesonide; Cyclopropanes; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Monitoring; Female; Forced Expiratory Volume; Glucocorticoids; Humans; Indoleacetic Acids; Male; Middle Aged; Pyridines; Quinolines; Receptors, Immunologic; Receptors, Prostaglandin; Severity of Illness Index; Sulfides; Treatment Outcome | 2017 |
[Micro-invasive embedding combined with montelukast sodium for children cough variant asthma:a randomized controlled trial].
Topics: Acetates; Acupuncture Points; Acupuncture Therapy; Anti-Asthmatic Agents; Asthma; Child; Cough; Cyclopropanes; Forced Expiratory Volume; Humans; Quinolines; Sulfides | 2017 |
Traditional Chinese medicine as an adjunctive therapy to oral montelukast for treating patients with chronic asthma.
Topics: Acetates; Administration, Oral; Adolescent; Adult; Asthma; China; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Follow-Up Studies; Hospitals, University; Humans; Male; Medicine, Chinese Traditional; Middle Aged; Quality of Life; Quinolines; Respiratory Function Tests; Risk Assessment; Statistics, Nonparametric; Sulfides; Treatment Outcome; Young Adult | 2017 |
Efficacy and safety of lebrikizumab in adult patients with mild-to-moderate asthma not receiving inhaled corticosteroids.
Topics: Acetates; Administration, Inhalation; Adult; Anti-Asthmatic Agents; Antibodies, Monoclonal; Asthma; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Glucocorticoids; Humans; Injections, Subcutaneous; Male; Middle Aged; Quinolines; Severity of Illness Index; Sulfides; Treatment Failure; Treatment Outcome | 2018 |
Leukotriene E
Topics: Acetates; Adult; Aspirin; Asthma; Bronchoconstriction; Bronchoconstrictor Agents; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Eicosanoids; Female; Humans; Leukotriene Antagonists; Male; Mast Cells; Middle Aged; Quinolines; Receptors, Leukotriene; Sulfides; Young Adult | 2018 |
Efficacy and safety of the CRTh2 antagonist AZD1981 as add-on therapy to inhaled corticosteroids and long-acting β
Topics: Acetates; Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Anti-Asthmatic Agents; Asthma; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Indoles; Male; Middle Aged; Receptors, Immunologic; Receptors, Prostaglandin | 2018 |
Seasonality of sputum eosinophilia in adolescents with asthma remission: effects of montelukast.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Eosinophilia; Female; Humans; Male; Poland; Prospective Studies; Quinolines; Seasons; Spirometry; Sputum; Sulfides | 2018 |
A Randomized, Multicenter, Double-blind, Phase III Study to Evaluate the Efficacy on Allergic Rhinitis and Safety of a Combination Therapy of Montelukast and Levocetirizine in Patients With Asthma and Allergic Rhinitis.
Topics: Acetates; Adult; Anti-Allergic Agents; Anti-Asthmatic Agents; Asthma; Cetirizine; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Quinolines; Republic of Korea; Respiratory Function Tests; Rhinitis, Allergic, Perennial; Sulfides; Treatment Outcome | 2018 |
Exercise training as an adjunctive therapy to montelukast in children with mild asthma: A randomized controlled trial.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Combined Modality Therapy; Cyclopropanes; Exercise Therapy; Female; Follow-Up Studies; Humans; Male; Quinolines; Severity of Illness Index; Sulfides; Treatment Outcome | 2019 |
An Open-Label, Multi-Institutional, Randomized Study to Evaluate the Additive Effect of a Leukotriene Receptor Antagonist on Cough Score in Patients with Cough-Variant Asthma Being Treated with Inhaled Corticosteroids.
Topics: Acetates; Administration, Inhalation; Adrenal Cortex Hormones; Adult; Asthma; Cough; Cyclopropanes; Drug Therapy, Combination; Female; Humans; Leukotriene Antagonists; Male; Middle Aged; Quinolines; Sulfides | 2018 |
[Clinical effect of fluticasone propionate, montelukast sodium and ketotifen in treatment of cough variant asthma in children].
Topics: Acetates; Androstadienes; Anti-Asthmatic Agents; Asthma; Child; Cough; Cyclopropanes; Drug Combinations; Fluticasone; Humans; Ketotifen; Quinolines; Sulfides | 2019 |
A randomized, double-blind, placebo-controlled trial of oral montelukast in acute asthma exacerbation.
Topics: Acetates; Acute Disease; Administration, Oral; Adult; Aged; Asthma; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Lung; Male; Middle Aged; Peak Expiratory Flow Rate; Placebos; Quinolines; Recovery of Function; Sulfides; Treatment Outcome | 2013 |
Effects of 24-week add-on treatment with ciclesonide and montelukast on small airways inflammation in asthma.
Topics: Acetates; Aged; Anti-Allergic Agents; Anti-Asthmatic Agents; Asthma; Cell Count; Cell Movement; Cyclopropanes; Drug Therapy, Combination; Eosinophils; Female; Humans; Male; Middle Aged; Nitric Oxide; Pregnenediones; Pulmonary Alveoli; Quinolines; Respiratory Function Tests; Sulfides | 2013 |
Montelukast improves air trapping, not airway remodeling, in patients with moderate-to-severe asthma: a pilot study.
Topics: Acetates; Adult; Airway Remodeling; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Middle Aged; Pilot Projects; Quinolines; Sulfides; Total Lung Capacity | 2013 |
The effect of montelukast on wheal reactions in skin prick tests: a double-blind-placebo-controlled randomized trial.
Topics: Acetates; Allergens; Animals; Asthma; Chi-Square Distribution; Child; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Pyroglyphidae; Quinolines; Reference Values; Rhinitis, Allergic; Rhinitis, Allergic, Perennial; Sensitivity and Specificity; Skin Tests; Statistics, Nonparametric; Sulfides; Terfenadine; Urticaria | 2013 |
Predictors of asthma control and lung function responsiveness to step 3 therapy in children with uncontrolled asthma.
Topics: Acetates; Adolescent; Adrenergic beta-Agonists; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Biomarkers; Bronchodilator Agents; Child; Cross-Over Studies; Cyclopropanes; Eosinophils; Female; Fluticasone; Forced Expiratory Volume; Humans; Leukocyte Count; Leukotriene Antagonists; Leukotriene E4; Male; Quinolines; Salmeterol Xinafoate; Sulfides; Vital Capacity | 2014 |
Childhood asthma clusters and response to therapy in clinical trials.
Topics: Acetates; Adolescent; Adrenergic beta-2 Receptor Agonists; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Child; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Drug Combinations; Female; Fluticasone; Fluticasone-Salmeterol Drug Combination; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfides | 2014 |
Budesonide inhalation suspension versus montelukast in children aged 2 to 4 years with mild persistent asthma.
Topics: Acetates; Administration, Inhalation; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Budesonide; Child, Preschool; Cyclopropanes; Drug Administration Schedule; Female; Humans; Male; Quinolines; Sulfides; Suspensions; Treatment Outcome | 2013 |
Leukotriene D4 inhalation challenge for predicting short-term efficacy of montelukast: a pilot study.
Topics: Acetates; Administration, Inhalation; Adult; Asthma; Bronchial Provocation Tests; Cyclopropanes; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Leukotriene D4; Male; Middle Aged; Pilot Projects; Predictive Value of Tests; Quality of Life; Quinolines; Sulfides; Treatment Outcome; Young Adult | 2015 |
Montelukast versus budesonide as a first line preventive therapy in mild persistent asthma in 2 to 18 y.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Budesonide; Child; Child, Preschool; Cyclopropanes; Female; Humans; Male; Prospective Studies; Quinolines; Severity of Illness Index; Sulfides | 2014 |
Pulmonary function assessment in mild to moderate persistent asthma patients receiving montelukast, doxofylline, and tiotropium with budesonide: a randomized controlled study.
Topics: Acetates; Adult; Asthma; Bronchodilator Agents; Budesonide; Cyclopropanes; Drug Therapy, Combination; Female; Forced Expiratory Volume; Formoterol Fumarate; Humans; Male; Middle Aged; Quinolines; Respiratory Function Tests; Sulfides; Theophylline; Tiotropium Bromide | 2014 |
The effects of a Gly16Arg ADRB2 polymorphism on responses to salmeterol or montelukast in Japanese patients with mild persistent asthma.
Topics: Acetates; Administration, Inhalation; Adrenal Cortex Hormones; Adult; Albuterol; Asthma; Cyclopropanes; Female; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; Quinolines; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Sulfides | 2014 |
Clinical efficacy of montelukast sodium in treating infantile wheezing.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Case-Control Studies; Cyclopropanes; Female; Humans; Infant; Male; Prospective Studies; Quinolines; Respiratory Sounds; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Sulfides; Treatment Outcome | 2014 |
Eczema and race as combined determinants for differential response to step-up asthma therapy.
Topics: Acetates; Adolescent; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Black or African American; Child; Cross-Over Studies; Cyclopropanes; Drug Combinations; Drug Monitoring; Eczema; Female; Fluticasone; Fluticasone-Salmeterol Drug Combination; Hispanic or Latino; Humans; Male; Quinolines; Sulfides; White People | 2014 |
Effects of JNJ-40929837, a leukotriene A4 hydrolase inhibitor, in a bronchial allergen challenge model of asthma.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Bronchial Provocation Tests; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Epoxide Hydrolases; Female; Forced Expiratory Volume; Humans; Leukotriene B4; Male; Quinolines; Sputum; Sulfides; Thiazoles; Treatment Outcome; Tropanes; Young Adult | 2014 |
Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial.
Topics: Acetates; Anti-Asthmatic Agents; Appointments and Schedules; Arachidonate 5-Lipoxygenase; Asthma; Child, Preschool; Cyclopropanes; Cysteine; Drug Administration Schedule; Female; Genotype; Humans; Infant; Leukotrienes; Male; Quinolines; Respiratory Sounds; Sulfides; Treatment Outcome | 2014 |
Assessment of montelukast, doxofylline, and tiotropium with budesonide for the treatment of asthma: which is the best among the second-line treatment? A randomized trial.
Topics: Acetates; Adolescent; Adult; Asthma; Bronchodilator Agents; Budesonide; Cyclopropanes; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Male; Quinolines; Respiratory Function Tests; Sulfides; Theophylline; Tiotropium Bromide | 2015 |
Do children with stable asthma benefit from addition of montelukast to inhaled corticosteroids: randomized, placebo controlled trial.
Topics: Acetates; Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Animals; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Exercise Test; Female; Humans; Hypersensitivity; Male; Nitric Oxide; Pyroglyphidae; Quinolines; Respiratory Function Tests; Severity of Illness Index; Sulfides | 2015 |
Genome-wide association study of leukotriene modifier response in asthma.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cohort Studies; Cyclopropanes; Gene-Environment Interaction; Genetic Loci; Genome-Wide Association Study; Genotype; Humans; Hydroxyurea; Leukotrienes; Phenotype; Polymorphism, Single Nucleotide; Quinolines; Sulfides | 2016 |
Roflumilast for asthma: Efficacy findings in non-placebo-controlled comparator and dosing studies.
Topics: Acetates; Adolescent; Adult; Aged; Aminopyridines; Asthma; Beclomethasone; Benzamides; Child; Cyclopropanes; Double-Blind Method; Forced Expiratory Volume; Humans; Middle Aged; Phosphodiesterase 4 Inhibitors; Quinolines; Sulfides; Young Adult | 2015 |
Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma.
Topics: Acetates; Aged; Aged, 80 and over; Aminopyridines; Anti-Asthmatic Agents; Asthma; Benzamides; Cyclopropanes; Disease Progression; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Leukocyte Count; Leukotriene Antagonists; Male; Middle Aged; Quinolines; Risk Factors; Severity of Illness Index; Spirometry; Sulfides; Treatment Outcome | 2016 |
Two Phase II randomized trials on the CRTh2 antagonist AZD1981 in adults with asthma.
Topics: Acetates; Administration, Oral; Adolescent; Adult; Asthma; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Receptors, Immunologic; Receptors, Prostaglandin; Young Adult | 2016 |
Fluctuation Analysis of Peak Expiratory Flow and Its Association with Treatment Failure in Asthma.
Topics: Acetates; Administration, Inhalation; Adult; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Cyclopropanes; Drug Therapy, Combination; Female; Fluticasone; Humans; Male; Peak Expiratory Flow Rate; Quinolines; Salmeterol Xinafoate; Sulfides; Treatment Failure | 2017 |
A randomized placebo-controlled trial of traditional Chinese medicine as an add-on therapy to oral montelukast in the treatment of mild persistent asthma in children.
Topics: Acetates; Adolescent; Asthma; Child; Cyclopropanes; Double-Blind Method; Drugs, Chinese Herbal; Female; Humans; Male; Medicine, Chinese Traditional; Quality of Life; Quinolines; Sulfides | 2016 |
Real-life effectiveness of Singulair (montelukast) in 506 children with mild to moderate asthma.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cyclopropanes; Female; Humans; Leukotriene Antagonists; Male; Patient Satisfaction; Quinolines; Severity of Illness Index; Sulfides; Treatment Outcome | 2008 |
Fluticasone or montelukast for preschool children with asthma-like symptoms: Randomized controlled trial.
Topics: Acetates; Administration, Oral; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Child, Preschool; Cyclopropanes; Double-Blind Method; Female; Fluticasone; Humans; Male; Metered Dose Inhalers; Netherlands; Outpatient Clinics, Hospital; Quinolines; Respiratory Function Tests; Sulfides; Tablets; Time Factors; Treatment Outcome | 2008 |
Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Child; Cyclopropanes; Double-Blind Method; Drug Combinations; Female; Fluticasone; Humans; Male; Peak Expiratory Flow Rate; Prospective Studies; Quality of Life; Quinolines; Sulfides | 2008 |
The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma.
Topics: Acetates; Administration, Inhalation; Adrenal Cortex Hormones; Adult; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchi; Cyclopropanes; Female; Fluticasone; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Nitric Oxide; Prospective Studies; Quinolines; Sulfides | 2009 |
Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down".
Topics: Acetates; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Fluticasone; Fluticasone-Salmeterol Drug Combination; Forced Expiratory Flow Rates; Humans; Kaplan-Meier Estimate; Male; Patient Satisfaction; Peak Expiratory Flow Rate; Quinolines; Salmeterol Xinafoate; Sulfides; Surveys and Questionnaires | 2008 |
Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study.
Topics: Acetates; Adolescent; Albuterol; Anti-Bacterial Agents; Asthma; Azithromycin; Bronchodilator Agents; Budesonide; Child; Cyclopropanes; Double-Blind Method; Female; Glucocorticoids; Humans; Male; Medication Adherence; Quinolines; Salmeterol Xinafoate; Severity of Illness Index; Sulfides; Time Factors | 2008 |
Impulse oscillometry versus spirometry in a long-term study of controller therapy for pediatric asthma.
Topics: Acetates; Adolescent; Albuterol; Androstadienes; Asthma; Biomarkers; Child; Cyclopropanes; Double-Blind Method; Female; Fluticasone; Forced Expiratory Volume; Humans; Male; Oscillometry; Quinolines; Salmeterol Xinafoate; Spirometry; Sulfides; Vital Capacity | 2009 |
[Therapeutic efficacy and follow-up study of inhaled corticosteroids vs. oral montelukast in treatment of cough variant asthma].
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Beclomethasone; Child; Child, Preschool; Cough; Cyclopropanes; Female; Follow-Up Studies; Humans; Male; Quinolines; Risk Factors; Sulfides; Treatment Outcome | 2008 |
Molecular mechanism of the additive effects of leukotriene modifier in asthmatic patients receiving steroid therapy.
Topics: Acetates; Administration, Inhalation; Adrenal Cortex Hormones; Adult; Asthma; Chemokine CCL5; Chromones; Cyclopropanes; Cysteine; Cytokines; Drug Synergism; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Leukotrienes; Male; Middle Aged; Quinolines; Sulfides | 2009 |
Single-dose desloratadine and montelukast and allergen-induced late airway responses.
Topics: Acetates; Adult; Allergens; Analysis of Variance; Anti-Asthmatic Agents; Asthma; Bronchial Provocation Tests; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Eosinophils; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Leukotriene Antagonists; Loratadine; Male; Methacholine Chloride; Middle Aged; Nitric Oxide; Placebos; Quinolines; Respiratory Function Tests; Sputum; Sulfides; Treatment Outcome | 2009 |
Efficacy of add-on montelukast in patients with non-controlled asthma: a Belgian open-label study.
Topics: Acetates; Adult; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Belgium; Budesonide; Cyclopropanes; Drug Therapy, Combination; Ethanolamines; Female; Fluticasone; Formoterol Fumarate; Humans; Male; Middle Aged; Quinolines; Salmeterol Xinafoate; Sulfides; Surveys and Questionnaires | 2009 |
5-lipoxygenase pharmacogenetics in asthma: overlap with Cys-leukotriene receptor antagonist loci.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Cysteine; Female; Forced Expiratory Volume; Genotype; Humans; Hydroxyurea; Leukotriene Antagonists; Lipoxygenase Inhibitors; Male; Middle Aged; Polymorphism, Single Nucleotide; Quinolines; Receptors, Leukotriene; Sulfides | 2009 |
Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trial.
Topics: Acetates; Adolescent; Adult; Analysis of Variance; Anti-Asthmatic Agents; Asthma; Cell Count; Cyclopropanes; Double-Blind Method; Eosinophils; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Mast Cells; Middle Aged; Quinolines; Respiratory Mucosa; Sulfides; Treatment Outcome; Young Adult | 2009 |
The efficacy of montelukast during the allergy season in pediatric patients with persistent asthma and seasonal aeroallergen sensitivity.
Topics: Acetates; Administration, Oral; Adolescent; Asthma; Child; Cross-Over Studies; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Forced Expiratory Volume; Humans; Hypersensitivity; Male; Multivariate Analysis; Probability; Prognosis; Quinolines; Reference Values; Respiratory Function Tests; Rhinitis, Allergic, Seasonal; Risk Assessment; Severity of Illness Index; Sulfides; Treatment Outcome | 2009 |
A randomized study comparing the effect of loratadine added to montelukast with montelukast, loratadine, and beclomethasone monotherapies in patients with chronic asthma.
Topics: Acetates; Adolescent; Adult; Aged; Anti-Allergic Agents; Asthma; Beclomethasone; Chronic Disease; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Loratadine; Male; Middle Aged; Quality of Life; Quinolines; Sulfides; Young Adult | 2009 |
Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: role of predictors in the setting of high adherence.
Topics: Acetates; Adolescent; Adrenergic beta-Agonists; Albuterol; Allergens; Androstadienes; Anti-Asthmatic Agents; Asthma; Biomarkers; Child; Cyclopropanes; Double-Blind Method; Exhalation; Female; Fluticasone; Follow-Up Studies; Humans; Immunoglobulin E; Male; Nitric Oxide; Patient Compliance; Practice Guidelines as Topic; Quinolines; Salmeterol Xinafoate; Skin Tests; Sulfides; Urban Population; Young Adult | 2009 |
Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers.
Topics: Acetates; Administration, Oral; Adult; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Double-Blind Method; Female; Follow-Up Studies; Humans; Leukotriene Antagonists; Lung; Male; Middle Aged; Quinolines; Sulfides; Surveys and Questionnaires; Treatment Outcome | 2009 |
Can montelukast shorten prednisolone therapy in children with mild to moderate acute asthma? A randomized controlled trial.
Topics: Acetates; Adolescent; Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Child; Child, Preschool; Cyclopropanes; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Emergency Service, Hospital; Female; Hospitalization; Humans; Leukotriene Antagonists; Male; Prednisolone; Quinolines; Sulfides; Treatment Outcome | 2009 |
[Efficacy of montelukas in the prevention of acute asthma episode in children].
Topics: Acetates; Acute Disease; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cyclopropanes; Female; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfides | 2009 |
Leukotriene receptor antagonist in the treatment of childhood allergic rhinitis--a randomized placebo-controlled study.
Topics: Acetates; Adolescent; Asthma; Child; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Leukotriene Antagonists; Male; Quinolines; Rhinitis, Allergic, Perennial; Rhinometry, Acoustic; Sulfides; Terfenadine | 2009 |
Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis.
Topics: Acetates; Adolescent; Adult; Aged; Anti-Allergic Agents; Anti-Asthmatic Agents; Asthma; Cetirizine; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Female; Genetic Predisposition to Disease; Haplotypes; Humans; Indoles; Male; Middle Aged; Promoter Regions, Genetic; Quinolines; Receptors, Prostaglandin; Rhinitis, Allergic, Seasonal; Sulfides; Young Adult | 2009 |
Predicting short term response to anti-inflammatory therapy in young children with asthma.
Topics: Acetates; Algorithms; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Biomarkers, Pharmacological; Breath Tests; Child; Child, Preschool; Cyclopropanes; Female; Fluticasone; Humans; Male; Prognosis; Quinolines; Sulfides; Time Factors; Treatment Outcome | 2010 |
Evaluation of 3-5 months' add-on therapy with montelukast in patients with non-controlled asthma in Austria: the STAR open-label, real-world, observational study.
Topics: Acetates; Adolescent; Adult; Anti-Asthmatic Agents; Asthma; Austria; Child; Cohort Studies; Cyclopropanes; Female; Humans; Male; Middle Aged; Practice Guidelines as Topic; Quality of Life; Quinolines; Sulfides; Surveys and Questionnaires; Time Factors | 2010 |
Add-on montelukast to inhaled corticosteroids protects against excessive airway narrowing.
Topics: Acetates; Administration, Inhalation; Adrenal Cortex Hormones; Adult; Asthma; Bronchial Hyperreactivity; Cyclopropanes; Double-Blind Method; Female; Humans; Leukotriene Antagonists; Male; Methacholine Chloride; Middle Aged; Quinolines; Sulfides; Treatment Outcome; Young Adult | 2010 |
One-year evaluation of combined treatment with an intranasal corticosteroid and montelukast for chronic rhinosinusitis associated with asthma.
Topics: Acetates; Administration, Intranasal; Adrenal Cortex Hormones; Adult; Aged; Androstadienes; Anti-Allergic Agents; Asthma; Chronic Disease; Cyclopropanes; Drug Therapy, Combination; Eosinophils; Female; Fluticasone; Humans; Leukotriene Antagonists; Male; Middle Aged; Nasal Polyps; Quinolines; Rhinitis, Allergic, Perennial; Sinusitis; Sulfides; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma.
Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Infusions, Intravenous; Male; Middle Aged; Quinolines; Respiratory Function Tests; Sulfides; Young Adult | 2010 |
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Adrenergic beta-Agonists; Albuterol; Androstadienes; Asthma; Bronchodilator Agents; Child; Cross-Over Studies; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Eczema; Female; Fluticasone; Forced Expiratory Volume; Glucocorticoids; Humans; Leukotriene Antagonists; Logistic Models; Male; Prednisone; Quinolines; Salmeterol Xinafoate; Sulfides; Treatment Outcome | 2010 |
Effect of inhaled steroid and montelukast on clinical symptoms in children with newly diagnosed asthma: a pilot study.
Topics: Acetates; Administration, Inhalation; Adolescent; Animals; Antigens, Dermatophagoides; Asthma; Budesonide; Child; Child, Preschool; Cyclopropanes; Evidence-Based Medicine; Female; Humans; Male; Pilot Projects; Pyroglyphidae; Quinolines; Respiratory Function Tests; Sulfides | 2010 |
Montelukast as monotherapy in children with mild persistent asthma.
Topics: Acetates; Adolescent; Asthma; Child; Child, Preschool; Cyclopropanes; Disease Progression; Female; Humans; Leukotriene Antagonists; Male; Peak Expiratory Flow Rate; Prospective Studies; Quinolines; Severity of Illness Index; Sulfides; Treatment Outcome | 2009 |
A randomized, placebo-controlled study of intravenous montelukast in children with acute asthma.
Topics: Acetates; Acute Disease; Adolescent; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Hospitalization; Humans; Injections, Intravenous; Leukotriene Antagonists; Male; Quinolines; Sulfides; Treatment Failure | 2010 |
Montelukast treatment may alter the early efficacy of immunotherapy in children with asthma.
Topics: Acetates; Administration, Inhalation; Animals; Anti-Asthmatic Agents; Antigens, Dermatophagoides; Asthma; Budesonide; Chemotherapy, Adjuvant; Child; Cyclopropanes; Desensitization, Immunologic; Double-Blind Method; Follow-Up Studies; Humans; Lymphocyte Activation; Pyroglyphidae; Quinolines; Sulfides; T-Lymphocytes, Regulatory; Time Factors | 2010 |
Randomized open comparison of montelukast and sublingual immunotherapy as add-on treatment in moderate persistent asthma due to birch pollen.
Topics: Acetates; Administration, Sublingual; Adolescent; Adult; Aged; Antigens, Plant; Asthma; Betula; Cell Count; Cyclopropanes; Desensitization, Immunologic; Disease Progression; Eosinophilia; Female; Follow-Up Studies; Humans; Leukotriene Antagonists; Male; Middle Aged; Nasal Obstruction; Quinolines; Rhinitis, Allergic, Seasonal; Sulfides | 2010 |
Acute additive effect of montelukast and beclomethasone on AMP induced bronchoconstriction.
Topics: Acetates; Administration, Inhalation; Adolescent; Adult; Anti-Inflammatory Agents; Asthma; Beclomethasone; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstriction; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Male; Quinolines; Sulfides; Treatment Outcome; Young Adult | 2010 |
Effect of addition of single dose of oral montelukast to standard treatment in acute moderate to severe asthma in children between 5 and 15 years of age: a randomised, double-blind, placebo controlled trial.
Topics: Acetates; Administration, Oral; Adolescent; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cyclopropanes; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Male; Quinolines; Severity of Illness Index; Sulfides | 2010 |
Sodium cromoglycate alone and in combination with montelukast on the airway response to mannitol in asthmatic subjects.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Bronchial Provocation Tests; Bronchoconstriction; Cromolyn Sodium; Cyclopropanes; Dose-Response Relationship, Drug; Drug Combinations; Female; Forced Expiratory Volume; Humans; Male; Mannitol; Quinolines; Sulfides | 2010 |
Effect of montelukast or salmeterol added to inhaled fluticasone on exercise-induced bronchoconstriction in children.
Topics: Acetates; Adolescent; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchoconstriction; Child; Cross-Sectional Studies; Cyclopropanes; Double-Blind Method; Exercise; Female; Fluticasone; Forced Expiratory Volume; Humans; Male; Quinolines; Salmeterol Xinafoate; Sulfides | 2010 |
The Back to School asthma study: the effect of montelukast on asthma burden when initiated prophylactically at the start of the school year.
Topics: Acetates; Adolescent; Anti-Allergic Agents; Asthma; Child; Clinical Protocols; Cyclopropanes; Disease Progression; Female; Humans; Male; Periodicity; Quinolines; Schools; Seasons; Sulfides; Treatment Outcome | 2010 |
Montelukast added to fluticasone propionate does not alter inflammation or outcomes.
Topics: Acetates; Administration, Inhalation; Adult; Androstadienes; Asthma; Bronchi; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Eosinophilia; Female; Fluticasone; Forced Expiratory Volume; Humans; Male; Quinolines; Sulfides; Treatment Outcome | 2010 |
Urinary leukotriene E4/exhaled nitric oxide ratio and montelukast response in childhood asthma.
Topics: Acetates; Adolescent; Age of Onset; Asthma; Biomarkers; Child; Cyclopropanes; Female; Humans; Immunoglobulin E; Leukotriene Antagonists; Leukotriene E4; Male; Nitric Oxide; Predictive Value of Tests; Quinolines; Sulfides; Treatment Outcome | 2010 |
A subgroup analysis of the MONICA study: a 12-month, open-label study of add-on montelukast treatment in asthma patients.
Topics: Acetates; Adrenergic beta-2 Receptor Agonists; Age Factors; Anti-Asthmatic Agents; Asthma; Clinical Trials as Topic; Cyclopropanes; Drug Therapy, Combination; Glucocorticoids; Humans; Leukotriene Antagonists; Quality of Life; Quinolines; Severity of Illness Index; Sex Factors; Sulfides; Time Factors | 2010 |
A phase I randomized, placebo-controlled, dose-exploration study of single-dose inhaled montelukast in patients with chronic asthma.
Topics: Acetates; Administration, Inhalation; Adolescent; Adult; Aged; Asthma; Chronic Disease; Cross-Over Studies; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Forced Expiratory Volume; Humans; Least-Squares Analysis; Leukotriene Antagonists; Middle Aged; Quinolines; Sulfides; Young Adult | 2010 |
Oral montelukast in acute asthma exacerbations: a randomised, double-blind, placebo-controlled trial.
Topics: Acetates; Acute Disease; Administration, Oral; Adolescent; Adult; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Cyclopropanes; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Hospitalization; Humans; Leukotriene Antagonists; Male; Middle Aged; Peak Expiratory Flow Rate; Quinolines; Sulfides; Treatment Outcome; Young Adult | 2011 |
Effect of citrus juice and SLCO2B1 genotype on the pharmacokinetics of montelukast.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Area Under Curve; Asthma; Beverages; Citrus paradisi; Citrus sinensis; Cross-Over Studies; Cyclopropanes; Female; Florida; Food-Drug Interactions; Fruit; Heterozygote; Homozygote; Humans; Isotonic Solutions; Leukotriene Antagonists; Male; Models, Biological; Organic Anion Transporters; Phenotype; Polymorphism, Genetic; Quinolines; Sulfides | 2011 |
Cysteinyl leukotriene antagonism inhibits bronchoconstriction in response to hypertonic saline inhalation in asthma.
Topics: Acetates; Administration, Inhalation; Adolescent; Adult; Aged; Asthma; Bronchoconstriction; Cyclopropanes; Cysteine; Epidemiologic Methods; Female; Humans; Leukotriene Antagonists; Leukotrienes; Male; Middle Aged; Polymorphism, Genetic; Quinolines; Receptors, Leukotriene; Saline Solution, Hypertonic; Sulfides; Young Adult | 2011 |
Cost-effectiveness analysis of fluticasone versus montelukast in children with mild-to-moderate persistent asthma in the Pediatric Asthma Controller Trial.
Topics: Acetates; Androstadienes; Anti-Asthmatic Agents; Asthma; Child; Cost-Benefit Analysis; Cyclopropanes; Female; Fluticasone; Humans; Male; Quinolines; Respiratory Function Tests; Sulfides | 2011 |
Inhaled corticosteroids may have a beneficial effect on bone metabolism in newly diagnosed asthmatic children.
Topics: Acetates; Administration, Inhalation; Adolescent; Asthma; Bone and Bones; Budesonide; Child; Child, Preschool; Cyclopropanes; Double-Blind Method; Female; Glucocorticoids; Humans; Male; Parathyroid Hormone; Phosphorus; Quinolines; Sulfides | 2011 |
Effects of montelukast on patients with asthma after experimental inoculation with human rhinovirus 16.
Topics: Acetates; Asthma; Common Cold; Cyclopropanes; Double-Blind Method; Female; Humans; Leukotriene Antagonists; Male; Pilot Projects; Quinolines; Respiratory Function Tests; Reverse Transcriptase Polymerase Chain Reaction; Rhinovirus; RNA, Viral; Sulfides; Young Adult | 2011 |
Anti-inflammatory properties of montelukast, a leukotriene receptor antagonist in patients with asthma and nasal polyposis.
Topics: Acetates; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Asthma, Aspirin-Induced; Cell Count; Cyclopropanes; Cysteine; Eosinophils; Female; Humans; Leukotriene Antagonists; Leukotrienes; Male; Middle Aged; Nasal Lavage Fluid; Nasal Polyps; Neurokinin A; Quinolines; Substance P; Sulfides; Treatment Outcome | 2011 |
Influence of leukotriene pathway polymorphisms on clinical responses to montelukast in Japanese patients with asthma.
Topics: Acetates; Adult; Aged; Alleles; Anti-Asthmatic Agents; Arachidonate 5-Lipoxygenase; Asian People; Asthma; Cyclopropanes; Epoxide Hydrolases; Female; Forced Expiratory Volume; Genotype; Humans; Japan; Leukotriene Antagonists; Leukotrienes; Male; Middle Aged; Peak Expiratory Flow Rate; Polymorphism, Single Nucleotide; Quinolines; Sequence Analysis, DNA; Sulfides; Treatment Outcome | 2012 |
The efficacy and tolerability of inhaled montelukast plus inhaled mometasone compared with mometasone alone in patients with chronic asthma.
Topics: Acetates; Administration, Inhalation; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Chronic Disease; Confidence Intervals; Cross-Over Studies; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Linear Models; Male; Maximum Tolerated Dose; Middle Aged; Mometasone Furoate; Patient Compliance; Pregnadienediols; Quinolines; Reference Values; Risk Assessment; Severity of Illness Index; Spirometry; Sulfides; Treatment Outcome; United States; Young Adult | 2011 |
Intermittent or daily montelukast versus placebo for episodic asthma in children.
Topics: Acetates; Administration, Oral; Anti-Asthmatic Agents; Asthma; Child, Preschool; Cyclopropanes; Double-Blind Method; Drug Administration Schedule; Female; Humans; Infant; Male; Placebos; Quinolines; Sulfides; Treatment Outcome | 2011 |
Neutrophil predominance in induced sputum from asthmatic patients. Therapeutic implications and role of clara cell 16-KD protein.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Budesonide; Cell Count; Cyclopropanes; Drug Therapy, Combination; Eosinophils; Female; Humans; Male; Neutrophils; Quinolines; Severity of Illness Index; Single-Blind Method; Sputum; Sulfides; Uteroglobin; Young Adult | 2011 |
The effect of montelukast on bronchial hyperreactivity and lung function in asthmatic children aged 6-13 years.
Topics: Acetates; Adolescent; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Child; Cyclopropanes; Disease Progression; Female; Humans; Leukotriene Antagonists; Lung; Male; Quinolines; Respiratory Function Tests; Sulfides; Thailand; Treatment Outcome | 2011 |
Risk factors for montelukast treatment failure in step-down therapy for controlled asthma.
Topics: Acetates; Administration, Inhalation; Age of Onset; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Double-Blind Method; Forced Expiratory Volume; Glucocorticoids; Humans; Logistic Models; Quinolines; Risk Factors; Sensitivity and Specificity; Sulfides; Treatment Failure | 2011 |
[Effect of montelukast sodium on TGF-beta(1) of peripheral blood mononuclear cells from children with mild persistent asthma].
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cyclopropanes; Female; Humans; Male; Quinolines; Single-Blind Method; Sulfides; T-Lymphocytes, Regulatory; Transforming Growth Factor beta1 | 2011 |
Montelukast as an add-on therapy to inhaled corticosteroids in the treatment of severe asthma in elderly patients.
Topics: Acetates; Administration, Inhalation; Age Factors; Aged; Aged, 80 and over; Albuterol; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Budesonide; Chi-Square Distribution; Cyclopropanes; Drug Therapy, Combination; Female; Humans; Leukotriene Antagonists; Male; Middle Aged; Quinolines; Salmeterol Xinafoate; Spirometry; Sulfides; Surveys and Questionnaires | 2012 |
The efficacy and tolerability of intravenous montelukast in acute asthma exacerbations in Japanese patients.
Topics: Acetates; Adolescent; Adult; Aged; Anti-Asthmatic Agents; Asian People; Asthma; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Infusions, Intravenous; Leukotriene Antagonists; Male; Middle Aged; Quinolines; Sulfides; Treatment Outcome; Young Adult | 2012 |
Tailored second-line therapy in asthmatic children with the Arg(16) genotype.
Topics: Acetates; Adolescent; Adrenergic beta-2 Receptor Agonists; Albuterol; Amino Acid Motifs; Anti-Asthmatic Agents; Arginine; Asthma; Child; Child, Preschool; Cyclopropanes; Drug Therapy, Combination; Female; Genotype; Humans; Male; Polymorphism, Genetic; Quinolines; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Sulfides | 2013 |
Implementation strategies of internet-based asthma self-management support in usual care. Study protocol for the IMPASSE cluster randomized trial.
Topics: Acetates; Administration, Inhalation; Adolescent; Adult; Anti-Asthmatic Agents; Asthma; Clinical Protocols; Cost-Benefit Analysis; Cyclopropanes; Female; Glucocorticoids; Health Status; Humans; Information Dissemination; Internet; Male; Medication Adherence; Middle Aged; Patient Education as Topic; Quality of Life; Quinolines; Randomized Controlled Trials as Topic; Self Care; Single-Blind Method; Sulfides; Young Adult | 2012 |
Management of Asthma in School age Children On Therapy (MASCOT): a randomised, double-blind, placebo-controlled, parallel study of efficacy and safety.
Topics: Absenteeism; Acetates; Adolescent; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Child; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Fluticasone; Humans; Male; Quality of Life; Quinolines; Salmeterol Xinafoate; Sulfides; United Kingdom | 2013 |
Effect of montelukast for treatment of asthma in cigarette smokers.
Topics: Acetates; Adolescent; Adult; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Fluticasone; Humans; Male; Middle Aged; Quinolines; Smoking; Sulfides; Young Adult | 2013 |
The combination of single-dose montelukast and loratadine on exercise-induced bronchospasm in children.
Topics: Acetates; Adolescent; Age Factors; Asthma; Asthma, Exercise-Induced; Child; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Exercise Test; Female; Forced Expiratory Volume; Histamine H1 Antagonists, Non-Sedating; Humans; Leukotriene Antagonists; Loratadine; Male; Quinolines; Sulfides | 2002 |
[Influence of montelukast on inhalational bronchial allergen provocation].
Topics: Acetates; Adult; Allergens; Anti-Asthmatic Agents; Asthma; Bronchial Provocation Tests; Cyclopropanes; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Quinolines; Reproducibility of Results; Sulfides | 2002 |
Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients.
Topics: Acetates; Administration, Inhalation; Adult; Analysis of Variance; Asthma; Betamethasone; Cyclopropanes; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Forced Expiratory Volume; Glucocorticoids; Humans; Leukotriene Antagonists; Male; Middle Aged; Peak Expiratory Flow Rate; Quinolines; Statistics, Nonparametric; Sulfides | 2002 |
Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Breath Tests; Budesonide; Child; Cyclopropanes; Drug Therapy, Combination; Female; Fluticasone; Forced Expiratory Volume; Humans; Male; Maximal Midexpiratory Flow Rate; Nitric Oxide; Prospective Studies; Quinolines; Single-Blind Method; Sulfides | 2002 |
Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma.
Topics: Acetates; Adolescent; Adult; Aged; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Chronic Disease; Cost-Benefit Analysis; Cyclopropanes; Double-Blind Method; Drug Combinations; Female; Fluticasone; Humans; Male; Middle Aged; Quinolines; Salmeterol Xinafoate; Sulfides | 2002 |
Effects of montelukast and budesonide on airway responses and airway inflammation in asthma.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Anti-Inflammatory Agents; Asthma; Budesonide; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Humans; Inflammation; Leukotriene Antagonists; Prospective Studies; Quinolines; Respiratory Hypersensitivity; Respiratory System; Sulfides | 2002 |
Montelukast versus fluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma.
Topics: Acetates; Administration, Inhalation; Adolescent; Adult; Airway Resistance; Analysis of Variance; Androstadienes; Asthma; Bronchial Hyperreactivity; Cross-Over Studies; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fluticasone; Follow-Up Studies; Humans; Male; Middle Aged; Nitric Oxide; Probability; Quinolines; Reference Values; Respiratory Function Tests; Severity of Illness Index; Sputum; Sulfides; Treatment Outcome | 2002 |
Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma.
Topics: Acetates; Administration, Inhalation; Adult; Albuterol; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Beclomethasone; Breath Tests; Bronchial Provocation Tests; Bronchodilator Agents; Cyclopropanes; Drug Therapy, Combination; Female; Forced Expiratory Volume; Glucocorticoids; Humans; Leukotriene Antagonists; Male; Nitric Oxide; Peak Expiratory Flow Rate; Quinolines; Sputum; Sulfides | 2002 |
A randomized controlled trial of intravenous montelukast in acute asthma.
Topics: Acetates; Acute Disease; Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; Analysis of Variance; Asthma; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Injections, Intravenous; Leukotriene Antagonists; Male; Middle Aged; Pilot Projects; Quinolines; Regression Analysis; Sulfides | 2003 |
Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma.
Topics: Acetates; Adenosine Monophosphate; Adolescent; Adult; Aged; Albuterol; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Biomarkers; Bronchial Provocation Tests; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Fluticasone; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Middle Aged; Quinolines; Salmeterol Xinafoate; Severity of Illness Index; Sulfides; Treatment Outcome | 2003 |
Effects of montelukast and beclomethasone on airway function and asthma control.
Topics: Acetates; Adolescent; Adult; Aged; Asthma; Beclomethasone; Cyclopropanes; Double-Blind Method; Forced Expiratory Volume; Humans; Middle Aged; Quinolines; Sulfides | 2002 |
Effect of the addition of montelukast to inhaled fluticasone propionate on airway inflammation.
Topics: Acetates; Administration, Inhalation; Administration, Topical; Adult; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Biopsy; Bronchi; Bronchodilator Agents; Cross-Over Studies; Cyclopropanes; Data Interpretation, Statistical; Double-Blind Method; Drug Therapy, Combination; Female; Fluticasone; Forced Expiratory Volume; Glucocorticoids; Humans; Immunohistochemistry; Inflammation; Interferon-gamma; Interleukin-4; Leukotriene Antagonists; Male; Middle Aged; Placebos; Quinolines; Sulfides; Time Factors | 2003 |
Clinical and genetic features underlying the response of patients with bronchial asthma to treatment with a leukotriene receptor antagonist.
Topics: Acetates; Adult; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Cyclopropanes; Eosinophils; Female; Humans; Leukotriene Antagonists; Leukotriene C4; Lung; Male; Middle Aged; Peak Expiratory Flow Rate; Quinolines; Single-Blind Method; Statistics, Nonparametric; Sulfides | 2002 |
Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Aged; Anti-Asthmatic Agents; Asthma; Beclomethasone; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Quinolines; Spirometry; Sulfides; Time Factors | 2003 |
Exercise-induced bronchoconstriction in children: montelukast attenuates the immediate-phase and late-phase responses.
Topics: Acetates; Administration, Oral; Adolescent; Anti-Asthmatic Agents; Asthma; Bronchoconstriction; Child; Cross-Over Studies; Cyclopropanes; Exercise; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfides | 2003 |
Comparative in vivo bioactivity of modern H1-antihistamines on AMP challenge in atopic asthma.
Topics: Acetates; Adenosine Monophosphate; Adult; Aged; Asthma; Bronchial Provocation Tests; Cetirizine; Cross-Over Studies; Double-Blind Method; Female; Forced Expiratory Volume; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Piperazines; Respiratory Hypersensitivity; Terfenadine | 2003 |
Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma.
Topics: Acetates; Administration, Inhalation; Adult; Aged; Analysis of Variance; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Budesonide; Cyclopropanes; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Quality of Life; Quinolines; Sulfides; Treatment Outcome | 2003 |
Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma.
Topics: Acetates; Administration, Inhalation; Adolescent; Adult; Aged; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Budesonide; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Quinolines; Single-Blind Method; Sulfides; Treatment Outcome | 2003 |
The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma.
Topics: Acetates; Administration, Oral; Adolescent; Adult; Aged; Albuterol; Androstadienes; Asthma; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Fluticasone; Forced Expiratory Volume; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Quinolines; Salmeterol Xinafoate; Sulfides; Treatment Outcome | 2003 |
Comparison of montelukast and budesonide on bronchial reactivity in subjects with mild-moderate persistent asthma.
Topics: Acetates; Adult; Analysis of Variance; Anti-Asthmatic Agents; Asthma; Bronchi; Bronchial Provocation Tests; Budesonide; Cyclopropanes; Female; Humans; Male; Quinolines; Sulfides; Treatment Outcome | 2003 |
Response to montelukast among subgroups of children aged 2 to 14 years with asthma.
Topics: Acetates; Adolescent; Asthma; Child; Child, Preschool; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfides | 2003 |
Effects of oral montelukast on airway function in acute asthma.
Topics: Acetates; Acute Disease; Administration, Oral; Aged; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Leukotriene Antagonists; Male; Middle Aged; Peak Expiratory Flow Rate; Prednisolone; Quinolines; Single-Blind Method; Sulfides | 2003 |
A randomized controlled trial on the effect of montelukast on sputum eosinophil cationic protein in children with corticosteroid-dependent asthma.
Topics: Acetates; Adolescent; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Blood Proteins; Budesonide; Child; Cyclopropanes; Drug Therapy, Combination; Eosinophil Granule Proteins; Eosinophils; Female; Humans; Male; Quinolines; Ribonucleases; Sputum; Sulfides; Treatment Outcome | 2003 |
Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma.
Topics: Acetates; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Pulmonary Ventilation; Quinolines; Rhinitis, Allergic, Seasonal; Sulfides; Treatment Outcome | 2003 |
Montelukast, a leukotriene receptor antagonist, in vernal keratoconjunctivitis associated with asthma.
Topics: Acetates; Adolescent; Adult; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Conjunctivitis, Allergic; Cyclopropanes; Enzyme-Linked Immunosorbent Assay; Female; Humans; Leukotriene Antagonists; Leukotriene B4; Leukotriene E4; Male; Ophthalmic Solutions; Peak Expiratory Flow Rate; Pilot Projects; Quinolines; Sulfides; Tears | 2003 |
"Real-world" effectiveness of daily controller medicine in children with mild persistent asthma.
Topics: Acetates; Administration, Intranasal; Administration, Oral; Adolescent; Adrenergic beta-Agonists; Androstadienes; Anti-Bacterial Agents; Asthma; Bronchodilator Agents; Child; Cyclopropanes; Emergency Medical Services; Female; Fluticasone; Humans; Leukotriene Antagonists; Male; Patient Compliance; Peak Expiratory Flow Rate; Pilot Projects; Prednisolone; Prospective Studies; Quinolines; Sulfides | 2003 |
Effects of mediator antagonism on mannitol and adenosine monophosphate challenges.
Topics: Acetates; Adenosine Monophosphate; Adult; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstrictor Agents; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Leukotriene Antagonists; Loratadine; Male; Mannitol; Middle Aged; Quinolines; Sulfides; Time Factors | 2003 |
A proof of concept study to evaluate putative benefits of montelukast in moderate persistent asthmatics.
Topics: Acetates; Adolescent; Adult; Anti-Asthmatic Agents; Asthma; Chronic Disease; Cyclopropanes; Double-Blind Method; Drug Evaluation; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Quinolines; Sulfides; Treatment Outcome | 2003 |
Add-on therapy with montelukast or formoterol in patients with the glycine-16 beta2-receptor genotype.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Down-Regulation; Drug Therapy, Combination; Ethanolamines; Forced Expiratory Volume; Formoterol Fumarate; Humans; Peak Expiratory Flow Rate; Quinolines; Receptors, Adrenergic, beta-2; Sulfides | 2003 |
Short-term effect of the addition of leukotriene receptor antagonists to the current therapy in severe asthmatics.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Female; Humans; Indoles; Leukotriene Antagonists; Lung Volume Measurements; Male; Middle Aged; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds; Treatment Outcome | 2003 |
[The effectiveness of leukotriene antagonists in the treatment of aspirin-intolerant asthmatic patients].
Topics: Acetates; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Bleeding Time; Cyclopropanes; Female; Humans; Leukotriene Antagonists; Male; Quality of Life; Quinolines; Rhinitis; Severity of Illness Index; Spirometry; Sulfides; Surveys and Questionnaires | 2003 |
Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids.
Topics: Acetates; Administration, Intranasal; Adolescent; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Double-Blind Method; Drug Synergism; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Pilot Projects; Quinolines; Sulfides | 2003 |
Effect of montelukast on time-course of exhaled nitric oxide in asthma: influence of LTC4 synthase A(-444)C polymorphism.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Breath Tests; Child; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Female; Glutathione Transferase; Humans; Male; Nitric Oxide; Pharmacogenetics; Polymorphism, Genetic; Quinolines; Spirometry; Sulfides; Time Factors | 2003 |
Evaluation of parental preference for the treatment of asthmatic children aged 6 to 11 years with oral montelukast or inhaled cromolyn: a randomized, open-label, crossover study.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Albuterol; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Child; Cromolyn Sodium; Cross-Over Studies; Cyclopropanes; Female; Humans; Male; Parents; Patient Compliance; Patient Satisfaction; Quinolines; Sulfides | 2003 |
Comparisons of the complementary effect on exhaled nitric oxide of salmeterol vs montelukast in asthmatic children taking regular inhaled budesonide.
Topics: Acetates; Administration, Inhalation; Adolescent; Albuterol; Asthma; Breath Tests; Bronchodilator Agents; Budesonide; Child; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Humans; Nitric Oxide; Quinolines; Salmeterol Xinafoate; Sulfides | 2003 |
Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Biomarkers; Breath Tests; Cross-Over Studies; Cyclopropanes; Cysteine; Double-Blind Method; Exhalation; Female; Forced Expiratory Volume; Humans; Hydrogen Peroxide; Inflammation Mediators; Leukotrienes; Male; Nitric Oxide; Peak Expiratory Flow Rate; Pneumonia; Quinolines; Severity of Illness Index; Sulfides | 2003 |
Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial.
Topics: Acetates; Adolescent; Adult; Aged; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Fluticasone; Forced Expiratory Volume; Humans; Middle Aged; Quinolines; Salmeterol Xinafoate; Sulfides; Treatment Outcome | 2003 |
The effect of montelukast on bronchial provocation tests and exhaled nitric oxide levels in asthmatic patients.
Topics: Acetates; Adenosine; Administration, Oral; Adolescent; Adult; Anti-Asthmatic Agents; Asthma; Bronchial Provocation Tests; Bronchoconstrictor Agents; Child; Cyclopropanes; Exercise; Female; Humans; Male; Methacholine Chloride; Middle Aged; Nitric Oxide; Quinolines; Spirometry; Sulfides; Treatment Outcome; Vasodilator Agents | 2003 |
Comparative efficacy of once-daily therapy with inhaled corticosteroid, leukotriene antagonist or sustained-release theophylline in patients with mild persistent asthma.
Topics: Acetates; Administration, Inhalation; Adrenergic beta-2 Receptor Antagonists; Adult; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Budesonide; Cyclopropanes; Delayed-Action Preparations; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Middle Aged; Peak Expiratory Flow Rate; Quinolines; Sulfides; Theophylline; Treatment Outcome | 2003 |
[A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
Topics: Acetates; Administration, Inhalation; Adult; Aerosols; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Beclomethasone; Bronchodilator Agents; Cyclopropanes; Drug Combinations; Female; Fluticasone; Humans; Leukotriene Antagonists; Male; Middle Aged; Peak Expiratory Flow Rate; Powders; Prospective Studies; Quinolines; Salmeterol Xinafoate; Sulfides; Treatment Outcome | 2003 |
Montelukast 10 mg improves nasal function and nasal response to aspirin in ASA-sensitive asthmatics: a controlled study vs placebo.
Topics: Acetates; Adult; Airway Resistance; Aspirin; Asthma; Cyclopropanes; Double-Blind Method; Female; Humans; Leukotriene Antagonists; Male; Middle Aged; Nasal Provocation Tests; Nose; Quinolines; Sulfides | 2004 |
Effect of montelukast and fluticasone propionate on airway mucosal blood flow in asthma.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Aged; Androstadienes; Asthma; Blood Flow Velocity; Bronchi; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluticasone; Follow-Up Studies; Humans; Male; Middle Aged; Mucous Membrane; Multivariate Analysis; Probability; Pulmonary Circulation; Quinolines; Severity of Illness Index; Spirometry; Sulfides; Treatment Outcome | 2004 |
Antihistamines added to an antileukotriene in treating seasonal allergic rhinitis: histamine and leukotriene antagonism.
Topics: Acetates; Adolescent; Adult; Asthma; Cetirizine; Cyclopropanes; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Forced Expiratory Volume; Histamine H1 Antagonists; Humans; Interleukin-15; Interleukin-18; Leukocyte Count; Leukotriene Antagonists; Male; Nasal Mucosa; Pruritus; Quinolines; Rhinitis, Allergic, Seasonal; Sneezing; Sulfides; Therapeutic Irrigation | 2004 |
Repeated dosing effects of mediator antagonists in inhaled corticosteroid-treated atopic asthmatic patients.
Topics: Acetates; Adenosine Monophosphate; Administration, Inhalation; Adrenal Cortex Hormones; Anti-Allergic Agents; Anti-Asthmatic Agents; Asthma; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Drug Administration Schedule; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Quinolines; Respiratory Hypersensitivity; Sulfides; Terfenadine; Treatment Outcome | 2004 |
Pharmacokinetics of montelukast in asthmatic patients 6 to 24 months old.
Topics: Acetates; Administration, Oral; Area Under Curve; Asthma; Blood Urea Nitrogen; Chemistry, Pharmaceutical; Child, Preschool; Cyclopropanes; Diarrhea; Half-Life; Humans; Infant; Male; Mastication; Quinolines; Receptors, Leukotriene B4; Sulfides; Tablets | 2004 |
Addition of montelukast versus double dose of inhaled budesonide in moderate persistent asthma.
Topics: Acetates; Adult; Asthma; Bronchodilator Agents; Budesonide; Cyclopropanes; Drug Therapy, Combination; Female; Humans; Leukotriene Antagonists; Male; Quinolines; Spirometry; Sulfides | 2004 |
Effect of cysteinyl leukotriene receptor antagonist on CD11b and CD23 expression in asthmatic children.
Topics: Acetates; Asthma; CD11b Antigen; Child; Cyclopropanes; Eosinophils; Female; Flow Cytometry; Forced Expiratory Volume; Humans; Immunoglobulin E; Leukocyte Count; Leukotriene Antagonists; Lung; Lymphocyte Count; Male; Membrane Proteins; Peak Expiratory Flow Rate; Quinolines; Receptors, IgE; Receptors, Leukotriene; Statistics, Nonparametric; Sulfides; T-Lymphocytes | 2004 |
A clinical trial of the efficacy and safety of montelukast as monotherapy in patients with chronic stable bronchial asthma.
Topics: Acetates; Adult; Aged; Anti-Asthmatic Agents; Asthma; Chronic Disease; Cyclopropanes; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Middle Aged; Peak Expiratory Flow Rate; Prospective Studies; Quinolines; Sulfides; Treatment Outcome | 2004 |
Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.
Topics: Acetates; Adolescent; Adult; Aged; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Fluticasone; Forced Expiratory Volume; History, 16th Century; Humans; Male; Middle Aged; Quinolines; Salmeterol Xinafoate; Sulfides; Treatment Outcome | 2004 |
Comparative effect of triamcinolone, nedocromil and montelukast on asthma control in children: A randomized pragmatic study.
Topics: Acetates; Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Anti-Inflammatory Agents; Asthma; Bronchial Hyperreactivity; Child; Cyclopropanes; Eosinophils; Female; Humans; Male; Nedocromil; Quinolines; Respiratory Function Tests; Sulfides; Triamcinolone | 2004 |
Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma.
Topics: Acetates; Administration, Inhalation; Adult; Aspirin; Asthma; Confidence Intervals; Cross-Over Studies; Cyclopropanes; Cysteine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Leukotrienes; Lysine; Male; Middle Aged; Nasal Provocation Tests; Peak Expiratory Flow Rate; Quinolines; Reference Values; Reproducibility of Results; Spirometry; Sulfides | 2004 |
Variability of symptoms in mild persistent asthma: baseline data from the MIAMI study.
Topics: Acetates; Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Albuterol; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Cohort Studies; Cyclopropanes; Double-Blind Method; Exercise; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Middle Aged; Patient Acceptance of Health Care; Quinolines; Severity of Illness Index; Sulfides | 2004 |
Effect of montelukast compared with inhaled fluticasone on airway inflammation.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adult; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Cyclopropanes; Double-Blind Method; Eosinophil Cationic Protein; Female; Fluticasone; Humans; Immunohistochemistry; Interleukin-5; Leukotriene Antagonists; Lung; Male; Mast Cells; Middle Aged; Quinolines; Receptors, Interleukin-2; Sulfides; T-Lymphocytes | 2004 |
Montelukast - evaluation in 6 to 14 years old children with persistent asthma - pediatric montelukast study group.
Topics: Acetates; Administration, Oral; Adolescent; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Drug Administration Schedule; Female; Humans; Male; Prospective Studies; Quinolines; Sulfides | 2004 |
The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis.
Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Double-Blind Method; Female; Humans; Male; Middle Aged; Quinolines; Rhinitis, Allergic, Seasonal; Single-Blind Method; Sulfides; Treatment Outcome | 2004 |
Montelukast in asthmatic patients 6 years-14 years old with an FEV1 > 75%.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Placebos; Quinolines; Severity of Illness Index; Sulfides; Treatment Outcome | 2004 |
Effectiveness of montelukast in the treatment of cough variant asthma.
Topics: Acetates; Adrenergic beta-Agonists; Adult; Aged; Anti-Asthmatic Agents; Antitussive Agents; Asthma; Bronchial Provocation Tests; Cough; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Methacholine Chloride; Middle Aged; Monitoring, Ambulatory; Pilot Projects; Quinolines; Severity of Illness Index; Sulfides; Treatment Outcome | 2004 |
Montelukast and airway remodeling in children with chronic persistent asthma: an open study.
Topics: Acetates; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Child; Chronic Disease; Cyclopropanes; Drug Therapy, Combination; Fluticasone; Follow-Up Studies; Humans; Lung; Quinolines; Respiratory Function Tests; Salmeterol Xinafoate; Sulfides | 2004 |
Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma.
Topics: Acetates; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Anti-Asthmatic Agents; Asthma; Child, Preschool; Cyclopropanes; Double-Blind Method; Drug Administration Schedule; Eosinophils; Female; Humans; Male; Quinolines; Respiratory Tract Infections; Severity of Illness Index; Sulfides; Time Factors; Treatment Outcome | 2005 |
Protective effect of montelukast on lower and upper respiratory tract responses to short-term cat allergen exposure.
Topics: Acetates; Adolescent; Adult; Allergens; Animals; Area Under Curve; Asthma; Cats; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Hypersensitivity; Male; Middle Aged; Quinolines; Respiratory System; Rhinitis, Allergic, Seasonal; Sulfides | 2004 |
Differential effects of fluticasone and montelukast on allergen-induced asthma.
Topics: Acetates; Adult; Allergens; Androstadienes; Asthma; Bronchial Provocation Tests; Bronchoconstrictor Agents; Bronchodilator Agents; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Eosinophils; Female; Fluticasone; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Methacholine Chloride; Quinolines; Sputum; Sulfides; Time Factors | 2005 |
Prolonged effect of montelukast in asthmatic children with exercise-induced bronchoconstriction.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Bronchoconstriction; Child; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Exercise Test; Female; Forced Expiratory Volume; Humans; Male; Quinolines; Spirometry; Sulfides; Time Factors; Treatment Outcome | 2005 |
The effect of montelukast versus usual care on health care resource utilization in children aged 2 to 5 years with asthma.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Child, Preschool; Cromolyn Sodium; Cyclopropanes; Double-Blind Method; Female; Health Resources; Humans; Male; Quinolines; Sulfides | 2004 |
Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma.
Topics: Acetates; Adult; Aged; Analysis of Variance; Asthma; Cross-Over Studies; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Eosinophilia; Eosinophils; Female; Humans; Leukotriene Antagonists; Male; Middle Aged; Prednisone; Probability; Quinolines; Reference Values; Respiratory Function Tests; Risk Assessment; Severity of Illness Index; Sputum; Sulfides; Treatment Failure | 2005 |
Effect of budesonide and montelukast in asthmatic children exposed to relevant allergens.
Topics: Acetates; Allergens; Anti-Asthmatic Agents; Antigens, Dermatophagoides; Asthma; Bronchial Hyperreactivity; Bronchoconstrictor Agents; Bronchodilator Agents; Budesonide; Child; Cyclopropanes; Eosinophils; Exhalation; Female; Humans; Lung; Male; Methacholine Chloride; Nitric Oxide; Quinolines; Respiratory Function Tests; Sputum; Sulfides | 2005 |
Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast.
Topics: Acetates; Adult; Androstadienes; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Double-Blind Method; Eosinophils; Female; Fluticasone; Humans; Leukotriene Antagonists; Male; Patient Compliance; Pulmonary Eosinophilia; Quinolines; Sputum; Sulfides; Treatment Outcome | 2005 |
The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma.
Topics: Acetates; Administration, Inhalation; Analysis of Variance; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Infant; Male; Nitric Oxide; Prospective Studies; Quinolines; Statistics, Nonparametric; Sulfides; Treatment Outcome | 2005 |
Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
Topics: Acetates; Administration, Inhalation; Adolescent; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Child; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Eosinophil Cationic Protein; Eosinophils; Exhalation; Female; Fluticasone; Forced Expiratory Volume; Humans; Immunoglobulin E; Leukocyte Count; Male; Nitric Oxide; Predictive Value of Tests; Quinolines; Sulfides; Vital Capacity | 2005 |
Impact of a soluble phospholipase A2 inhibitor on inhaled allergen challenge in subjects with asthma.
Topics: Acetates; Administration, Inhalation; Adult; Asthma; Bronchial Provocation Tests; Bronchoconstriction; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Indoles; Keto Acids; Male; Phospholipases A; Phospholipases A2; Skin Tests | 2005 |
Montelukast protects against bradykinin-induced bronchospasm.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Bradykinin; Bronchial Provocation Tests; Bronchial Spasm; Cyclopropanes; Forced Expiratory Volume; Humans; Quinolines; Sulfides | 2005 |
Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Androstadienes; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Double-Blind Method; Fluticasone; Forced Expiratory Volume; Humans; Quinolines; Sulfides; Treatment Outcome | 2005 |
The effect of montelukast and different doses of budesonide on IgE serum levels and clinical parameters in children with newly diagnosed asthma.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Anti-Asthmatic Agents; Antigens, Dermatophagoides; Asthma; Budesonide; Child; Child, Preschool; Cyclopropanes; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunoglobulin E; Male; Quinolines; Severity of Illness Index; Sulfides; Treatment Outcome | 2005 |
Discrepant clinical responses and blood chemokine profiles between two non-steroidal anti-inflammatory medications for children with mild persistent asthma.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Chemokine CCL17; Chemokine CCL22; Chemokines; Chemokines, CC; Child; Cyclopropanes; Double-Blind Method; Histamine H1 Antagonists; Humans; Ketotifen; Leukotriene Antagonists; Peak Expiratory Flow Rate; Quinolines; Respiratory Function Tests; Sulfides; Th2 Cells | 2005 |
Inflammatory basis of exercise-induced bronchoconstriction.
Topics: Acetates; Adolescent; Adult; Asthma; Bronchitis; Bronchoconstriction; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Exercise; Female; Forced Expiratory Volume; Histamine H1 Antagonists, Non-Sedating; Humans; Inflammation Mediators; Leukotriene Antagonists; Loratadine; Lung; Male; Middle Aged; Quinolines; Severity of Illness Index; Sulfides | 2005 |
Safety, tolerability, and exploratory efficacy of montelukast in 6- to 24-month-old patients with asthma.
Topics: Acetates; Administration, Oral; Adrenergic beta-Agonists; Anti-Asthmatic Agents; Asthma; Child, Preschool; Cyclopropanes; Double-Blind Method; Female; Humans; Infant; Male; Placebos; Quinolines; Sulfides | 2005 |
Traditional and patient-centred outcomes with three classes of asthma medication.
Topics: Acetates; Adolescent; Adult; Aged; Androstadienes; Asthma; Cross-Over Studies; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Ethanolamines; Female; Fluticasone; Follow-Up Studies; Forced Expiratory Volume; Formoterol Fumarate; Humans; Linear Models; Male; Middle Aged; New South Wales; Patient Satisfaction; Patient-Centered Care; Probability; Quality of Life; Quinolines; Respiratory Function Tests; Severity of Illness Index; Single-Blind Method; Sulfides; Treatment Outcome | 2005 |
Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study.
Topics: Acetates; Administration, Inhalation; Adolescent; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Child; Cyclopropanes; Double-Blind Method; Female; Fluticasone; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfides | 2005 |
Tapering dose of inhaled budesonide in subjects with mild-to-moderate persistent asthma treated with montelukast: a 16-week single-blind randomized study.
Topics: Acetates; Administration, Inhalation; Adolescent; Adult; Aged; Asthma; Budesonide; Cyclopropanes; Female; Humans; Male; Middle Aged; Quinolines; Respiratory Function Tests; Single-Blind Method; Sulfides; Time Factors | 2005 |
Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma.
Topics: Acetates; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Child; Cyclopropanes; Double-Blind Method; Female; Fluticasone; Humans; Hydrocortisone; Male; Quinolines; Respiratory Function Tests; Severity of Illness Index; Sulfides; Treatment Outcome | 2005 |
Leukotriene D4-induced hypoxaemia in asthma is mediated by the cys-leukotriene1 receptor.
Topics: Acetates; Adult; Asthma; Bronchial Provocation Tests; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Female; Humans; Hypoxia; Leukotriene Antagonists; Leukotriene D4; Male; Membrane Proteins; Quinolines; Receptors, Leukotriene; Severity of Illness Index; Sulfides; Ventilation-Perfusion Ratio | 2005 |
Determining economic feasibility of fluticasone propionate-salmeterol vs montelukast in the treatment of persistent asthma using a net benefit approach and cost-effectiveness acceptability curves.
Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Cost-Benefit Analysis; Cyclopropanes; Double-Blind Method; Drug Combinations; Drug Costs; Female; Fluticasone-Salmeterol Drug Combination; Humans; Leukotriene Antagonists; Male; Middle Aged; Prospective Studies; Quinolines; Respiratory Function Tests; Sulfides | 2005 |
Effect of combined montelukast and desloratadine on the early asthmatic response to inhaled allergen.
Topics: Acetates; Adult; Allergens; Anti-Asthmatic Agents; Asthma; Bronchial Provocation Tests; Cross-Over Studies; Cyclopropanes; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Loratadine; Male; Middle Aged; Quinolines; Sulfides; Time Factors | 2005 |
Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control.
Topics: Acetates; Administration, Inhalation; Adult; Androstadienes; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Female; Fluticasone; Forced Expiratory Volume; Humans; Male; Patient Selection; Quinolines; Reproducibility of Results; Respiratory Distress Syndrome; Respiratory Function Tests; Rhinitis, Allergic, Perennial; Sleep Wake Disorders; Sulfides; Treatment Outcome; Wakefulness | 2005 |
Effect of montelukast on exhaled leukotrienes and quality of life in asthmatic patients.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Breath Tests; Cyclopropanes; Exhalation; Family Practice; Female; Forced Expiratory Volume; Humans; Leukotrienes; Male; Middle Aged; Quality of Life; Quinolines; Sulfides; Vital Capacity | 2005 |
Montelukast improves pulmonary function measured by impulse oscillometry in children with asthma (Mio study).
Topics: Acetates; Administration, Oral; Adolescent; Airway Resistance; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Oscillometry; Peak Expiratory Flow Rate; Quinolines; Sulfides; Treatment Outcome | 2006 |
Effects of montelukast on symptoms and eNO in children with mild to moderate asthma.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Breath Tests; Child; Cyclopropanes; Female; Humans; Male; Nitric Oxide; Peak Expiratory Flow Rate; Quinolines; Sulfides; Time Factors; Treatment Outcome | 2005 |
Effect of montelukast on basophil releasability in patients with asthma.
Topics: Acetates; Adult; Asthma; Basophils; Cyclopropanes; Cysteine; Female; Histamine; Humans; Immunologic Factors; Leukotriene Antagonists; Leukotrienes; Male; Quinolines; Sulfides | 2005 |
Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma.
Topics: Acetates; Adolescent; Androstadienes; Asthma; Child; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Female; Fluticasone; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Nitric Oxide; Quinolines; Sulfides | 2006 |
Double-blind, randomised, controlled trial assessing controller medications in asthma.
Topics: Acetates; Adolescent; Adult; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Budesonide; Cyclopropanes; Delayed-Action Preparations; Double-Blind Method; Forced Expiratory Volume; Humans; Middle Aged; Patient Selection; Quinolines; Sulfides; Theophylline | 2006 |
Montelukast in asthma treatment in Croatia.
Topics: Acetates; Analysis of Variance; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Drug Therapy, Combination; Humans; Quinolines; Safety; Sulfides | 2005 |
Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity.
Topics: Acetates; Administration, Oral; Adolescent; Adult; Aged; Anti-Asthmatic Agents; Asthma; Chronic Disease; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Logistic Models; Male; Middle Aged; Peak Expiratory Flow Rate; Quinolines; Rhinitis, Allergic, Seasonal; Sulfides | 2006 |
Improvement of otitis media with effusion after treatment of asthma with leukotriene antagonists in children with co-existing disease.
Topics: Acetates; Administration, Inhalation; Adolescent; Asthma; Bronchodilator Agents; Budesonide; Child; Cyclopropanes; Drug Therapy, Combination; Humans; Leukotriene Antagonists; Otitis Media with Effusion; Quinolines; Sulfides; Terbutaline | 2005 |
Montelukast improves regional air-trapping due to small airways obstruction in asthma.
Topics: Acetates; Adolescent; Adult; Aged; Anti-Asthmatic Agents; Asthma; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Female; Humans; Linear Models; Male; Methacholine Chloride; Middle Aged; Quinolines; Respiratory Function Tests; Statistics, Nonparametric; Sulfides; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness.
Topics: Acetates; Administration, Inhalation; Adult; Aged; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Budesonide; Cross-Over Studies; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Eosinophils; Ethanolamines; Formoterol Fumarate; Glucocorticoids; Humans; Leukocyte Count; Lung Volume Measurements; Male; Methacholine Chloride; Middle Aged; Quinolines; Sputum; Sulfides | 2006 |
Influence of body mass index on the response to asthma controller agents.
Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Asthmatic Agents; Asthma; Beclomethasone; Body Mass Index; Cyclopropanes; Double-Blind Method; Female; Humans; Male; Middle Aged; Quinolines; Sulfides; Treatment Outcome | 2006 |
Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Female; Humans; Leukotriene Antagonists; Male; Middle Aged; Product Surveillance, Postmarketing; Quality of Life; Quinolines; Respiratory Hypersensitivity; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sulfides; Treatment Outcome | 2006 |
Effect of montelukast on peripheral airflow obstruction in children with asthma.
Topics: Acetates; Adolescent; Airway Obstruction; Airway Resistance; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Lung Volume Measurements; Male; Oscillometry; Plethysmography; Quinolines; Spirometry; Sulfides | 2006 |
Oral montelukast treatment of preschool-aged children with acute asthma.
Topics: Acetates; Acute Disease; Administration, Oral; Albuterol; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Child; Child, Preschool; Cyclopropanes; Drug Therapy, Combination; Female; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfides | 2006 |
Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: a 56-week randomized double-blind study.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Beclomethasone; Body Height; Child; Cyclopropanes; Double-Blind Method; Female; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfides | 2006 |
Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma.
Topics: Acetates; Allergens; Anti-Asthmatic Agents; Asthma; Biomarkers; Breath Tests; Child; Cross-Sectional Studies; Cyclopropanes; Dinoprost; Dinoprostone; Humans; Hypersensitivity; Leukotriene Antagonists; Leukotriene E4; Nitric Oxide; Quinolines; Skin Tests; Spirometry; Sulfides | 2006 |
Effect of obesity on clinical presentation and response to treatment in asthma.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Cyclopropanes; Cytokines; Disease Progression; Double-Blind Method; Female; Forced Expiratory Volume; Gastroesophageal Reflux; Humans; Male; Middle Aged; Obesity; Quinolines; Risk Factors; Sleep Wake Disorders; Sulfides; Theophylline; Treatment Outcome; Vital Capacity | 2006 |
Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Bronchial Provocation Tests; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fibroblasts; Forced Expiratory Volume; Humans; Male; Muscle, Smooth; Pneumonia; Quinolines; Respiratory System; Sulfides | 2006 |
Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma.
Topics: Acetates; Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Anti-Asthmatic Agents; Asthma; Combined Modality Therapy; Cyclopropanes; Double-Blind Method; Female; Humans; Leukotriene Antagonists; Male; Middle Aged; Placebos; Quinolines; Salmeterol Xinafoate; Sulfides; Treatment Outcome | 2007 |
Clinical trial of low-dose theophylline and montelukast in patients with poorly controlled asthma.
Topics: Acetates; Administration, Inhalation; Adult; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Forced Expiratory Flow Rates; Glucocorticoids; Humans; Leukotriene Antagonists; Lung; Male; Middle Aged; Quinolines; Severity of Illness Index; Sulfides; Theophylline; Treatment Outcome | 2007 |
Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
Topics: Acetates; Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Drug Therapy, Combination; Female; Fluticasone; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; Quinolines; Receptors, Adrenergic, beta-2; Respiratory Function Tests; Salmeterol Xinafoate; Sulfides | 2006 |
Efficacy and safety of montelukast as monotherapy in children with mild persistent asthma.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cyclopropanes; Female; Humans; Male; Quinolines; Sulfides; Treatment Outcome | 2006 |
Treatment with 400 microg of inhaled budesonide vs 200 microg of inhaled budesonide and oral montelukast in children with moderate persistent asthma: randomized controlled trial.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Anti-Asthmatic Agents; Asthma; Budesonide; Child; Cyclopropanes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Quinolines; Respiratory Function Tests; Sulfides | 2006 |
A randomized, double-blind trial of the effect of anti-asthma treatment on lung function in children with asthma.
Topics: Acetates; Adolescent; Airway Resistance; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Budesonide; Child; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Ethanolamines; Female; Forced Expiratory Volume; Formoterol Fumarate; Humans; Male; Maximal Midexpiratory Flow Rate; Plethysmography, Whole Body; Quinolines; Respiratory Function Tests; Sulfides | 2007 |
A randomized open-label comparative study of montelukast versus theophylline added to inhaled corticosteroid in asthmatic children.
Topics: Acetates; Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Child; Cyclopropanes; Delayed-Action Preparations; Female; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfides; Theophylline | 2006 |
Short-course montelukast for intermittent asthma in children: a randomized controlled trial.
Topics: Absenteeism; Acetates; Adolescent; Adrenergic beta-Agonists; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cyclopropanes; Double-Blind Method; Drug Administration Schedule; Drug Utilization; Emergency Service, Hospital; Female; Glucocorticoids; Hospitalization; Humans; Male; Office Visits; Physicians, Family; Prednisolone; Quinolines; Severity of Illness Index; Sulfides; Treatment Outcome | 2007 |
Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.
Topics: Acetates; Adolescent; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Body Height; Child; Cyclopropanes; Drug Therapy, Combination; Female; Fluticasone; Forced Expiratory Volume; Humans; Male; Quinolines; Salmeterol Xinafoate; Sulfides | 2007 |
Combined mediator blockade or topical steroid for treating the unified allergic airway.
Topics: Acetates; Administration, Topical; Adolescent; Adult; Aged; Anti-Allergic Agents; Anti-Asthmatic Agents; Asthma; Beclomethasone; Cetirizine; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Drug Administration Routes; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Quinolines; Rhinitis, Allergic, Perennial; Sulfides | 2007 |
Montelukast decreases plasma endothelin-1 and serum eosinophil cationic protein levels in paediatric atopic asthma.
Topics: Acetates; Administration, Intranasal; Adolescent; Albuterol; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Child; Cyclopropanes; Drug Administration Schedule; Endothelin-1; Eosinophil Cationic Protein; Female; Humans; Leukotriene Antagonists; Male; Quinolines; Severity of Illness Index; Sulfides; Time Factors | 2006 |
Effect of leukotriene modifier drugs on the safety of oral aspirin challenges.
Topics: Acetates; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Asthmatic Agents; Aspirin; Asthma; Cyclopropanes; Desensitization, Immunologic; Drug Hypersensitivity; Female; Forced Expiratory Volume; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Lipoxygenase Inhibitors; Male; Middle Aged; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds; Treatment Outcome | 2006 |
Improvements in distal lung function correlate with asthma symptoms after treatment with oral montelukast.
Topics: Acetates; Adolescent; Adult; Anti-Asthmatic Agents; Asthma; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Middle Aged; Quinolines; Residual Volume; Respiratory Mechanics; Statistics as Topic; Sulfides; Vital Capacity | 2006 |
Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma.
Topics: Acetates; Adult; Asthma; Beclomethasone; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Female; Glucocorticoids; Humans; Leukotriene Antagonists; Male; Quality of Life; Quinolines; Respiratory Function Tests; Smoking; Sulfides; Treatment Outcome | 2007 |
The effect of montelukast on bronchial hyperreactivity in preschool children.
Topics: Acetates; Analysis of Variance; Anti-Asthmatic Agents; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Child; Child, Preschool; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Quinolines; Spirometry; Sulfides; Treatment Outcome | 2007 |
Effect of azelastine, montelukast, and their combination on allergen-induced bronchoconstriction in asthma.
Topics: Acetates; Adult; Anti-Allergic Agents; Asthma; Bronchial Provocation Tests; Bronchoconstriction; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Phthalazines; Quinolines; Respiratory Function Tests; Sulfides | 2008 |
Regulation of stromal cell-derived factor-1 and exhaled nitric oxide in asthmatic children following montelukast and ketotifen treatment.
Topics: Acetates; Administration, Oral; Adolescent; Anti-Allergic Agents; Anti-Asthmatic Agents; Asthma; Budesonide; Calcium; Cell Line; Cell Movement; Chemokine CXCL12; Chemokines, CXC; Chemotaxis; Child; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Exhalation; Female; Flavonoids; Humans; Ketotifen; Male; Monocytes; Nitric Oxide; Peak Expiratory Flow Rate; Prospective Studies; Quinolines; Sulfides | 2007 |
Montelukast as add-on therapy to beta-agonists and late airway response.
Topics: Acetates; Administration, Oral; Adrenergic beta-Agonists; Adult; Anti-Asthmatic Agents; Asthma; Bronchi; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Female; Humans; Leukotriene Antagonists; Male; Placebos; Quinolines; Sulfides; Time Factors | 2007 |
Safety of leukotriene receptor antagonists in pregnancy.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Female; Fetus; Humans; Indoles; Infant, Newborn; Leukotriene Antagonists; Phenylcarbamates; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Quinolines; Safety; Sulfides; Sulfonamides; Teratogens; Tosyl Compounds | 2007 |
Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Androstadienes; Anti-Allergic Agents; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Double-Blind Method; Drug Administration Schedule; Female; Fluticasone; Humans; Male; Middle Aged; Patient Compliance; Quinolines; Sulfides | 2007 |
Formoterol, montelukast, and budesonide in asthmatic children: effect on lung function and exhaled nitric oxide.
Topics: Acetates; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Breath Tests; Bronchodilator Agents; Budesonide; Child; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Ethanolamines; Female; Formoterol Fumarate; Humans; Male; Nitric Oxide; Quinolines; Sulfides | 2007 |
Roles of angiopoietin-1 and angiopoietin-2 on airway microvascular permeability in asthmatic patients.
Topics: Acetates; Adult; Androstadienes; Angiopoietin-1; Angiopoietin-2; Asthma; Biomarkers; Bronchi; Bronchodilator Agents; Capillary Permeability; Cyclopropanes; Female; Fluticasone; Follow-Up Studies; Humans; Immunoassay; Male; Microcirculation; Prognosis; Quinolines; Severity of Illness Index; Sputum; Sulfides; Vascular Endothelial Growth Factor A | 2007 |
Pharmacogenetics of the 5-lipoxygenase biosynthetic pathway and variable clinical response to montelukast.
Topics: Acetates; Adolescent; Adult; Arachidonate 5-Lipoxygenase; Asthma; Cyclopropanes; Double-Blind Method; Female; Haplotypes; Humans; Male; Membrane Proteins; Middle Aged; Pharmacogenetics; Placebos; Quinolines; Receptors, Leukotriene; Signal Transduction; Sulfides | 2007 |
Effects of montelukast compared to double dose budesonide on airway inflammation and asthma control.
Topics: Acetates; Administration, Inhalation; Adolescent; Adult; Aged; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Budesonide; Cyclopropanes; Double-Blind Method; Female; Humans; Male; Middle Aged; Quinolines; Sputum; Sulfides; Treatment Outcome | 2007 |
Randomized comparison of strategies for reducing treatment in mild persistent asthma.
Topics: Acetates; Administration, Inhalation; Adolescent; Adult; Albuterol; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Child; Cyclopropanes; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluticasone; Forced Expiratory Volume; Humans; Kaplan-Meier Estimate; Male; Peak Expiratory Flow Rate; Quinolines; Salmeterol Xinafoate; Sulfides; Treatment Failure; Vital Capacity | 2007 |
Differential anti-inflammatory effects of large and small particle size inhaled corticosteroids in asthma.
Topics: Acetates; Administration, Inhalation; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Beclomethasone; Chemistry, Pharmaceutical; Chlorofluorocarbons; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Eosinophils; Humans; Hydrocarbons, Fluorinated; Inflammation; Nitric Oxide; Particle Size; Quinolines; Sulfides | 2007 |
Montelukast vs. inhaled low-dose budesonide as monotherapy in the treatment of mild persistent asthma: a randomized double blind controlled trial.
Topics: Acetates; Administration, Inhalation; Adolescent; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Budesonide; Child; Child, Preschool; Chronic Disease; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Humans; India; Male; Quinolines; Sulfides | 2007 |
The effect of montelukast and low-dose theophylline on cardiovascular disease risk factors in asthmatics.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cyclopropanes; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Interleukin-6; Lipids; Male; Middle Aged; Quinolines; Risk Factors; Sulfides; Theophylline | 2007 |
Placebo-controlled study of montelukast and budesonide on short-term growth in prepubertal asthmatic children.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Body Height; Budesonide; Child; Cyclopropanes; Double-Blind Method; Female; Humans; Leg; Male; Quinolines; Sulfides; Treatment Outcome | 2007 |
Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy.
Topics: Acetates; Adolescent; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Age Factors; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Common Cold; Cyclopropanes; Disease Outbreaks; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Multivariate Analysis; Office Visits; Ontario; Quinolines; Schools; Seasons; Severity of Illness Index; Sex Factors; Sulfides; Surveys and Questionnaires | 2007 |
Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.
Topics: Acetates; Adrenergic beta-Agonists; Adult; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchial Hyperreactivity; Cyclopropanes; Cysteine; Double-Blind Method; Drug Combinations; Female; Fluticasone; Fluticasone-Salmeterol Drug Combination; Forced Expiratory Volume; Histamine; Humans; Interleukin-8; Leukotriene Antagonists; Leukotrienes; Lung; Male; Quinolines; Spirometry; Sputum; Sulfides; Time Factors; Treatment Outcome; United Kingdom | 2007 |
Prevalence of alpha-1 antitrypsin deficiency in poorly controlled asthma--results from the ALA-ACRC low-dose theophylline trial.
Topics: Acetates; Adolescent; Adult; Aged; alpha 1-Antitrypsin Deficiency; Asthma; Bronchodilator Agents; Cohort Studies; Cyclopropanes; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Phenotype; Prevalence; Quinolines; Statistics, Nonparametric; Sulfides; Theophylline; United States | 2007 |
Effect of different antiasthmatic treatments on exercise-induced bronchoconstriction in children with asthma.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Antigens, Dermatophagoides; Asthma; Bronchoconstriction; Bronchodilator Agents; Budesonide; Child; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Ethanolamines; Exercise; Female; Forced Expiratory Volume; Formoterol Fumarate; Glucocorticoids; Humans; Hypersensitivity; Male; Quinolines; Sulfides; Treatment Outcome | 2008 |
Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
Topics: Acetates; Administration, Inhalation; Age Factors; Anti-Asthmatic Agents; Asthma; Budesonide; Child; Child, Preschool; Cyclopropanes; Female; Humans; Infant; Infant, Newborn; Male; Quinolines; Sulfides; Treatment Outcome | 2007 |
Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma.
Topics: Acetates; Administration, Oral; Analysis of Variance; Asthma; Child; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Nitric Oxide; Placebos; Quinolines; Skin Tests; Sulfides; Treatment Outcome; Vital Capacity | 2007 |
Effects of montelukast on subjective and objective outcome measures in preschool asthmatic children.
Topics: Acetates; Adenosine Monophosphate; Anti-Asthmatic Agents; Asthma; Child, Preschool; Cyclopropanes; Exhalation; Female; Forced Expiratory Volume; Humans; Infant; Leukotriene Antagonists; Male; Nitric Oxide; Prospective Studies; Quinolines; Respiratory Function Tests; Severity of Illness Index; Spirometry; Sulfides; Treatment Outcome; Vital Capacity | 2008 |
Pilot study of oral montelukast added to standard therapy for acute asthma exacerbations in children aged 6 to 14 years.
Topics: Acetates; Administration, Oral; Adolescent; Anti-Asthmatic Agents; Asthma; Child; Confidence Intervals; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Male; Pilot Projects; Probability; Prospective Studies; Quinolines; Recurrence; Reference Values; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Sulfides; Treatment Outcome | 2008 |
Pharmacokinetics and safety of montelukast oral granules in children 1 to 3 months of age with bronchiolitis.
Topics: Acetates; Anti-Asthmatic Agents; Area Under Curve; Asthma; Bronchiolitis; Child, Preschool; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Infant; Male; Nonlinear Dynamics; Powders; Quinolines; Sulfides | 2008 |
ALOX5 promoter genotype and response to montelukast in moderate persistent asthma.
Topics: Acetates; Adolescent; Adult; Age Distribution; Anti-Asthmatic Agents; Arachidonate 5-Lipoxygenase; Asthma; Cyclopropanes; Female; Forced Expiratory Volume; Genotype; Humans; Immunoglobulin E; Male; Middle Aged; Polymorphism, Genetic; Promoter Regions, Genetic; Quinolines; Sex Distribution; Sulfides; Tandem Repeat Sequences; Treatment Outcome | 2008 |
Leukotriene receptor antagonists: a good choice in the treatment of premenstrual asthma?
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Estrogens; Female; Follicle Stimulating Hormone; Humans; Leukotriene Antagonists; Luteinizing Hormone; Menstruation; Middle Aged; Premenstrual Syndrome; Progesterone; Quinolines; Respiratory Function Tests; Severity of Illness Index; Sulfides; Treatment Outcome | 2008 |
Effects of exercise training and montelukast in children with mild asthma.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Asthma, Exercise-Induced; Breath Tests; Bronchoconstriction; Bronchospirometry; Child; Cyclopropanes; Exercise Test; Exercise Therapy; Exhalation; Female; Humans; Italy; Male; Methacholine Chloride; Physical Fitness; Quinolines; Sulfides | 2008 |
Sleep quality in asthma: results of a large prospective clinical trial.
Topics: Acetates; Adult; Asthma; Bronchodilator Agents; Cyclopropanes; Double-Blind Method; Female; Humans; Leukotriene Antagonists; Male; Quality of Life; Quinolines; Respiratory Function Tests; Sleep Wake Disorders; Sulfides; Surveys and Questionnaires; Theophylline | 2008 |
The efficacy of montelukast and airway mast cell profiles in patients with cough variant asthma.
Topics: Acetates; Adult; Aged; Anti-Asthmatic Agents; Asthma; Basophils; Cough; Cyclopropanes; Eosinophils; Female; Humans; Immunoglobulin E; Leukocyte Count; Leukotriene Antagonists; Male; Mast Cells; Middle Aged; Quinolines; Respiratory Mucosa; Sulfides; Treatment Outcome | 2008 |
Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast.
Topics: Acetates; Adolescent; Albuterol; Anti-Asthmatic Agents; Asthma; Biomarkers; Breath Tests; Bronchodilator Agents; Child; Cotinine; Cyclopropanes; Female; Humans; Leukotriene Antagonists; Leukotriene E4; Male; Nitric Oxide; Quinolines; Sex Factors; Sulfides; Tobacco Smoke Pollution | 2008 |
Relationship between ultrasonically nebulized distilled water-induced bronchoconstriction and acetic acid-induced cough in asthmatic children.
Topics: Acetates; Acetic Acid; Adolescent; Asthma; Bronchoconstriction; Child; Cough; Female; Furosemide; Histamine; Humans; Male; Single-Blind Method | 1995 |
Inhaled diuretics attenuate acid-induced cough in children with asthma.
Topics: Acetates; Acetic Acid; Administration, Inhalation; Amiloride; Asthma; Bronchoconstriction; Child; Cough; Double-Blind Method; Female; Forced Expiratory Volume; Furosemide; Humans; Male | 1995 |
Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma.
Topics: Acetates; Adolescent; Adrenal Cortex Hormones; Adult; Asthma; Chronic Disease; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Drug Administration Schedule; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Leukotriene D4; Male; Membrane Proteins; Middle Aged; Quinolines; Receptors, Leukotriene; Sulfides | 1996 |
Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma.
Topics: Acetates; Adult; Asthma; Bronchoconstriction; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Humans; Leukotriene Antagonists; Male; Membrane Proteins; Middle Aged; Quinolines; Receptors, Leukotriene; Sulfides; Time Factors; Treatment Outcome | 1997 |
Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids.
Topics: Acetates; Adolescent; Adult; Albuterol; Analysis of Variance; Asthma; Bronchodilator Agents; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Quinolines; Receptors, Leukotriene B4; Sulfides | 1997 |
Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group.
Topics: Acetates; Adolescent; Adrenergic beta-Agonists; Analysis of Variance; Anti-Asthmatic Agents; Asthma; Child; Chronic Disease; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfides | 1998 |
Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.
Topics: Acetates; Adolescent; Adult; Aged; Analysis of Variance; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Double-Blind Method; Drug Administration Schedule; Female; Humans; Leukotriene Antagonists; Male; Middle Aged; Quinolines; Respiration; Single-Blind Method; Sulfides; Treatment Outcome | 1998 |
Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group.
Topics: Acetates; Adolescent; Adult; Aged; Asthma; Chronic Disease; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Middle Aged; Peak Expiratory Flow Rate; Quality of Life; Quinolines; Spirometry; Sulfides | 1998 |
New oral therapy for childhood asthma.
Topics: Acetates; Administration, Oral; Adolescent; Asthma; Child; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Long-Term Care; Male; Quinolines; Sulfides; Treatment Outcome | 1998 |
A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group.
Topics: Acetates; Adolescent; Adult; Aged; Anti-Asthmatic Agents; Asthma; Consumer Product Safety; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Leukotriene Antagonists; Male; Middle Aged; Quinolines; Single-Blind Method; Sulfides; Treatment Outcome | 1998 |
Montelukast.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Drug Tolerance; Humans; Quinolines; Sulfides | 1998 |
Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma.
Topics: Acetates; Administration, Oral; Adolescent; Analysis of Variance; Asthma; Bronchoconstriction; Child; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Physical Exertion; Placebos; Quinolines; Sulfides; Tablets; Time Factors; Treatment Outcome | 1998 |
[Leukotriene receptor antagonist effective in chronic asthma].
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Chronic Disease; Cyclopropanes; Double-Blind Method; Humans; Leukotriene Antagonists; Placebos; Quinolines; Sulfides; Time Factors | 1998 |
The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.
Topics: Acetates; Adult; Allergens; Anti-Asthmatic Agents; Asthma; Blood Proteins; Bronchial Hyperreactivity; Bronchial Provocation Tests; Cell Count; Cell Survival; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Eosinophil Granule Proteins; Forced Expiratory Volume; Humans; Hypersensitivity, Delayed; Hypersensitivity, Immediate; Leukotriene Antagonists; Male; Patient Compliance; Quinolines; Ribonucleases; Sputum; Sulfides; Treatment Outcome | 1999 |
Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Asthmatic Agents; Asthma; Beclomethasone; Blood Cell Count; Cyclopropanes; Double-Blind Method; Drug Administration Schedule; Eosinophils; Female; Humans; Leukotriene Antagonists; Male; Middle Aged; Peak Expiratory Flow Rate; Placebos; Quality of Life; Quinolines; Sulfides | 1999 |
Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients.
Topics: Acetates; Administration, Inhalation; Adolescent; Adult; Aged; Asthma; Chronic Disease; Cyclopropanes; Double-Blind Method; Drug Administration Schedule; Female; Glucocorticoids; Humans; Leukotriene Antagonists; Lung; Male; Middle Aged; Quinolines; Single-Blind Method; Sulfides | 1999 |
Montelukast dose selection in 6- to 14-year-olds: comparison of single-dose pharmacokinetics in children and adults.
Topics: Acetates; Administration, Oral; Adolescent; Adult; Area Under Curve; Asthma; Child; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Female; Half-Life; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfides; Tablets; Tablets, Enteric-Coated; Treatment Outcome | 1999 |
Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial.
Topics: Acetates; Adult; Asthma; Cyclopropanes; Double-Blind Method; Eosinophils; Female; Humans; Leukocyte Count; Leukotriene Antagonists; Male; Middle Aged; Pulmonary Eosinophilia; Quinolines; Respiratory Function Tests; Respiratory Tract Diseases; Safety; Sputum; Sulfides; Treatment Outcome | 1999 |
What are minimal important changes for asthma measures in a clinical trial?
Topics: Acetates; Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Age Factors; Aged; Asthma; Circadian Rhythm; Cyclopropanes; Double-Blind Method; Epidemiologic Measurements; Female; Humans; Leukotriene Antagonists; Lung; Male; Middle Aged; Quinolines; Respiratory Function Tests; Severity of Illness Index; Sex Factors; Single-Blind Method; Sulfides | 1999 |
NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Breath Tests; Child; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Forced Expiratory Volume; Glucocorticoids; Humans; Leukotriene Antagonists; Maximal Midexpiratory Flow Rate; Nitric Oxide; Quinolines; Spirometry; Sulfides | 1999 |
Exhaled nitric oxide before and after montelukast sodium therapy in school-age children with chronic asthma: a preliminary study.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Analysis of Variance; Asthma; Biomarkers; Breath Tests; Child; Cross-Over Studies; Cyclopropanes; Female; Follow-Up Studies; Humans; Leukotriene Antagonists; Male; Nitric Oxide; Quinolines; Reference Values; Respiratory Function Tests; Sulfides; Treatment Outcome | 1999 |
Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Aged; Anti-Asthmatic Agents; Asthma; Beclomethasone; Chronic Disease; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Forced Expiratory Volume; Glucocorticoids; Humans; Leukotriene Antagonists; Male; Middle Aged; Quinolines; Single-Blind Method; Sulfides | 1999 |
Montelukast, a leukotriene receptor antagonist, reduces the concentration of leukotrienes in the respiratory tract of children with persistent asthma.
Topics: Acetates; Asthma; Beclomethasone; Blood Proteins; Child; Cromolyn Sodium; Cross-Over Studies; Cyclopropanes; Eosinophil Granule Proteins; Female; Humans; Inflammation Mediators; Leukotriene Antagonists; Leukotrienes; Male; Quinolines; Respiratory System; Ribonucleases; Sulfides | 1999 |
Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients.
Topics: Acetates; Adolescent; Adult; Analysis of Variance; Anti-Asthmatic Agents; Asthma; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Quinolines; Sulfides | 2000 |
Additive bronchoprotective and bronchodilator effects with single doses of salmeterol and montelukast in asthmatic patients receiving inhaled corticosteroids.
Topics: Acetates; Adenosine Monophosphate; Administration, Inhalation; Administration, Oral; Adrenergic beta-Agonists; Albuterol; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Cross-Over Studies; Cyclopropanes; Drug Therapy, Combination; Glucocorticoids; Humans; Leukotriene Antagonists; Quinolines; Respiratory Function Tests; Salmeterol Xinafoate; Single-Blind Method; Sulfides; Treatment Outcome | 2000 |
Bronchoprotection with a leukotriene receptor antagonist in asthmatic preschool children.
Topics: Acetates; Asthma; Child, Preschool; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Female; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfides | 2000 |
Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
Topics: Acetates; Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Middle Aged; Peak Expiratory Flow Rate; Quality of Life; Quinolines; Quinolones; Sulfides; Surveys and Questionnaires | 2000 |
Leukotriene receptor antagonists: efficacy and safety in children with asthma.
Topics: Acetates; Activities of Daily Living; Adolescent; Asthma; Child; Cyclopropanes; Double-Blind Method; Emotions; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Quality of Life; Quinolines; Sulfides; Treatment Outcome | 2000 |
Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma.
Topics: Acetates; Adolescent; Adult; Aged; Asthma; Chronic Disease; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Histamine H1 Antagonists; Humans; Leukotriene Antagonists; Loratadine; Male; Middle Aged; Quinolines; Sulfides | 2000 |
Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Anti-Asthmatic Agents; Asthma; Bronchial Provocation Tests; Budesonide; Cetirizine; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Forced Expiratory Volume; Humans; Inflammation Mediators; Leukotriene Antagonists; Quinolines; Rhinitis, Allergic, Seasonal; Sulfides | 2000 |
Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast.
Topics: Acetates; Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Adult; Albuterol; Androstadienes; Asthma; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Fluticasone; Humans; Male; Patient Compliance; Quinolines; Salmeterol Xinafoate; Sulfides | 2000 |
Anti-inflammatory and lung function effects of montelukast in asthmatic volunteers exposed to sulfur dioxide.
Topics: Acetates; Adult; Asthma; Cyclopropanes; Double-Blind Method; Eosinophils; Female; Forced Expiratory Volume; Humans; Leukocyte Count; Leukotriene Antagonists; Lung; Male; Middle Aged; Quinolines; Sputum; Sulfides; Sulfur Dioxide | 2001 |
Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial.
Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Cyclopropanes; Dose-Response Relationship, Drug; Female; Fluticasone; Humans; Male; Middle Aged; Quinolines; Sulfides | 2001 |
Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast.
Topics: Acetates; Adolescent; Adult; Androstadienes; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cyclopropanes; Female; Fluticasone; Health Care Costs; Humans; Linear Models; Logistic Models; Male; Middle Aged; Quinolines; Regression Analysis; Retrospective Studies; Statistics, Nonparametric; Sulfides | 2001 |
Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids.
Topics: Acetates; Adenosine Monophosphate; Administration, Inhalation; Administration, Topical; Adrenergic beta-Agonists; Adult; Albuterol; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Breath Tests; Bronchial Provocation Tests; Bronchodilator Agents; Cross-Over Studies; Cyclopropanes; Eosinophils; Female; Glucocorticoids; Humans; Leukocyte Count; Leukotriene Antagonists; Male; Nitric Oxide; Peak Expiratory Flow Rate; Quinolines; Respiratory Mechanics; Salmeterol Xinafoate; Single-Blind Method; Steroids; Sulfides | 2001 |
Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Budesonide; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Forced Expiratory Volume; Humans; Predictive Value of Tests; Quality of Life; Quinolines; Sulfides; Treatment Outcome | 2001 |
A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma.
Topics: Acetates; Administration, Oral; Administration, Topical; Adult; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Biomarkers; Budesonide; Confidence Intervals; Cross-Over Studies; Cyclopropanes; Humans; Quinolines; Rhinitis, Allergic, Seasonal; Single-Blind Method; Sulfides | 2001 |
Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol.
Topics: Acetates; Administration, Inhalation; Adolescent; Adult; Aged; Anti-Asthmatic Agents; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Cyclopropanes; Double-Blind Method; Drug Interactions; Female; Forced Expiratory Volume; Histamine H1 Antagonists; Humans; Leukotriene Antagonists; Male; Mannitol; Middle Aged; Quinolines; Recovery of Function; Sulfides; Terfenadine; Time Factors | 2001 |
Montelukast dose selection in children ages 2 to 5 years: comparison of population pharmacokinetics between children and adults.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Area Under Curve; Asthma; Child; Child, Preschool; Cyclopropanes; Dosage Forms; Female; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfides | 2001 |
Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Asthmatic Agents; Asthma; Beclomethasone; Child; Chronic Disease; Cyclopropanes; Double-Blind Method; Eosinophils; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Leukocyte Count; Leukotriene Antagonists; Male; Middle Aged; Predictive Value of Tests; Quinolines; Sulfides; Time | 2001 |
Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial.
Topics: Acetates; Adrenergic beta-Agonists; Adult; Aged; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Chronic Disease; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Leukotriene Antagonists; Male; Middle Aged; Peak Expiratory Flow Rate; Quinolines; Steroids; Sulfides | 2001 |
[Preventive monotherapy with montelukast versus DNCG in children with mild asthma. Results of and exploratory pilot study].
Topics: Acetates; Administration, Inhalation; Adolescent; Anti-Asthmatic Agents; Asthma; Child; Cromolyn Sodium; Cross-Over Studies; Cyclopropanes; Female; Forced Expiratory Volume; Humans; Male; Pilot Projects; Quinolines; Respiratory Function Tests; Sulfides | 2001 |
Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.
Topics: Acetates; Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Albuterol; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Powders; Quinolines; Salmeterol Xinafoate; Sulfides | 2001 |
Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
Topics: Acetates; Administration, Oral; Analysis of Variance; Anti-Asthmatic Agents; Asthma; Child, Preschool; Cyclopropanes; Double-Blind Method; Drug Administration Schedule; Eosinophils; Female; Humans; Leukocyte Count; Leukotriene Antagonists; Male; Quality of Life; Quinolines; Sulfides; Tablets; Treatment Outcome | 2001 |
Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting beta(2)-agonists alone.
Topics: Acetates; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Fluticasone; Humans; Male; Middle Aged; Quinolines; Salmeterol Xinafoate; Sulfides | 2001 |
In patients with asthma that is not well controlled with inhaled steroids, does salmeterol (Serevent) or montelukast (Singulair) offer better symptom relief?
Topics: Acetates; Adrenal Cortex Hormones; Albuterol; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Cross-Over Studies; Cyclopropanes; Drug Therapy, Combination; Humans; Quinolines; Salmeterol Xinafoate; Sulfides | 2001 |
Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis.
Topics: Acetates; Administration, Inhalation; Administration, Intranasal; Adult; Airway Resistance; Anti-Allergic Agents; Anti-Inflammatory Agents; Asthma; Budesonide; Cetirizine; Cross-Over Studies; Cyclopropanes; Female; Glucocorticoids; Histamine H1 Antagonists; Humans; Leukotriene Antagonists; Male; Nasal Obstruction; Quinolines; Rhinitis, Allergic, Seasonal; Rhinomanometry; Rhinometry, Acoustic; Sulfides | 2001 |
[Montelukast in treatment mild chronic asthma].
Topics: Acetates; Adolescent; Asthma; Child; Chronic Disease; Cyclopropanes; Female; Humans; Leukotriene Antagonists; Male; Predictive Value of Tests; Quinolines; Spirometry; Sulfides; Treatment Outcome | 2001 |
Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Beclomethasone; Child; Cross-Over Studies; Cyclopropanes; Female; Forced Expiratory Volume; Health Resources; Humans; Male; Patient Compliance; Patient Satisfaction; Quinolines; Sulfides; Time Factors; Treatment Outcome | 2001 |
[The effect of triamcinolone, montelukast and formoterol on serum levels of il-4, IgE and clinical parameters in children with asthma].
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Child; Cyclopropanes; Double-Blind Method; Ethanolamines; Female; Formoterol Fumarate; Humans; Immunoglobulin E; Interleukin-4; Male; Quinolines; Sulfides; Triamcinolone | 2001 |
Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
Topics: Acetates; Administration, Oral; Adult; Aged; Anti-Asthmatic Agents; Aspirin; Asthma; Cyclopropanes; Double-Blind Method; Drug Hypersensitivity; Drug Monitoring; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Leukotriene E4; Male; Middle Aged; Peak Expiratory Flow Rate; Quality of Life; Quinolines; Sulfides; Treatment Outcome | 2002 |
Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with mild persistent asthma.
Topics: Acetates; Administration, Inhalation; Adolescent; Adult; Asthma; Bronchial Hyperreactivity; Cross-Over Studies; Cyclopropanes; Drug Administration Schedule; Female; Humans; Leukotriene Antagonists; Male; Middle Aged; Quinolines; Single-Blind Method; Sulfides; Triamcinolone | 2002 |
Marginal utility of montelukast for persistent asthma.
Topics: Acetates; Adolescent; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Humans; Leukotriene Antagonists; Middle Aged; Quinolines; Retrospective Studies; Sulfides; Treatment Outcome | 2002 |
A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICA
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Blood Proteins; Bronchial Hyperreactivity; Child; Cyclopropanes; Double-Blind Method; Eosinophil Granule Proteins; Female; Humans; Intercellular Adhesion Molecule-1; Interleukin-4; Leukotriene Antagonists; Male; Quinolines; Receptors, Interleukin-2; Ribonucleases; Sulfides | 2002 |
Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma.
Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Chronic Disease; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Fluticasone; Humans; Male; Middle Aged; Quinolines; Salmeterol Xinafoate; Sulfides | 2002 |
Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast.
Topics: Acetates; Adult; Asthma; Bronchi; Bronchial Hyperreactivity; Cell Count; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Eosinophils; Humans; Inflammation; Leukotriene Antagonists; Middle Aged; Quinolines; Respiratory Function Tests; Sputum; Sulfides | 2002 |
Role of cysteinyl leukotrienes in adenosine 5'-monophosphate induced bronchoconstriction in asthma.
Topics: Acetates; Adenosine Monophosphate; Adult; Anti-Asthmatic Agents; Asthma; Bronchoconstriction; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Leukotriene E4; Male; Membrane Proteins; Middle Aged; Quinolines; Receptors, Leukotriene; Sulfides | 2002 |
A randomized, double-blind trial of the effect of glucocorticoid, antileukotriene and beta-agonist treatment on IL-10 serum levels in children with asthma.
Topics: Acetates; Adolescent; Adrenergic beta-Agonists; Anti-Asthmatic Agents; Asthma; Blood Proteins; Child; Cyclopropanes; Double-Blind Method; Eosinophil Granule Proteins; Eosinophils; Ethanolamines; Female; Forced Expiratory Volume; Formoterol Fumarate; Glucocorticoids; Humans; Interleukin-10; Leukocyte Count; Leukotriene Antagonists; Male; Quinolines; Ribonucleases; Sulfides; Triamcinolone | 2002 |
The efficacy of montelukast in the treatment of cat allergen-induced asthma in children.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Child; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Glycoproteins; Humans; Male; Quinolines; Respiratory System; Sulfides | 2002 |
[Spirometry evaluation of montelukast treatment in children with bronchial asthma].
Topics: Acetates; Adolescent; Asthma; Child; Cyclopropanes; Female; Humans; Male; Quinolines; Spirometry; Sulfides; Treatment Outcome | 2002 |
[The effect of triamcinolone acetonide, montelukast, nedocromil sodium, formoterol on levels levels of sICAM-1, sIL-2R in serum and clinical course of asthma in children].
Topics: Acetates; Adolescent; Asthma; Biomarkers; Child; Cyclopropanes; Double-Blind Method; Ethanolamines; Formoterol Fumarate; Humans; Intercellular Adhesion Molecule-1; Interleukin-2 Receptor alpha Subunit; Nedocromil; Quinolines; Receptors, Interleukin; Sulfides; Triamcinolone Acetonide | 2002 |
Effect of montelukast on exhaled NO in asthmatic children exposed to relevant allergens.
Topics: Acetates; Adolescent; Allergens; Androstadienes; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Breath Tests; Child; Cyclopropanes; Dust; Fluticasone; Humans; Leukotriene Antagonists; Mites; Nitric Oxide; Quinolines; Respiratory Function Tests; Respiratory Hypersensitivity; Sulfides; Treatment Outcome | 2002 |
Efficacy and safety of low-dose fluticasone propionate compared with montelukast for maintenance treatment of persistent asthma.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Aged; Androstadienes; Anti-Allergic Agents; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Chronic Disease; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluticasone; Headache; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Patient Satisfaction; Quality of Life; Quinolines; Respiratory Tract Infections; Sleep Initiation and Maintenance Disorders; Sulfides; Treatment Outcome | 2002 |
[Effect of triamcinolone acetonide, montelukast, nedocromil sodium and formoterol on eosinophil blood counts, ECP serum levels and clinical progression of asthma in children].
Topics: Acetates; Adolescent; Anti-Inflammatory Agents; Asthma; Biomarkers; Blood Proteins; Child; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Eosinophil Granule Proteins; Eosinophils; Ethanolamines; Formoterol Fumarate; Humans; Leukocyte Count; Nedocromil; Quinolines; Ribonucleases; Sulfides; Triamcinolone Acetonide | 2002 |
The urinary excretion of 1-methylimidazole-4-acetic acid, a histamine metabolite, by healthy and asthmatic children.
Topics: Acetates; Acute Disease; Adolescent; Adrenocorticotropic Hormone; Adult; Asthma; Child; Child, Preschool; Chromatography, Gas; Chronic Disease; Clinical Trials as Topic; Histamine; Humans; Imidazoles; Peptides; Prednisolone; Remission, Spontaneous | 1973 |
Adverse effects of phenobarbital on corticosteroid metabolism in patients with bronchial asthma.
Topics: Acetates; Adolescent; Adrenal Cortex Hormones; Adult; Asthma; Chloroform; Clinical Trials as Topic; Dexamethasone; Eosinophils; Female; Half-Life; Humans; Hydrocortisone; Hydroxycorticosteroids; Hydroxylation; Kinetics; Leukocyte Count; Male; Middle Aged; Phenobarbital; Placebos; Prednisone; Spirometry; Tritium | 1972 |
418 other study(ies) available for phenyl acetate and Asthma, Bronchial
Article | Year |
---|---|
LTA4H rs2660845 association with montelukast response in early and late-onset asthma.
Topics: Acetates; Adolescent; Adult; Age of Onset; Alleles; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cross-Sectional Studies; Cyclopropanes; Epoxide Hydrolases; Europe; Female; Genotype; Hospitalization; Humans; Leukotriene Antagonists; Longitudinal Studies; Male; Middle Aged; Odds Ratio; Pharmacogenetics; Quinolines; Regression Analysis; Risk; Sulfides; Young Adult | 2021 |
Treatment of pediatric mild persistent asthma with low-dose budesonide inhalation suspension vs. montelukast in China.
Topics: Acetates; Administration, Inhalation; Adolescent; Anti-Asthmatic Agents; Asthma; Budesonide; Child; Child, Preschool; China; Cyclopropanes; Humans; Quinolines; Retrospective Studies; Sulfides | 2021 |
Leukotriene inhibition and the risk of lung cancer among U.S. veterans with asthma.
Topics: Acetates; Animals; Asthma; Cyclopropanes; Humans; Leukotriene Antagonists; Leukotrienes; Lung Neoplasms; Mice; Quinolines; Receptors, Leukotriene; Retrospective Studies; Sulfides; Veterans | 2021 |
The Impact of Non-Invasive Ventilation Combined with Montelukast on Clinical Efficiency and Pulmonary Function in Patients with Bronchial Asthma Complicated by Obstructive Sleep Apnea Hypopnea Syndrome.
Topics: Acetates; Asthma; Cyclopropanes; Humans; Noninvasive Ventilation; Quinolines; Sleep Apnea, Obstructive; Sulfides | 2022 |
Budesonide promotes airway epithelial barrier integrity following double-stranded RNA challenge.
Topics: Acetates; Administration, Inhalation; Animals; Asthma; Bronchi; Bronchodilator Agents; Budesonide; Cell Line; Cell Membrane Permeability; Cyclopropanes; Dextrans; Electric Impedance; Epithelial Cells; Female; Fluorescein-5-isothiocyanate; Formoterol Fumarate; Humans; Male; Mice; Mice, Inbred C57BL; Models, Biological; Molecular Mimicry; Poly I-C; Quinolines; RNA, Double-Stranded; RNA, Viral; Sulfides; Tight Junctions | 2021 |
Therapeutic effect of acupuncture combined montelukast sodium on cough variant asthma in children: A protocol for systematic review and meta-analysis.
Topics: Acetates; Acupuncture Therapy; Anti-Asthmatic Agents; Asthma; Child; Combined Modality Therapy; Cough; Cyclopropanes; Humans; Meta-Analysis as Topic; Quinolines; Research Design; Sulfides; Systematic Reviews as Topic; Treatment Outcome | 2021 |
Relationship between montelukast and behavioral problems in preschool children with asthma.
Topics: Acetates; Administration, Inhalation; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Child, Preschool; Cyclopropanes; Drug Therapy, Combination; Hallucinations; Humans; Infant; Problem Behavior; Quinolines; Sulfides | 2022 |
Montelukast and neuropsychiatric events - a sequence symmetry analysis.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Humans; Quinolines | 2022 |
Analysis of Neuropsychiatric Diagnoses After Montelukast Initiation.
Topics: Acetates; Adolescent; Adult; Anti-Asthmatic Agents; Asthma; Cohort Studies; Cyclopropanes; Female; Humans; Male; Mental Disorders; Middle Aged; Quinolines; Rhinitis, Allergic; Sulfides; Young Adult | 2022 |
Associations between sleep, obesity, and asthma in urban minority children.
Topics: Acetates; Adolescent; Adrenal Cortex Hormones; Anti-Allergic Agents; Asthma; Body Mass Index; Carbon Dioxide; Child; Cyclopropanes; Humans; Oxygen; Pediatric Obesity; Quinolines; Retrospective Studies; Sleep; Sulfides | 2022 |
The comparison between the effect of Glycyrrhizae uralensis (Gan-Cao) and Montelukast on the expression of T-bet and GATA-3 genes in children with allergic asthma.
Topics: Acetates; Asthma; Child; Cyclopropanes; Glycyrrhiza uralensis; Humans; Leukocytes, Mononuclear; Quinolines; Sulfides; T-Box Domain Proteins | 2022 |
Study on the Effect of Self-Made Lifei Dingchuan Decoction Combined with Western Medicine on Cough Variant Asthma.
Topics: Acetates; Asthma; Carbon Dioxide; Cough; Cyclopropanes; Fluticasone; Humans; Oxygen; Powders; Quinolines; Salmeterol Xinafoate; Sulfides; Tablets | 2022 |
Multicenter Prospective Observational Study to Evaluate the Therapeutic Effect and Safety of a Combination of Montelukast and Levocetirizine for Allergic Rhinitis when Administered to Patients with Allergic Rhinitis and Asthma.
Topics: Acetates; Asthma; Cyclopropanes; Drug Combinations; Humans; Quality of Life; Quinolines; Rhinitis, Allergic; Treatment Outcome | 2022 |
Enhanced efficacy of formoterol-montelukast salt in relieving asthma features and in preserving β2-agonists rescue therapy.
Topics: Acetates; Adrenergic beta-Agonists; Animals; Asthma; Formoterol Fumarate; Mice | 2022 |
Adverse drug reactions affecting treatment adherence in first-line treatment of asthma: An observational study.
Topics: Acetates; Administration, Inhalation; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Child; Drug-Related Side Effects and Adverse Reactions; Humans; Leukotriene Antagonists; Male; Quinolines; Rhinitis, Allergic; Treatment Adherence and Compliance | 2023 |
Psychiatric Adverse Effects of Montelukast-A Nationwide Cohort Study.
Topics: Acetates; Adolescent; Adult; Anti-Asthmatic Agents; Asthma; Cohort Studies; Drug-Related Side Effects and Adverse Reactions; Humans; Leukotriene Antagonists; Quinolines; Young Adult | 2023 |
Broncho-Vaxom bacterial lysate prevents asthma via acetate enhancement in mouse model.
Topics: Acetates; Animals; Asthma; Disease Models, Animal; Humans; Inflammation; Mice; Respiratory Hypersensitivity | 2023 |
Effects of montelukast sodium plus budesonide on lung function, inflammatory factors, and immune levels in elderly patients with asthma.
Topics: Acetates; Aged; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Budesonide; Cyclopropanes; Female; Humans; Inflammation; Male; Middle Aged; Quinolines; Respiratory Function Tests; Sulfides | 2020 |
Cysteinyl Leukotriene Synthesis via Phospholipase A2 Group IV Mediates Exercise-induced Bronchoconstriction and Airway Remodeling.
Topics: Acetates; Airway Remodeling; Animals; Asthma; Bronchial Hyperreactivity; Bronchoconstriction; Cyclopropanes; Cysteine; Female; Group II Phospholipases A2; Leukotrienes; Lung; Methacholine Chloride; Mice; Mice, Inbred BALB C; Physical Conditioning, Animal; Quinolines; Respiratory Hypersensitivity; Sulfides | 2020 |
Clinical course of asthma in 4 cases of coronavirus disease 2019 infection.
Topics: Acetates; Adult; Albuterol; Anti-Asthmatic Agents; Asthma; Betacoronavirus; Black or African American; Coronavirus Infections; COVID-19; Cyclopropanes; Dyspnea; Female; Histamine Antagonists; Humans; Lung; Male; Pandemics; Pneumonia, Viral; Quinolines; SARS-CoV-2; Severity of Illness Index; Sulfides | 2020 |
lncRNA PCGEM1 strengthens anti-inflammatory and lung protective effects of montelukast sodium in children with cough-variant asthma.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cough; Cyclopropanes; Disease Models, Animal; Female; Humans; Male; Mice; Mice, Inbred BALB C; Protective Agents; Quinolines; RNA, Long Noncoding; Sulfides | 2020 |
COVID-19, severe asthma, and biologics.
Topics: Acetates; Adrenergic beta-2 Receptor Antagonists; Amoxicillin-Potassium Clavulanate Combination; Anti-Asthmatic Agents; Antibodies, Monoclonal, Humanized; Asthma; Azithromycin; Betacoronavirus; Budesonide; Convalescence; Coronavirus Infections; COVID-19; Cyclopropanes; Eosinophils; Female; Humans; Hydroxychloroquine; Ipratropium; Male; Middle Aged; Pandemics; Pneumonia, Viral; Quinolines; SARS-CoV-2; Sulfides; Treatment Outcome | 2020 |
Montelukast's ability to fight COVID-19 infection.
Topics: Acetates; Aged; Aged, 80 and over; Anti-Asthmatic Agents; Asthma; Case-Control Studies; COVID-19; COVID-19 Serological Testing; Cyclopropanes; Female; Humans; Leukotriene Antagonists; Male; Middle Aged; Quinolines; SARS-CoV-2; Sulfides | 2021 |
Risk of Psychiatric Adverse Events Among Montelukast Users.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Drug Therapy, Combination; Humans; Quinolines; Sulfides | 2021 |
Cost-effectiveness analysis of double low-dose budesonide and low-dose budesonide plus montelukast among pediatric patients with persistent asthma receiving Step 3 treatment in China.
Topics: Acetates; Administration, Inhalation; Anti-Asthmatic Agents; Asthma; Budesonide; Child; China; Cost-Benefit Analysis; Cyclopropanes; Drug Therapy, Combination; Humans; Quinolines; Sulfides | 2020 |
Montelukast does not increase the risk of attention-deficit/hyperactivity disorder in pediatric asthma patients: A nationwide population-based matched cohort study.
Topics: Acetates; Asthma; Attention Deficit Disorder with Hyperactivity; Child; Cohort Studies; Cyclopropanes; Humans; Prospective Studies; Quinolines; Retrospective Studies; Risk Factors; Sulfides; Taiwan | 2021 |
Formation of a Thiol-Ene Addition Product of Asthma Medication Montelukast Caused by a Widespread Tin-Based Thermal Stabilizer.
Topics: Acetates; Asthma; Cyclopropanes; Humans; Molecular Structure; Organotin Compounds; Quinolines; Sulfhydryl Compounds; Sulfides; Temperature | 2020 |
Effect of Montelukast Sodium and Graphene Oxide Nanomaterials on Mouse Asthma Model.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Graphite; Humans; Mice; Nanostructures; Quinolines; Sulfides | 2021 |
[What is the role of montelukast in asthma treatment?]
Topics: Acetates; Administration, Inhalation; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Glucocorticoids; Humans; Patient Compliance; Quinolines; Sulfides | 2020 |
Efficacy and safety of montelukast sodium combined with fluticasone in the treatment of adult bronchial asthma: A protocol for systematic review and meta-analysis.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Cyclopropanes; Drug Combinations; Fluticasone; Humans; Meta-Analysis as Topic; Quinolines; Research Design; Sulfides; Systematic Reviews as Topic; Treatment Outcome | 2020 |
Montelukast in hospitalized patients diagnosed with COVID-19.
Topics: Acetates; Asthma; Clinical Deterioration; COVID-19 Drug Treatment; Cyclopropanes; Humans; Leukotriene Antagonists; Prospective Studies; Quinolines; Retrospective Studies; SARS-CoV-2; Sulfides; Treatment Outcome | 2022 |
Clinical analysis of montelukast combined with Pumike Aerosol in the treatment of infantile asthma.
Topics: Acetates; Aerosols; Asthma; Cyclopropanes; Humans; Quinolines; Sulfides | 2022 |
Lower Limb Bruising Associated with Montelukast in an Asthmatic Child.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Humans; Lower Extremity; Quinolines; Sulfides | 2021 |
Evaluation of efficiency and safety of combined montelukast sodium and budesonide in children with cough variant asthma: A protocol for systematic review and meta-analysis.
Topics: Acetates; Administration, Inhalation; Asthma; Budesonide; Child; Chronic Disease; Cough; Cyclopropanes; Drug Therapy, Combination; Glucocorticoids; Humans; Leukotriene Antagonists; Meta-Analysis as Topic; Quinolines; Randomized Controlled Trials as Topic; Sulfides; Systematic Reviews as Topic; Treatment Outcome | 2021 |
Ecotoxicity and photodegradation of Montelukast (a drug to treat asthma) in water.
Topics: Acetates; Animals; Asthma; Cyclopropanes; Daphnia; Pharmaceutical Preparations; Photolysis; Quinolines; Sulfides; Water; Water Pollutants, Chemical | 2021 |
Cost-Utility Analysis of Fixed-Dose Combination of Indacaterol Acetate Glycopyrronium Bromide and Mometasone Furoate as a Maintenance Treatment in Adult Patients with Asthma Not Adequately Controlled with a Maintenance Combination of a Long-Acting Beta-Ag
Topics: Acetates; Adrenal Cortex Hormones; Adult; Asthma; Bronchodilator Agents; Cost-Benefit Analysis; Drug Combinations; Glycopyrrolate; Humans; Indans; Mometasone Furoate; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolones; Treatment Outcome | 2021 |
Asthma status is an independent risk factor for herpes zoster in children: a population-based cohort study.
Topics: Acetates; Administration, Inhalation; Adrenal Cortex Hormones; Asthma; Case-Control Studies; Child; Child, Preschool; Cyclopropanes; Drug Therapy, Combination; Emergency Service, Hospital; Female; Herpes Zoster; Humans; Infant; Male; Proportional Hazards Models; Quinolines; Retrospective Studies; Risk Factors; Sulfides; Taiwan | 2017 |
Fetal Exposure to Montelukast and Congenital Anomalies: A Population Based Study in Denmark.
Topics: Abnormalities, Drug-Induced; Acetates; Anti-Asthmatic Agents; Asthma; Congenital Abnormalities; Cross-Sectional Studies; Cyclopropanes; Denmark; Female; Humans; Odds Ratio; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, First; Prenatal Exposure Delayed Effects; Quinolines; Registries; Sulfides | 2017 |
Montelukast use-a 19-year nationwide drug utilisation study.
Topics: Acetates; Asthma; Cyclopropanes; Denmark; Drug Utilization Review; Humans; Pharmacoepidemiology; Quinolines; Sulfides | 2017 |
Leukotriene receptor antagonist attenuated airway inflammation and hyperresponsiveness in a double-stranded RNA-induced asthma exacerbation model.
Topics: Acetates; Alum Compounds; Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; Cyclopropanes; Cysteine; Cytokines; Disease Models, Animal; Disease Progression; Eosinophils; Immunization; Inflammation Mediators; Leukotriene Antagonists; Leukotrienes; Male; Mice; Ovalbumin; Poly I-C; Quinolines; Respiratory Hypersensitivity; RNA, Double-Stranded; RNA, Viral; Sulfides | 2017 |
Should we use montelukast in wheezy children?
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cyclopropanes; Humans; Practice Guidelines as Topic; Quinolines; Respiratory Sounds; Sulfides | 2017 |
Neuropsychiatric adverse effects of montelukast in children.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Double-Blind Method; Humans; Quinolines; Sulfides | 2017 |
Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice.
Topics: Acetates; Adolescent; Aggression; Anti-Asthmatic Agents; Asthma; Canada; Child, Preschool; Cyclopropanes; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Glucocorticoids; Humans; Infant; Irritable Mood; Male; Neuropsychological Tests; Product Surveillance, Postmarketing; Quinolines; Retrospective Studies; Sleep Wake Disorders; Sulfides; Withholding Treatment | 2017 |
Back to the future of targeting leukotriene B
Topics: 5-Lipoxygenase-Activating Proteins; Acetates; Animals; Asthma; Cell Movement; Chemokines; Cyclopropanes; Epoxide Hydrolases; Humans; Inflammation; Leukotriene B4; Lipid Metabolism; Molecular Targeted Therapy; Neutrophil Activation; Neutrophils; Quinolines; Sulfides; T-Lymphocytes | 2017 |
Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Drug-Related Side Effects and Adverse Reactions; Humans; Quinolines; Sulfides | 2017 |
Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Drug-Related Side Effects and Adverse Reactions; Humans; Quinolines; Sulfides | 2017 |
Role of montelukast in management of episodic viral wheeze.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Australia; Cyclopropanes; Humans; Quinolines; Respiratory Sounds; Sulfides | 2017 |
Rothia mucilaginosa bacteraemia in an immunocompetent paediatric patient: a new pathogen to take into account. A case report.
Topics: Acetates; Actinomycetales Infections; Anti-Asthmatic Agents; Asthma; Bacteremia; Communicable Diseases, Emerging; Cyclopropanes; Herpangina; Humans; Immunocompetence; Infant; Male; Micrococcaceae; Otitis Media; Quinolines; Sulfides | 2017 |
Early Discontinuation of Montelukast Treatment; A Danish Nationwide Utilization Study.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Aged; Asthma; Child; Child, Preschool; Cyclopropanes; Denmark; Drug Prescriptions; Drug Utilization; Female; Glucocorticoids; Humans; Infant; Infant, Newborn; Leukotriene Antagonists; Male; Middle Aged; Off-Label Use; Patents as Topic; Patient Compliance; Quinolines; Registries; Risk Factors; Sulfides; Time Factors; Young Adult | 2018 |
Montelukast reverses airway remodeling in actively sensitized young mice.
Topics: Acetates; Age Factors; Airway Remodeling; Allergens; Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; Cyclopropanes; Disease Models, Animal; Female; Lung; Mice, Inbred BALB C; Ovalbumin; Quinolines; Sulfides | 2018 |
The Variants in the 3' Untranslated Region of the Matrix Metalloproteinase 9 Gene as Modulators of Treatment Outcome in Children with Asthma.
Topics: 3' Untranslated Regions; Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Child; Cyclopropanes; Female; Fluticasone; Forced Expiratory Volume; Genetic Variation; Humans; Male; Matrix Metalloproteinase 9; Nitric Oxide; Prognosis; Quinolines; Respiration; Respiratory Hypersensitivity; Sequence Analysis, DNA; Slovenia; Sulfides; Treatment Outcome; Vital Capacity | 2018 |
Mepolizumab in the treatment of severe eosinophilic asthma: Results from a physician in the field.
Topics: Acetates; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Anti-Asthmatic Agents; Antibodies, Monoclonal, Humanized; Asthma; Cyclopropanes; Drug Administration Schedule; Eosinophils; Female; Humans; Injections, Subcutaneous; Interleukin-5; Male; Middle Aged; Prednisone; Pulmonary Eosinophilia; Quinolines; Retrospective Studies; Rhinitis, Allergic; Severity of Illness Index; Sulfides; Surveys and Questionnaires | 2018 |
Autism and Allergy - Are They Linked?
Topics: Acetates; Anti-Asthmatic Agents; Antipsychotic Agents; Asthma; Autism Spectrum Disorder; Bronchodilator Agents; Child; Cyclopropanes; Drug Therapy, Combination; Female; Fluticasone-Salmeterol Drug Combination; Humans; Quinolines; Rhinitis, Allergic; Risperidone; Sulfides; Treatment Outcome | 2018 |
Montelukast and budesonide combination for children with chronic cough-variant asthma.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Budesonide; Child; Child, Preschool; Cough; Cyclopropanes; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Male; Quinolines; Respiratory Function Tests; Retrospective Studies; Sulfides; Symptom Assessment; Treatment Outcome | 2018 |
Treatment with montelukast and antidepressive medication-a symmetry analysis.
Topics: Acetates; Adult; Aged; Antidepressive Agents; Asthma; Cyclopropanes; Denmark; Depression; Drug Prescriptions; Female; Humans; Leukotriene Antagonists; Male; Middle Aged; Quinolines; Rhinitis, Allergic; Severity of Illness Index; Sulfides; Young Adult | 2018 |
Antileukotrienes improve naso-ocular symptoms and biomarkers in patients with NARES and asthma.
Topics: Acetates; Adult; Asthma; Biomarkers; Cyclopropanes; Eosinophilia; Eye Diseases; Female; Humans; Leukotriene Antagonists; Male; Nose Diseases; Prospective Studies; Quinolines; Rhinitis; Sulfides; Syndrome | 2019 |
Montelukast Sodium Formulation Containing Green Tea Extract to Reduce the Oxidative Stress in Guinea Pig Model of Chronic Allergic Asthma.
Topics: Acetates; Administration, Oral; Animals; Anti-Asthmatic Agents; Asthma; Chronic Disease; Cyclopropanes; Drug Combinations; Female; Glutathione; Guinea Pigs; Histamine; Liver; Lung; Male; Malondialdehyde; Oxidative Stress; Oxygen Radical Absorbance Capacity; Patents as Topic; Plant Extracts; Quinolines; Sulfides; Tea | 2018 |
[Effects of montelukast sodium and bacterial lysates on airway remodeling and expression of transforming growth factor-β1 and Smad7 in guinea pigs with bronchial asthma].
Topics: Acetates; Airway Remodeling; Animals; Asthma; Cell Extracts; Cyclopropanes; Guinea Pigs; Lung; Male; Ovalbumin; Quinolines; Sulfides; Transforming Growth Factor beta1 | 2018 |
Characterization of cysteinyl leukotriene-related receptors and their interactions in a mouse model of asthma.
Topics: Acetates; Animals; Asthma; Clopidogrel; Cyclohexanecarboxylic Acids; Cyclopropanes; Disease Models, Animal; Drug Therapy, Combination; Eosinophils; Female; Inflammation; Interleukins; Leukotriene Antagonists; Mice; Mice, Inbred BALB C; Ovalbumin; Phthalic Acids; Purinergic P2Y Receptor Antagonists; Quinolines; Receptors, Leukotriene; Receptors, Purinergic P2Y12; Sulfides; Th2 Cells | 2019 |
[Association of cytoplasmic phospholipase A2 gene polymorphism with bronchial asthma and response to montelukast in children].
Topics: Acetates; Asthma; Child; Cyclopropanes; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 2019 |
Montelukast and Neuropsychiatric Events in Children with Asthma: A Nested Case-Control Study.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Case-Control Studies; Child; Child, Preschool; Cyclopropanes; Female; Humans; Male; Mental Disorders; Nervous System Diseases; Quinolines; Sulfides | 2019 |
Montelukast and Budesonide for Childhood Cough Variant Asthma.
Topics: Acetates; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Budesonide; C-Reactive Protein; Child; Child, Preschool; Cough; Cyclopropanes; Female; Humans; Interleukin-6; Lung; Male; Quinolines; Respiratory Function Tests; Sulfides; Treatment Outcome; Tumor Necrosis Factor-alpha | 2019 |
Eosinophilic Granulomatosis with Polyangiitis in a 4-Year-Old Child: Is Montelukast and/or Clarithromycin a Trigger?
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Child, Preschool; Cyclopropanes; Eosinophils; Female; Granulomatosis with Polyangiitis; Humans; Quinolines; Sulfides | 2019 |
Adverse events associated with weight-based, high-dose montelukast exposures in children.
Topics: Acetates; Asthma; Body Weight; Child; Cyclopropanes; Dose-Response Relationship, Drug; Drug Dosage Calculations; Female; Humans; Leukotriene Antagonists; Male; Poison Control Centers; Quinolines; Sulfides | 2020 |
Neuropsychiatric side effects of montelukast.
Topics: Acetates; Asthma; Case-Control Studies; Child; Cyclopropanes; Humans; Quinolines; Sulfides | 2019 |
Reply.
Topics: Acetates; Asthma; Case-Control Studies; Child; Cyclopropanes; Humans; Quinolines; Sulfides | 2019 |
Concomitant bilastine and montelukast as additive therapy for seasonal allergic rhinoconjunctivits and mild-to-moderate asthma. The SKY study.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Benzimidazoles; Cyclopropanes; Humans; Piperidines; Quinolines; Seasons; Sulfides | 2020 |
Comparative effectiveness of budesonide inhalation suspension and montelukast in children with mild asthma in Korea.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Budesonide; Child; Child, Preschool; Cyclopropanes; Drug Costs; Female; Humans; Male; Medication Adherence; Office Visits; Patient Acceptance of Health Care; Quinolines; Republic of Korea; Retrospective Studies; Sulfides; Suspensions; Symptom Flare Up; Time Factors; Treatment Outcome | 2020 |
[Effect of montelukast on the expression of neurokinin-1 receptor in young asthmatic rats with airway remodeling].
Topics: Acetates; Airway Remodeling; Animals; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Female; Leukotriene Antagonists; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; RNA, Messenger; Sulfides | 2013 |
Montelukast can reduce the severity and extent of atopic dermatitis.
Topics: Acetates; Asthma; Child; Clinical Trials as Topic; Cyclopropanes; Dermatitis, Atopic; Humans; Information Storage and Retrieval; Leukotriene Antagonists; Male; Quinolines; Sulfides | 2013 |
Samter's triad in childhood: a warning for those prescribing NSAIDs.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Asthma, Aspirin-Induced; Bronchodilator Agents; Cranial Sinuses; Critical Care; Cyclopropanes; Epinephrine; Humans; Male; Nasal Polyps; Quinolines; Respiration, Artificial; Respiratory Tract Diseases; Sulfides; Tomography, X-Ray Computed | 2013 |
Mast cell mediators cause early allergic bronchoconstriction in guinea-pigs in vivo: a model of relevance to asthma.
Topics: Acetates; Animals; Asthma; Bronchial Hyperreactivity; Constriction, Pathologic; Cyclopropanes; Disease Models, Animal; Guinea Pigs; Histamine Antagonists; Hypersensitivity; Indomethacin; Leukotriene Antagonists; Lung; Mast Cells; Ovalbumin; Prostaglandin Antagonists; Pyrilamine; Quinolines; Sulfides | 2013 |
Antidepressant medication dispensing among montelukast initiators.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Antidepressive Agents; Asthma; Cyclopropanes; Depression; Female; Humans; Male; Quinolines; Sulfides; Young Adult | 2013 |
Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema.
Topics: Acetates; Animals; Asthma; Bronchoalveolar Lavage Fluid; Chemokines; Cyclopropanes; Cysteine; Female; Leukotriene Antagonists; Leukotrienes; Lung; Mice; Mice, Inbred BALB C; Pneumonia; Pulmonary Emphysema; Quinolines; Receptors, Leukotriene; Sulfides; Tumor Necrosis Factor-alpha | 2014 |
Hallucination development with montelukast in a child with asthma: case presentation.
Topics: Acetates; Adolescent; Adult; Asthma; Cyclopropanes; Hallucinations; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfides | 2013 |
Restoration of the normal Clara cell phenotype after chronic allergic inflammation.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchi; Budesonide; Chronic Disease; Cyclopropanes; Cytochrome P-450 CYP2E1; Disease Models, Animal; Epithelium; Female; Mice; Mice, Inbred BALB C; Ovalbumin; Phenotype; Pulmonary Surfactant-Associated Protein D; Quinolines; Sulfides; Uteroglobin | 2013 |
Inhibitory effects of Montelukast on mediator release by nasal epithelial cells from asthmatic subjects with or without allergic rhinitis.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Cells, Cultured; Cyclopropanes; Cytokines; Epithelial Cells; Female; Humans; Male; Middle Aged; Nasal Mucosa; Quinolines; Rhinitis, Allergic; Rhinitis, Allergic, Perennial; Sulfides | 2013 |
Effects of montelukast on subepithelial/peribronchial fibrosis in a murine model of ovalbumin induced chronic asthma.
Topics: Acetates; Allergens; Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; Cyclopropanes; Cytokines; Disease Models, Animal; Female; Immunoglobulin E; Leukotriene Antagonists; Lung; Mice; Mice, Inbred BALB C; Mucus; Ovalbumin; Pulmonary Fibrosis; Quinolines; Smad3 Protein; Sulfides; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A | 2013 |
Effect of concomitant use of montelukast and efavirenz on neuropsychiatric adverse events.
Topics: Acetates; Adult; Alkynes; Anti-Asthmatic Agents; Anti-HIV Agents; Asthma; Benzoxazines; Cyclopropanes; Drug Interactions; Female; HIV Infections; Humans; Neurotoxicity Syndromes; Quinolines; Sulfides | 2014 |
Classification and pharmacological treatment of preschool wheezing: changes since 2008.
Topics: Acetates; Administration, Oral; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Biomarkers; Child; Child, Preschool; Cyclopropanes; Glucocorticoids; Humans; International Cooperation; Practice Guidelines as Topic; Pulmonary Medicine; Quinolines; Respiratory Sounds; Sulfides | 2014 |
Low-level environmental tobacco smoke exposure and inflammatory biomarkers in children with asthma.
Topics: Acetates; Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Child; Cohort Studies; Cotinine; Cyclopropanes; Environmental Monitoring; Female; Follow-Up Studies; Humans; Inflammation Mediators; Leukotriene E4; Male; Prospective Studies; Quinolines; Risk Assessment; Severity of Illness Index; Spirometry; Sulfides; Tobacco Smoke Pollution; Treatment Outcome | 2014 |
Drugs to avoid during pregnancy: omalizumab and montelukast, too many uncertainties.
Topics: Acetates; Anti-Asthmatic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Asthma; Cyclopropanes; Female; Humans; Omalizumab; Pregnancy; Pregnancy Complications; Quinolines; Sulfides | 2014 |
Montelukast suppresses epithelial to mesenchymal transition of bronchial epithelial cells induced by eosinophils.
Topics: Acetates; Airway Remodeling; Asthma; Bronchi; Cell Line, Tumor; Coculture Techniques; Collagen Type I; Cyclopropanes; Cysteine; Eosinophils; Epithelial-Mesenchymal Transition; Humans; Leukotriene Antagonists; Leukotrienes; Phosphorylation; Quinolines; Respiratory Mucosa; Smad3 Protein; Sulfides; Transforming Growth Factor beta1; Vimentin | 2014 |
Impact of a prior authorization policy for montelukast on clinical outcomes for asthma and allergic rhinitis among children and adolescents in a state Medicaid program.
Topics: Acetates; Adolescent; Age Factors; Anti-Allergic Agents; Anti-Asthmatic Agents; Anti-Bacterial Agents; Asthma; Child; Child, Preschool; Cyclopropanes; Drug Utilization Review; Emergency Medical Services; Female; Humans; Infant; Infant, Newborn; Insurance Coverage; Insurance, Pharmaceutical Services; Linear Models; Logistic Models; Male; Medicaid; Odds Ratio; Office Visits; Policy Making; Program Evaluation; Quinolines; Retrospective Studies; Rhinitis, Allergic; Rhinitis, Allergic, Seasonal; State Health Plans; Sulfides; Time Factors; Treatment Outcome; United States | 2014 |
Montelukast-loaded nanostructured lipid carriers: part I oral bioavailability improvement.
Topics: Acetates; Animals; Area Under Curve; Asthma; Calorimetry, Differential Scanning; Chromatography, High Pressure Liquid; Cyclopropanes; Drug Carriers; Lipids; Male; Microscopy, Electron, Transmission; Nanoparticles; Nanostructures; Particle Size; Quinolines; Rats; Rats, Wistar; Solubility; Spectroscopy, Fourier Transform Infrared; Sulfides; Surface-Active Agents; X-Ray Diffraction | 2014 |
Aerosolized montelukast polymeric particles-an alternative to oral montelukast-alleviate symptoms of asthma in a rodent model.
Topics: Acetates; Aerosols; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Cyclopropanes; Cysteine; Disease Models, Animal; Inflammation; L-Lactate Dehydrogenase; Lactic Acid; Leukotrienes; Lung; Ovalbumin; Peroxidase; Polyesters; Polymers; Quinolines; Rats; Rats, Sprague-Dawley; Sulfides | 2014 |
Management of acute loss of asthma control in the yellow zone: a practice parameter.
Topics: Acetates; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Asthma; Bronchodilator Agents; Cyclopropanes; Humans; Leukotriene Antagonists; Nebulizers and Vaporizers; Quinolines; Respiratory Tract Infections; Self Care; Sulfides | 2014 |
Wheezing in young children: WAITing for pharmacogenomics?
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Female; Humans; Male; Quinolines; Respiratory Sounds; Sulfides | 2014 |
Montelukast--place in therapy.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Humans; Quinolines; Rhinitis, Allergic; Rhinitis, Allergic, Perennial; Sulfides | 2014 |
Exploring the possible association between montelukast and neuropsychiatric events among children with asthma: a matched nested case-control study.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Case-Control Studies; Child; Cyclopropanes; Female; Humans; Logistic Models; Male; Mental Disorders; Quinolines; Sulfides | 2015 |
IMD-4690, a novel specific inhibitor for plasminogen activator inhibitor-1, reduces allergic airway remodeling in a mouse model of chronic asthma via regulating angiogenesis and remodeling-related mediators.
Topics: Acetates; Airway Remodeling; Animals; Antigens, Dermatophagoides; Asthma; Biphenyl Compounds; Bronchi; Bronchoalveolar Lavage Fluid; Chronic Disease; Cytokines; Dermatophagoides pteronyssinus; Disease Models, Animal; Eosinophils; Female; Immunoglobulin E; Mice; Neovascularization, Pathologic; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator | 2015 |
Effect of the plant derivative Compound A on the production of corticosteroid-resistant chemokines in airway smooth muscle cells.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Case-Control Studies; Chemokine CCL5; Chemokine CX3CL1; Chemokine CXCL10; Drug Resistance; Dual Specificity Phosphatase 1; Epithelial Cells; Female; Fluticasone; Gene Expression; Humans; Interferon Regulatory Factor-1; Interferon-gamma; Male; Middle Aged; Mifepristone; Primary Cell Culture; Receptors, Glucocorticoid; Respiratory Mucosa; RNA, Small Interfering; Tumor Necrosis Factor-alpha; Tyramine | 2015 |
Effectiveness of Montelukast on asthma control in infants: methodology of a French claims data study.
Topics: Acetates; Administration, Inhalation; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Cohort Studies; Cyclopropanes; Databases, Factual; Female; France; Humans; Infant; Male; Pilot Projects; Quinolines; Sulfides; Treatment Outcome | 2015 |
Monitoring the ionic content of exhaled breath condensate in various respiratory diseases by capillary electrophoresis with contactless conductivity detection.
Topics: Acetates; Adult; Aged; Ammonium Compounds; Asthma; Breath Tests; Butyrates; Calcium; Chlorides; Crown Ethers; Cystic Fibrosis; Electrophoresis, Capillary; Female; Humans; Hydrogen-Ion Concentration; Ions; Lactic Acid; Magnesium; Male; Middle Aged; Nitrates; Nitrites; Potassium; Propionates; Pulmonary Disease, Chronic Obstructive; Pulmonary Fibrosis; Sarcoidosis, Pulmonary; Sodium; Sulfates | 2015 |
Genome-Wide Association Study Identifies Novel Pharmacogenomic Loci For Therapeutic Response to Montelukast in Asthma.
Topics: Acetates; Adult; Asthma; Cyclopropanes; Female; Genetic Loci; Genome-Wide Association Study; Humans; Lung; Male; Pharmacogenetics; Polymorphism, Single Nucleotide; Quinolines; Sulfides; Treatment Outcome | 2015 |
Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites.
Topics: Acetates; Acetylation; Animals; Asthma; Diet; Dietary Fiber; Disease Models, Animal; Epigenesis, Genetic; Fatty Acids, Volatile; Female; Forkhead Transcription Factors; Gastrointestinal Microbiome; Histone Deacetylases; Mice; Pregnancy; Prenatal Exposure Delayed Effects; Promoter Regions, Genetic; Repressor Proteins; T-Lymphocytes, Regulatory | 2015 |
Effect of montelukast monotherapy on oxidative stress parameters and DNA damage in children with asthma.
Topics: Acetates; Anti-Asthmatic Agents; Antioxidants; Asthma; Case-Control Studies; Child; Child, Preschool; Cyclopropanes; DNA Damage; Female; Humans; Male; Oxidative Stress; Quinolines; Sulfides | 2015 |
Can a single dose response predict the effect of montelukast on exercise-induced bronchoconstriction?
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Bronchoconstriction; Child; Cyclopropanes; Exercise Test; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Predictive Value of Tests; Prospective Studies; Quinolines; Sulfides; Treatment Outcome | 2016 |
Beliefs about medication predict the misattribution of a common symptom as a medication side effect--Evidence from an analogue online study.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Medicine; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Perception; Quinolines; Sulfides; Surveys and Questionnaires | 2015 |
Plasma total thiol pool in children with asthma: Modulation during montelukast monotherapy.
Topics: Acetates; Antioxidants; Asthma; Child; Child, Preschool; Cyclopropanes; Female; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfhydryl Compounds; Sulfides | 2016 |
Effectiveness of leukotriene receptor antagonism in the postoperative management of chronic rhinosinusitis.
Topics: Acetates; Adolescent; Adult; Aged; Asthma; Chronic Disease; Cyclopropanes; Eosinophils; Female; Follow-Up Studies; Humans; Leukotriene Antagonists; Male; Middle Aged; Postoperative Complications; Quinolines; Retrospective Studies; Rhinitis; Rhinoplasty; Sinusitis; Sulfides; Treatment Outcome; Young Adult | 2016 |
[POSSIBILITIES FOR THE USE OF THE ANTI-LEUKOTRIENE DRUG MONTELUKAST IN COMBINED THERAPY OF PATIENTS WITH BRONCHIAL ASTHMA AND COLD-INDUCED BRONCHIAL HYPERACTIVITY].
Topics: Acetates; Administration, Inhalation; Adolescent; Adult; Anti-Asthmatic Agents; Asthma; Bronchial Hyperreactivity; Cold Temperature; Cyclopropanes; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Quinolines; Sulfides; Treatment Outcome; Young Adult | 2015 |
Predictors of asthma following severe respiratory syncytial virus (RSV) bronchiolitis in early childhood.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Asthma; Bronchiolitis, Viral; Child; Child, Preschool; Cyclopropanes; Dander; Dogs; Europe; Female; Humans; Hypersensitivity; Hypersensitivity, Immediate; Infant; Interleukin-16; Interleukin-18; Interleukin-5; Longitudinal Studies; Male; Medical History Taking; Prevalence; Prospective Studies; Quinolines; Respiratory Rate; Respiratory Sounds; Respiratory Syncytial Virus Infections; Rhinitis, Allergic; Risk Factors; Severity of Illness Index; Sex Factors; Sulfides | 2016 |
Seizures as a rare but serious adverse effect of leukotriene receptor.
Topics: Acetates; Adolescent; Asthma; Child; Child, Preschool; Cyclopropanes; Epilepsy; Female; Humans; Leukotriene Antagonists; Male; Quinolines; Receptors, Leukotriene; Rhinitis, Allergic; Seizures; Sulfides; Withholding Treatment | 2016 |
Inflammatory markers as exacerbation risk factors after asthma therapy switch from inhaled steroids to montelukast.
Topics: Acetates; Administration, Inhalation; Anti-Asthmatic Agents; Asthma; Bronchial Hyperreactivity; Child; Cyclopropanes; Eosinophils; Female; Follow-Up Studies; Glucocorticoids; Humans; Inflammation; Leukotriene Antagonists; Male; Nitric Oxide; Practice Guidelines as Topic; Prospective Studies; Quinolines; Risk Factors; Sputum; Sulfides | 2016 |
MONITORING THE EFFICACY OF MONTELUKAST USED IN CHILDREN WITH RISK OF ASTHMA.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cyclopropanes; Female; Humans; Leukotriene Antagonists; Male; Quinolines; Risk; Sulfides | 2016 |
Effect of Traditional Chinese Medicine on Inflammatory Mediators in Pediatric Asthma.
Topics: Acetates; Albuterol; Asthma; Child, Preschool; Cyclopropanes; Enzyme-Linked Immunosorbent Assay; Female; Humans; Interleukin-10; Interleukin-17; Male; Matrix Metalloproteinase 9; Medicine, Chinese Traditional; Quinolines; Randomized Controlled Trials as Topic; Real-Time Polymerase Chain Reaction; RNA, Messenger; Single-Blind Method; Sulfides; Transforming Growth Factor beta1 | 2016 |
Montelukast, current indications and prospective future applications.
Topics: Acetates; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Asthma, Exercise-Induced; Cyclopropanes; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 2016 |
Effect of montelukast on markers of airway remodeling in children with asthma.
Topics: Acetates; Adolescent; Airway Remodeling; Anti-Asthmatic Agents; Asthma; Biomarkers; Child; Cyclopropanes; Female; Humans; Male; Quinolines; Respiratory Function Tests; Sulfides; Treatment Outcome | 2016 |
Early patient experiences with montelukast orally disintegrating tablets in Japan: a cross-sectional survey of treatment satisfaction in patients with asthma and/or allergic rhinitis.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Asthma; Chemistry, Pharmaceutical; Cross-Sectional Studies; Cyclopropanes; Female; Humans; Japan; Leukotriene Antagonists; Male; Middle Aged; Patient Satisfaction; Quinolines; Rhinitis, Allergic; Sulfides; Surveys and Questionnaires; Tablets; Treatment Outcome; Young Adult | 2017 |
[Effect of montelukast sodium intervention on airway remodeling and percentage of Th17 cells/CD4+CD25+ regulatory T cells in asthmatic mice].
Topics: Acetates; Airway Remodeling; Animals; Asthma; Cyclopropanes; Female; Lung; Mice; Mice, Inbred BALB C; Quinolines; Sulfides; T-Lymphocytes, Regulatory; Th17 Cells | 2016 |
GENETIC INTERACTIONS BETWEEN ADRB2 AND PTGER4 ON RESPONSES TO SALMETEROL OR MONTELUKAST IN JAPANESE PATIENTS WITH MILD PERSISTENT ASTHMA.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Female; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Quinolines; Receptors, Adrenergic, beta-2; Receptors, Prostaglandin E, EP4 Subtype; Salmeterol Xinafoate; Sulfides | 2016 |
Aerosolizable modified-release particles of montelukast improve retention and availability of the drug in the lungs.
Topics: Acetates; Administration, Inhalation; Animals; Anti-Asthmatic Agents; Asthma; Biological Availability; Bronchoalveolar Lavage Fluid; Cyclopropanes; Drug Carriers; Humans; Lactic Acid; Lung; Macrophages, Alveolar; Male; Particle Size; Polyethyleneimine; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Quinolines; Rats; Rats, Sprague-Dawley; Sulfides | 2017 |
Clinical effect of treating secondary asthma attacks of children Mycoplasma pneumoniae with combined therapy of montelukast and azithromycin.
Topics: Acetates; Asthma; Azithromycin; Child; Cyclopropanes; Humans; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Quinolines; Sulfides | 2016 |
Low-Molecular-Weight Heparin-Coated and Montelukast-Filled Inhalable Particles: A Dual-Drug Delivery System for Combination Therapy in Asthma.
Topics: Acetates; Administration, Inhalation; Animals; Anti-Asthmatic Agents; Anticoagulants; Asthma; Cyclopropanes; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Therapy, Combination; Heparin, Low-Molecular-Weight; Inflammation Mediators; Male; Microspheres; Particle Size; Polyesters; Polyethylene Glycols; Quinolines; Rats; Rats, Sprague-Dawley; Sulfides | 2017 |
Can the response to Omalizumab be influenced by treatment duration? A real-life study.
Topics: Acetates; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Female; Forced Expiratory Volume; Humans; Linear Models; Male; Middle Aged; Omalizumab; Quinolines; Retrospective Studies; Sulfides; Time Factors; Treatment Outcome | 2017 |
Gender differences in the effectiveness of asthma treatment.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Female; Humans; Lung; Male; Quinolines; Sex Characteristics; Sulfides | 2008 |
[Importance of leukotriene antagonists in asthma therapy raised].
Topics: Acetates; Adolescent; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Algorithms; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Clinical Trials as Topic; Cohort Studies; Cyclopropanes; Drug Therapy, Combination; Humans; Leukotriene Antagonists; Practice Guidelines as Topic; Quinolines; Respiratory Therapy; Smoking; Sulfides; Time Factors | 2008 |
Histological appearances of putative montelukast related Churg-Strauss syndrome.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Biopsy; Churg-Strauss Syndrome; Cyclopropanes; Humans; Leukotriene Antagonists; Lung; Male; Quinolines; Sulfides | 2008 |
[The relevance of leukotriene C(4) synthase gene A (-444) C polymorphism to clinical responsiveness to montelukast in patients with asthma].
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asian People; Asthma; Case-Control Studies; Cyclopropanes; Female; Gene Frequency; Genotype; Glutathione Transferase; Humans; Leukotriene Antagonists; Male; Middle Aged; Polymorphism, Single Nucleotide; Quinolines; Sulfides; Treatment Outcome | 2008 |
Predicting an asthma exacerbation in children 2 to 5 years of age.
Topics: Acetates; Adrenergic beta-Agonists; Anti-Asthmatic Agents; Asthma; Child, Preschool; Cough; Cyclopropanes; Drug Administration Schedule; Humans; Multivariate Analysis; Prognosis; Quinolines; Remission, Spontaneous; Respiratory Sounds; Severity of Illness Index; Sulfides | 2008 |
Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthma.
Topics: Acetates; Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Androstadienes; Anti-Allergic Agents; Asthma; Child; Cyclopropanes; Exhalation; Female; Fluticasone; Humans; Leukotriene Antagonists; Male; Nitric Oxide; Prognosis; Quinolines; Randomized Controlled Trials as Topic; Sulfides; Treatment Outcome | 2009 |
[Churg-Strauss syndrome associated with montelukast].
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Eosinophilia; Eosinophils; Female; Humans; Middle Aged; Quinolines; Sulfides | 2008 |
Effects of the immunomodulatory agent Cordyceps militaris on airway inflammation in a mouse asthma model.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Asthma; Cordyceps; Cyclopropanes; Disease Models, Animal; Female; Immunologic Factors; Mice; Mice, Inbred BALB C; Prednisolone; Quinolines; Random Allocation; Sulfides | 2008 |
[Effects of montelukast and BCG-PSN on the expression of STAT5b mRNA and IL-4 mRNA in blood mononuclearcells of rats with asthma].
Topics: Acetates; Animals; Asthma; BCG Vaccine; Cyclopropanes; Interferon-gamma; Interleukin-4; Leukocytes, Mononuclear; Male; Quinolines; Rats; Rats, Sprague-Dawley; RNA, Messenger; STAT5 Transcription Factor; Sulfides | 2009 |
Singulair-induced anaphylaxis?
Topics: Acetates; Anaphylaxis; Anti-Asthmatic Agents; Asthma; Child, Preschool; Conjunctivitis, Allergic; Cyclopropanes; Dermatitis, Atopic; Humans; Infant; Leukotriene Antagonists; Male; Prognosis; Quinolines; Respiratory Hypersensitivity; Sulfides | 2009 |
Urinary cysteinyl leukotriene E4 significantly increases during pain in children and adults with sickle cell disease.
Topics: Acetates; Adolescent; Adult; Anemia, Sickle Cell; Anti-Asthmatic Agents; Asthma; beta-Thalassemia; Biomarkers; Child; Cohort Studies; Cyclopropanes; Female; Fetal Hemoglobin; Hemoglobin C Disease; Heterozygote; Hospitalization; Humans; Ischemia; Leukotriene Antagonists; Leukotriene E4; Male; Pain; Quinolines; Retrospective Studies; Sickle Cell Trait; Sulfides; Young Adult | 2009 |
Rates of asthma attacks in patients with previously inadequately controlled mild asthma treated in clinical practice with combination drug therapy: an exploratory post-hoc analysis.
Topics: Acetates; Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Drug Therapy, Combination; Europe; Female; Follow-Up Studies; Glucocorticoids; Humans; Incidence; Male; Middle Aged; Quinolines; Recurrence; Retrospective Studies; Sulfides; Time Factors; Young Adult | 2009 |
Montelukast-associated Churg-Strauss vasculitis: another associated report.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Churg-Strauss Syndrome; Cough; Cyclopropanes; Eosinophils; Female; Humans; Quinolines; Skin; Sulfides | 2009 |
The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte P-glycoprotein (PGP) expression in asthmatic children.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Adrenal Cortex Hormones; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Budesonide; Case-Control Studies; Child; Child, Preschool; Cyclopropanes; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Humans; Inflammation Mediators; Leukotriene Antagonists; Male; Nebulizers and Vaporizers; Probability; Quinolines; Reference Values; Sensitivity and Specificity; Severity of Illness Index; Sulfides; T-Lymphocytes; Treatment Outcome | 2009 |
A prostaglandin D2 receptor antagonist modifies experimental asthma in sheep.
Topics: Acetates; Allergens; Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Cyclic AMP; Cyclopropanes; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Prostaglandin D2; Quinolines; Receptors, Immunologic; Receptors, Prostaglandin; Sulfides; Thiophenes; Time Factors | 2009 |
[Non-interventional study with remarkable results. Improved asthma control and quality of life with montelukast].
Topics: Acetates; Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Quinolines; Sulfides | 2009 |
[Effects of leukotriene receptor antagonists on vascular endothelial growth factor and its receptors in a sensitized rat model].
Topics: Acetates; Airway Remodeling; Animals; Asthma; Cyclopropanes; Leukotriene Antagonists; Leukotriene D4; Male; Neovascularization, Pathologic; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Vascular Endothelial Growth Factor; Sulfides; Vascular Endothelial Growth Factor A | 2009 |
Churg-Strauss syndrome associated with montelukast therapy.
Topics: Acetates; Adult; Aged, 80 and over; Anti-Asthmatic Agents; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Female; Humans; Leukotriene Antagonists; Male; Pulmonary Eosinophilia; Quinolines; Sulfides | 2009 |
Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
Topics: Acetates; Administration, Inhalation; Animals; Asthma; Bronchial Hyperreactivity; Bronchoconstriction; Cyclopropanes; Cysteine; Disease Models, Animal; Guinea Pigs; Immunologic Factors; Leukotriene Antagonists; Leukotriene C4; Leukotriene D4; Leukotrienes; Lung; Male; Ovalbumin; Quinolines; Sulfides | 2009 |
Montelukast use during pregnancy: a multicentre, prospective, comparative study of infant outcomes.
Topics: Acetates; Adult; Asthma; Cyclopropanes; Female; Humans; Infant, Newborn; Leukotriene Antagonists; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prospective Studies; Quinolines; Sulfides | 2009 |
The placebo effect in asthma: Far more complex than simply "I shall please".
Topics: Acetates; Asthma; Central Nervous System; Cyclopropanes; Humans; Leukotriene Antagonists; Placebo Effect; Quinolines; Randomized Controlled Trials as Topic; Sulfides | 2009 |
Predictors of asthma control in everyday clinical practice in Switzerland.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Cohort Studies; Cyclopropanes; Female; Humans; Male; Middle Aged; Quinolines; Sulfides; Switzerland | 2009 |
Churg-Strauss syndrome secondary to antileucotriene therapy in a patient not receiving oral corticosteroids.
Topics: Acetates; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Drug Eruptions; Female; Glucocorticoids; Humans; Leukotriene Antagonists; Quinolines; Sulfides; Vasculitis, Leukocytoclastic, Cutaneous; Young Adult | 2009 |
Reports of suicidality in clinical trials of montelukast.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Female; Humans; Leukotriene Antagonists; Male; Mental Disorders; Quinolines; Retrospective Studies; Risk Assessment; Self-Injurious Behavior; Suicide; Sulfides | 2009 |
Assessing risk: Data from montelukast clinical trials.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Humans; Leukotriene Antagonists; Mental Disorders; Quinolines; Risk Assessment; Suicide; Sulfides | 2009 |
Analysis of behavior-related adverse experiences in clinical trials of montelukast.
Topics: Acetates; Adolescent; Adult; Aged; Anti-Asthmatic Agents; Asthma; Behavioral Symptoms; Child; Child, Preschool; Clinical Trials as Topic; Cyclopropanes; Female; Humans; Male; Mental Disorders; Middle Aged; Quinolines; Retrospective Studies; Sulfides; Young Adult | 2009 |
Adherence to combined montelukast and fluticasone treatment in economically disadvantaged african american youth with asthma.
Topics: Acetates; Adolescent; Albuterol; Ambulatory Care; Androstadienes; Anti-Allergic Agents; Anti-Asthmatic Agents; Asthma; Black or African American; Caregivers; Child; Child, Preschool; Cyclopropanes; Emergency Medical Services; Female; Fluticasone; Follow-Up Studies; Hospitalization; Humans; Male; Medication Adherence; Poverty; Quinolines; Sulfides; Time Factors; Treatment Outcome | 2009 |
Effect of ciclesonide on bronchial asthma in athletes.
Topics: Acetates; Adolescent; Asthma; Athletes; Breath Tests; Cyclopropanes; Female; Forced Expiratory Volume; Humans; Male; Maximal Midexpiratory Flow Rate; Nitric Oxide; Pregnenediones; Quinolines; Retrospective Studies; Sulfides; Treatment Outcome; Vital Capacity; Young Adult | 2009 |
Add-on montelukast in inadequately controlled asthma patients in a 6-month open-label study: the MONtelukast In Chronic Asthma (MONICA) study.
Topics: Acetates; Adrenergic beta-Agonists; Adult; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prospective Studies; Quality of Life; Quinolines; Sulfides; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2010 |
Oral ulcerations in a patient with severe asthma.
Topics: Acetates; Adrenal Cortex Hormones; Aged; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Diagnosis, Differential; Female; Histoplasmosis; Humans; Immunosuppression Therapy; Leukotriene Antagonists; Mouth Mucosa; Mouth Neoplasms; Oral Ulcer; Prednisone; Quinolines; Severity of Illness Index; Stomatitis, Aphthous; Sulfides; Tongue Diseases | 2010 |
Corticosteroids and montelukast: effects on airway epithelial and human umbilical vein endothelial cells.
Topics: Acetates; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Apoptosis; Asthma; Cell Line; Cyclopropanes; Cytokines; Desmosomes; Endothelium, Vascular; Humans; Intercellular Adhesion Molecule-1; Leukotriene Antagonists; Necrosis; Quinolines; Respiratory Mucosa; Sulfides; Umbilical Veins | 2010 |
The efficacy of montelukast monotherapy in moderate persistent asthmatic children.
Topics: Acetates; Adolescent; Asthma; Budesonide; Child; Cyclopropanes; Drug Therapy, Combination; Humans; Leukotriene Antagonists; Prospective Studies; Quinolines; Sulfides | 2009 |
Recent-onset bronchial asthma as a manifestation of systemic mastocytosis.
Topics: Abdominal Pain; Acetates; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Budesonide; Capillary Permeability; Cough; Cyclopropanes; Diarrhea; Dyspnea; Female; Humans; Lung; Mast Cells; Mastocytosis, Systemic; Middle Aged; Nedocromil; Quinolines; Sulfides | 2009 |
Choosing asthma step-up care.
Topics: Acetates; Adolescent; Albuterol; Androstadienes; Asthma; Bronchodilator Agents; Child; Cyclopropanes; Drug Therapy, Combination; Fluticasone; Humans; Quinolines; Salmeterol Xinafoate; Sulfides | 2010 |
Antitussive effects of the leukotriene receptor antagonist montelukast in patients with cough variant asthma and atopic cough.
Topics: Acetates; Adult; Aged; Antitussive Agents; Asthma; Clenbuterol; Cough; Cyclopropanes; Drug Therapy, Combination; Female; Humans; Leukotriene Antagonists; Male; Middle Aged; Quinolines; Respiratory Function Tests; Sulfides; Treatment Outcome | 2010 |
sCD14 in bronchoalveolar lavage 18, 42 and 162 hours after segmental allergen provocation.
Topics: Acetates; Adolescent; Adult; Allergens; Asthma; Bronchial Provocation Tests; Bronchoalveolar Lavage Fluid; Cyclopropanes; Enzyme-Linked Immunosorbent Assay; Female; Humans; Leukotriene Antagonists; Leukotriene D4; Lipopolysaccharide Receptors; Lipopolysaccharides; Male; Quinolines; Sulfides; Time; Young Adult | 2010 |
Churg-Strauss syndrome with severe granulomatous angiitis and crescentic glomerulonephritis, which developed during therapy with a leukotriene receptor antagonist.
Topics: Acetates; Aged; Antibodies, Antineutrophil Cytoplasmic; Asthma; C-Reactive Protein; Churg-Strauss Syndrome; Cyclopropanes; Female; Humans; Leukotriene Antagonists; Prednisolone; Quinolines; Sulfides; Vasculitis, Central Nervous System | 2010 |
Leukotrienes produced in allergic lung inflammation activate alveolar macrophages.
Topics: Acetates; Allergens; Animals; Asthma; Cyclopropanes; Cysteine; Disease Models, Animal; Klebsiella pneumoniae; Leukotriene Antagonists; Leukotriene C4; Leukotrienes; Lung; Macrophages, Alveolar; Male; Nitric Oxide; Ovalbumin; Phagocytosis; Pneumonia; Quinolines; Rats; Rats, Wistar; Receptors, IgG; Sulfides | 2010 |
Safety of using montelukast during pregnancy.
Topics: Abnormalities, Drug-Induced; Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Female; Humans; Leukotriene Antagonists; Pregnancy; Pregnancy Complications; Quinolines; Sulfides | 2010 |
Montelukast might improve compliance with subcutaneous immunotherapy treatments in patients with allergic asthma.
Topics: Acetates; Allergens; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Desensitization, Immunologic; Humans; Hypersensitivity; Injections, Subcutaneous; Patient Compliance; Quinolines; Sulfides | 2011 |
[New approaches to treatment of occupational bronchial asthma].
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclic AMP; Cyclic GMP; Cyclopropanes; Humans; Leukotriene Antagonists; Occupational Diseases; Quinolines; Sulfides | 2010 |
Oral montelukast may have a role in severe and in life-threatening acute asthma.
Topics: Acetates; Acute Disease; Administration, Oral; Adult; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Humans; Quinolines; Sulfides | 2011 |
Lack of pretreatment cost-effectiveness and side effects of omalizumab versus prednisone/montelukast on tolerability of immunotherapy.
Topics: Acetates; Anti-Asthmatic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Asthma; Cost-Benefit Analysis; Cyclopropanes; Desensitization, Immunologic; Humans; Hypersensitivity; Omalizumab; Prednisone; Quinolines; Sulfides | 2011 |
Polymorphisms of the PTGDR and LTC4S influence responsiveness to leukotriene receptor antagonists in Korean children with asthma.
Topics: Acetates; Asthma; Child; Cyclopropanes; Exercise Test; Fluorescence; Genome-Wide Association Study; Genotype; Glutathione Transferase; Humans; Immunoenzyme Techniques; Immunoglobulin E; Korea; Leukotriene Antagonists; Odds Ratio; Phenotype; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Quinolines; Receptors, Immunologic; Receptors, Prostaglandin; Sulfides | 2011 |
Prostaglandin D₂ receptor CRTH2 antagonists for the treatment of inflammatory diseases.
Topics: Acetates; Animals; Asthma; Carbazoles; Clinical Trials as Topic; Drug Discovery; Humans; Indoleacetic Acids; Receptors, Immunologic; Receptors, Prostaglandin; Sulfonamides | 2011 |
Montelukast in childhood asthma: what is the evidence for its use?
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Bronchoconstriction; Child; Child, Preschool; Cyclopropanes; Dose-Response Relationship, Drug; Humans; Leukotriene Antagonists; Leukotrienes; Quinolines; Sulfides; Treatment Outcome | 2011 |
Clinical trials and tribulations: the MASCOT study.
Topics: Acetates; Adrenergic beta-Agonists; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Drug Therapy, Combination; Glucocorticoids; Humans; Patient Selection; Quinolines; Randomized Controlled Trials as Topic; Research Design; Sulfides | 2011 |
Ontology-based knowledge discovery in pharmacogenomics.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Computational Biology; Cyclopropanes; Data Interpretation, Statistical; Data Mining; Databases, Genetic; Genetic Association Studies; Humans; Knowledge Bases; Logistic Models; Pharmacogenetics; Quinolines; Sulfides | 2011 |
Effects of a cysteinyl leukotriene dual 1/2 receptor antagonist on antigen-induced airway hypersensitivity and airway inflammation in a guinea pig asthma model.
Topics: Acetates; Acetylcholine; Animals; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoalveolar Lavage Fluid; Cyclopropanes; Eosinophils; Guinea Pigs; Inflammation; Leukotriene Antagonists; Lung; Male; Ovalbumin; Quinolines; Receptors, Leukotriene; SRS-A; Sulfides | 2011 |
[Association of leukotriene gene polymorphisms with response to antileukotriene treatment in patients with asthma].
Topics: Acetates; Adolescent; Adult; Alleles; Asthma; Case-Control Studies; Cyclopropanes; Female; Gene Frequency; Genotype; Haplotypes; Humans; Leukotriene Antagonists; Leukotrienes; Male; Middle Aged; Polymorphism, Single Nucleotide; Quinolines; Sulfides; Young Adult | 2011 |
[Antileukotrienes in asthma: a nice story, still to be completed].
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 2011 |
Congenital malformations among infants born to women receiving montelukast, inhaled corticosteroids, and other asthma medications.
Topics: Acetates; Administration, Inhalation; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Congenital Abnormalities; Cyclopropanes; Female; Humans; Infant; Pregnancy; Quinolines; Sulfides | 2012 |
A case of Churg-Strauss syndrome treated with montelukast.
Topics: Acetates; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Female; Humans; Leukotriene Antagonists; Middle Aged; Quinolines; Sulfides | 2012 |
Clinical, physiological and anti-inflammatory effect of montelukast in patients with cough variant asthma.
Topics: Acetates; Adult; Aged; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Cohort Studies; Cough; Cyclopropanes; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Leukotriene Antagonists; Linear Models; Male; Methacholine Chloride; Middle Aged; Multivariate Analysis; Odds Ratio; Prospective Studies; Quinolines; Respiratory Function Tests; Risk Assessment; Severity of Illness Index; Sulfides; Treatment Outcome | 2012 |
[Pathogenesis, diagnosis and therapy of bronchial asthma. How can the lungs be freed?].
Topics: Acetates; Administration, Inhalation; Adult; Airway Obstruction; Asthma; Atherosclerosis; Bronchodilator Agents; Bronchoscopy; Child; Cyclopropanes; Glucocorticoids; Humans; Hyperthermia, Induced; Leukotriene Antagonists; Quinolines; Scopolamine Derivatives; Sulfides; Tiotropium Bromide | 2011 |
Anti-cholinergic effect of singulair on isolated rat's tracheal smooth muscle.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Asthma; Bronchoconstrictor Agents; Cholinergic Antagonists; Cyclopropanes; Dose-Response Relationship, Drug; Electric Stimulation; In Vitro Techniques; Methacholine Chloride; Muscle Contraction; Muscle Tonus; Muscle, Smooth; Quinolines; Rats; Sulfides; Trachea | 2012 |
Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease.
Topics: Acetates; Aged; Asthma; Cardiovascular Diseases; Cohort Studies; Comorbidity; Cyclopropanes; Drug Utilization; Female; Follow-Up Studies; Humans; Leukotriene Antagonists; Male; Middle Aged; Quinolines; Risk; Sex Factors; Socioeconomic Factors; Sulfides; Survival Analysis; Sweden | 2012 |
Higher levels of soluble Fas ligand and transforming growth factor-β after omalizumab treatment: a case report.
Topics: Acetates; Adolescent; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Apoptosis; Asthma; Budesonide; Cyclopropanes; Fas Ligand Protein; Female; Humans; Immunologic Factors; Lung; Omalizumab; Quinolines; Respiratory Function Tests; Sulfides; T-Lymphocytes, Regulatory; Transforming Growth Factor beta; Treatment Outcome | 2012 |
Influence of inhaled beclomethasone and montelukast on airway remodeling in mice.
Topics: Acetates; Administration, Inhalation; Airway Remodeling; Animals; Anti-Asthmatic Agents; Asthma; Beclomethasone; Cyclopropanes; Disease Models, Animal; Inflammation; Male; Mice; Ovalbumin; Quinolines; Severity of Illness Index; Sulfides; Time Factors | 2013 |
Pharmacogenetics of asthma controller treatment.
Topics: Acetates; Administration, Inhalation; Adolescent; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Female; Fluticasone; Forced Expiratory Volume; Genetic Association Studies; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Precision Medicine; Quinolines; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Sulfides | 2013 |
A dissociated glucocorticoid receptor modulator reduces airway hyperresponsiveness and inflammation in a mouse model of asthma.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cytokines; Dexamethasone; Disease Models, Animal; Drug Evaluation, Preclinical; Dual Specificity Phosphatase 1; Enzyme Induction; Gene Expression Regulation; Goblet Cells; Inflammation; Leukocytes; Lung; Mast Cells; Metaplasia; Mice; Mice, Inbred BALB C; Ovalbumin; Quaternary Ammonium Compounds; Receptors, Glucocorticoid; STAT6 Transcription Factor; Transcriptional Activation; Tyramine | 2012 |
A novel prostacyclin agonist protects against airway hyperresponsiveness and remodeling in mice.
Topics: Acetates; Airway Remodeling; Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cyclopropanes; Dexamethasone; Epoprostenol; Female; Goblet Cells; Hepatocyte Growth Factor; Inflammation; Lung; Metaplasia; Mice; Mice, Inbred BALB C; Muscle, Smooth; Ovalbumin; Pulmonary Fibrosis; Pyridines; Quinolines; Receptors, Leukotriene; Sulfides; Thromboxanes; Up-Regulation | 2012 |
Asthma treatment outcome in children is associated with vascular endothelial growth factor A (VEGFA) polymorphisms.
Topics: Acetates; Androstadienes; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Female; Fluticasone; Forced Expiratory Volume; Humans; Male; Polymorphism, Single Nucleotide; Quinolines; Sulfides; Treatment Outcome; Vascular Endothelial Growth Factor A | 2012 |
Churg-Strauss syndrome related to montelukast.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Churg-Strauss Syndrome; Cough; Cyclopropanes; Dyspnea; Hemoptysis; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfides | 2012 |
Bronchoalveolar lavage fluid exosomes contribute to cytokine and leukotriene production in allergic asthma.
Topics: Acetates; Adult; Allergens; Anti-Asthmatic Agents; Asthma; Bronchi; Bronchoalveolar Lavage Fluid; Cyclopropanes; Cytokines; Eosinophils; Epithelial Cells; Exosomes; Female; Humans; Leukotrienes; Male; Middle Aged; Quinolines; Sulfides; Young Adult | 2012 |
Montelukast inhibits leukotriene stimulation of human dendritic cells in vitro.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cell Proliferation; Chemokine CCL5; Coculture Techniques; Cyclopropanes; Dendritic Cells; Humans; Leukotriene C4; Primary Cell Culture; Quinolines; Receptors, Leukotriene; Respiratory Syncytial Viruses; Sulfides; T-Lymphocytes | 2012 |
Neuropsychiatric reactions to montelukast.
Topics: Acetates; Adolescent; Asthma; Child; Child Behavior Disorders; Cyclopropanes; Humans; Male; Mood Disorders; Quinolines; Sulfides | 2012 |
Simultaneous determination of montelukast as sparing therapy with some inhaled corticosteroids in plasma of asthmatic patients.
Topics: Acetates; Administration, Inhalation; Adrenal Cortex Hormones; Adult; Asthma; Chromatography, High Pressure Liquid; Cyclopropanes; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Quinolines; Sulfides | 2013 |
Methacholine PC20 in African Americans and whites with asthma with homozygous genotypes at ADRB2 codon 16.
Topics: Acetates; Adolescent; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Adult; Anti-Asthmatic Agents; Asthma; Black or African American; Bronchial Hyperreactivity; Bronchodilator Agents; Cyclopropanes; Female; Genotype; Histamine Antagonists; Humans; Ipratropium; Male; Methacholine Chloride; Middle Aged; Quinolines; Receptors, Adrenergic, beta-2; Respiratory Function Tests; Sulfides; White People; Young Adult | 2013 |
Cutaneous lesions of Churg-Strauss syndrome associated with montelukast therapy.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Drug Eruptions; Humans; Leg Dermatoses; Leukotriene Antagonists; Male; Middle Aged; Quinolines; Sulfides | 2002 |
Treatment of asthmatic patients with a cysteinyl leukotriene receptor-1 antagonist montelukast (Singulair), decreases the eosinophil survival-enhancing activity produced by peripheral blood mononuclear leukocytes in vitro.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Cell Survival; Controlled Clinical Trials as Topic; Cyclopropanes; Cytokines; Double-Blind Method; Eosinophils; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukocytes, Mononuclear; Leukotriene Antagonists; Male; Membrane Proteins; Middle Aged; Quinolines; Receptors, Leukotriene; Staining and Labeling; Statistics as Topic; Sulfides; Time Factors; Treatment Outcome | 2002 |
Irritable bowel syndrome helped by montelukast.
Topics: Acetates; Asthma; Celiac Disease; Colonic Diseases, Functional; Cyclopropanes; Humans; Leukotriene Antagonists; Patient Satisfaction; Quinolines; Sulfides; Treatment Outcome | 2002 |
[Montelukast].
Topics: Acetates; Adolescent; Adult; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Clinical Trials as Topic; Cyclopropanes; Dose-Response Relationship, Drug; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 2002 |
Choice of a medication to treat asthma: is an improvement in symptoms sufficient for deciding?
Topics: Acetates; Asthma; Beclomethasone; Cyclopropanes; Forced Expiratory Volume; Humans; Quinolines; Sulfides | 2002 |
Dispensing error leading to alendronate ingestion.
Topics: Acetates; Alendronate; Asthma; Calcium Channel Blockers; Child; Cyclopropanes; Drug Packaging; Esophagitis; Humans; Leukotriene Antagonists; Male; Medication Errors; Quinolines; Sulfides | 2003 |
Asthma control and patient satisfaction among early pediatric users of montelukast.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Child; Child Welfare; Cyclopropanes; Disease Management; Female; Follow-Up Studies; Humans; Male; Patient Satisfaction; Prospective Studies; Quinolines; Sulfides; Time; Time Factors; Treatment Outcome; United States | 2002 |
Montelukast pharmacokinetics in cystic fibrosis.
Topics: Acetates; Adolescent; Adult; Anti-Asthmatic Agents; Asthma; Case-Control Studies; Chromatography, High Pressure Liquid; Cyclopropanes; Cystic Fibrosis; Drug Administration Schedule; Female; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfides | 2003 |
[Leukotriene antagonist. All around talent in asthma and allergies].
Topics: Acetates; Asthma; Cyclopropanes; Dermatitis, Atopic; Humans; Leukotriene Antagonists; Quinolines; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sulfides; Treatment Outcome | 2002 |
Impact of montelukast on symptoms in mild-to-moderate persistent asthma and exercise-induced asthma: results of the ASTHMA survey. Adding Singulair Treatment to Handle symptoms in Mild to moderate Asthmatics.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Belgium; Child; Cyclopropanes; Data Collection; Exercise; Female; Humans; Male; Patient Satisfaction; Physicians, Family; Quinolines; Sulfides | 2002 |
Broadening the therapeutic options in acute asthma.
Topics: Acetates; Acute Disease; Asthma; Cyclopropanes; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 2003 |
Anti-inflammatory effects of high-dose montelukast in an animal model of acute asthma.
Topics: Acetates; Administration, Inhalation; Animals; Asthma; Bronchoalveolar Lavage Fluid; Chemokines, CC; Cyclopropanes; Eosinophils; Humans; Immunoglobulin E; Interleukins; Leukocyte Count; Leukotriene Antagonists; Mice; Mice, Inbred BALB C; Models, Animal; Ovalbumin; Quinolines; RNA, Messenger; Sulfides; Th2 Cells; Vascular Cell Adhesion Molecule-1 | 2003 |
Effect of pharmacist counseling in patients hospitalized with acute exacerbation of asthma.
Topics: Acetates; Acute Disease; Administration, Inhalation; Adrenal Cortex Hormones; Adult; Albuterol; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Counseling; Cyclopropanes; Female; Hospitals, Teaching; Humans; Inpatients; Male; Middle Aged; Patient Compliance; Patient Education as Topic; Patient Satisfaction; Pharmacists; Quinolines; Salmeterol Xinafoate; Sulfides; United States | 2003 |
Acute hepatitis associated with montelukast.
Topics: Acetates; Acute Disease; Aged; Anti-Asthmatic Agents; Asthma; Chemical and Drug Induced Liver Injury; Cyclopropanes; Humans; Male; Quinolines; Sulfides | 2003 |
Wheeze monitoring in children for assessment of nocturnal asthma and response to therapy.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Bronchial Provocation Tests; Child; Cyclopropanes; Female; Humans; Male; Monitoring, Physiologic; Pilot Projects; Prospective Studies; Quinolines; Respiratory Sounds; Sleep; Statistics, Nonparametric; Sulfides | 2003 |
Asthma variability.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Beclomethasone; Clinical Trials as Topic; Cyclopropanes; Humans; Quinolines; Sulfides; Treatment Outcome | 2003 |
[Leukotriene antagonist added in asthma therapy. Loophole in anti-inflammatory therapy closed].
Topics: Acetates; Adult; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Budesonide; Clinical Trials as Topic; Cyclopropanes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 2003 |
Acute Churg-Strauss syndrome in an asthmatic patient receiving montelukast therapy.
Topics: Acetates; Acute Disease; Anti-Asthmatic Agents; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Humans; Male; Middle Aged; Quinolines; Skin Diseases; Sulfides | 2003 |
Effect of montelukast on polymorphonuclear leukocyte functions in asthmatic patients.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Candida albicans; Cyclopropanes; Humans; Leukotriene Antagonists; Middle Aged; Neutrophils; Phagocytosis; Quinolines; Sulfides | 2003 |
Montelukast-associated Churg-Strauss syndrome.
Topics: Acetates; Aged; Anti-Asthmatic Agents; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfides | 2003 |
Outcomes of patients treated with fluticasone propionate or montelukast sodium.
Topics: Acetates; Adolescent; Adult; Androstadienes; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Emergency Service, Hospital; Female; Fluticasone; Hospitalization; Humans; Male; Middle Aged; Multivariate Analysis; Outcome Assessment, Health Care; Quinolines; Retrospective Studies; Sulfides; United States | 2003 |
Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists.
Topics: Acetates; Adolescent; Adult; Aged; Antibodies, Antineutrophil Cytoplasmic; Asthma; Biopsy; Central Nervous System Diseases; Child; Churg-Strauss Syndrome; Cyclopropanes; Electromyography; Eosinophilic Granuloma; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Indoles; Leukotriene Antagonists; Male; Middle Aged; Minnesota; Peroxidase; Phenylcarbamates; Predictive Value of Tests; Quinolines; Statistics as Topic; Sulfides; Sulfonamides; Survival Analysis; Tosyl Compounds; Treatment Outcome | 2003 |
[Role of a local point of irritation in the production in the white rat of an experimental asthmatic attack by intraperitoneal injection of ovalbumin].
Topics: Acetates; Albumins; Animals; Asthma; Castration; Humans; Injections, Intraperitoneal; Male; Orchiectomy; Ovalbumin; Rats | 1954 |
Effects of 9alpha-fluorohydrocortisone acetate administered to patients with asthmatic bronchitis.
Topics: Acetates; Asthma; Bronchitis; Humans | 1954 |
CELLULOSE-ACETATE MEMBRANE AS A MEDIUM FOR DEMONSTRATING MILK PRECIPITINS; APPLICATION TO SELECTED PATIENTS.
Topics: Acetates; Animals; Asthma; Cattle; Cellulose; Child; Food Hypersensitivity; Humans; Immune Sera; Immunoelectrophoresis; Infant; Milk; Precipitin Tests; Precipitins; Rabbits; Rhinitis, Allergic, Seasonal | 1963 |
IDENTIFICATION OF HISTAMINE METABOLITE 1-METHYL, 4-IMIDAZOLE ACETIC ACID IN HUMAN URINE AND ITS ABSENCE IN STATUS ASTHMATICUS.
Topics: Acetates; Adrenocorticotropic Hormone; Animals; Asthma; Autoradiography; Carbon Isotopes; Chromatography; Eosinophilia; Guinea Pigs; Histamine; Histamine Release; Humans; Imidazoles; Metabolism; Methylhistamines; Pharmacology; Spectrum Analysis; Status Asthmaticus; Ultraviolet Rays; Urine | 1964 |
[Treatment of bronchial asthma with tropacine].
Topics: Acetates; Asthma; Cardiovascular Agents; Humans; Muscle Relaxants, Central; Tropanes | 1955 |
Distribution of therapeutic response in asthma control.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Beclomethasone; Cyclopropanes; Humans; Quinolines; Statistics as Topic; Sulfides | 2003 |
A leukotriene receptor antagonist modulates iNOS in the lung and in a leukotriene-free cell model.
Topics: Acetates; Allergens; Animals; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Bronchoalveolar Lavage Fluid; Cell Line; Cyclopropanes; Cysteine; Cytokines; Dexamethasone; Epithelial Cells; Immunohistochemistry; Leukotriene Antagonists; Leukotrienes; Lung; Male; Models, Animal; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Quinolines; Rats; Rats, Inbred BN; Sulfides | 2003 |
[A study on the heterogeneous apoptosis of lymphocytes, eosinophils, and neutrophils from peripheral blood of asthmatic patients].
Topics: Acetates; Adult; Apoptosis; Asthma; Caspase 3; Caspases; Cyclopropanes; Dexamethasone; Eosinophils; fas Receptor; Female; Humans; Lymphocytes; Male; Neutrophils; Quinolines; Sulfides | 2003 |
Effect of montelukast pretreatment on inducible nitric oxide synthase mRNA expression in the lungs of antigen-challenged allergic mice.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Antigens; Asthma; Cyclopropanes; Dexamethasone; Female; Leukotriene Antagonists; Lung; Mice; Mice, Inbred BALB C; Models, Animal; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Quinolines; RNA, Messenger; Skin Tests; Sulfides | 2003 |
Intravenous montelukast in acute asthma.
Topics: Acetates; Acute Disease; Adult; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cyclopropanes; Female; Humans; Infusions, Intravenous; Male; Peak Expiratory Flow Rate; Quinolines; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Sulfides; Treatment Outcome | 2004 |
Montelukast and fluticasone propionate.
Topics: Acetates; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Cyclopropanes; Fluticasone; Humans; Leukotriene Antagonists; Peak Expiratory Flow Rate; Quinolines; Sulfides | 2003 |
[An anti-leukotriene combined with inhaled corticosteroids: results of the COMPACT study].
Topics: Acetates; Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Asthma; Bronchodilator Agents; Budesonide; Chronic Disease; Cyclopropanes; Drug Therapy, Combination; Humans; Leukotriene Antagonists; Middle Aged; Quinolines; Sulfides | 2003 |
[Adding a prolonged action beta-2-agonist].
Topics: Acetates; Adrenergic beta-Agonists; Albuterol; Asthma; Bronchodilator Agents; Chronic Disease; Cyclopropanes; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Leukotriene Antagonists; Quinolines; Salmeterol Xinafoate; Sulfides | 2003 |
[Adding an anti-leukotriene: results of the IMPACT study].
Topics: Acetates; Adrenergic beta-Agonists; Albuterol; Androstadienes; Asthma; Bronchodilator Agents; Chronic Disease; Cyclopropanes; Delayed-Action Preparations; Drug Therapy, Combination; Ethanolamines; Fluticasone; Formoterol Fumarate; Humans; Leukotriene Antagonists; Quinolines; Salmeterol Xinafoate; Sulfides | 2003 |
Intravenous montelukast in acute asthma.
Topics: Acetates; Acute Disease; Anti-Asthmatic Agents; Asthma; Critical Care; Cyclopropanes; Female; Humans; Infusions, Intravenous; Male; Prognosis; Quinolines; Risk Assessment; Severity of Illness Index; Sulfides; Treatment Outcome | 2004 |
Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in an experimental model of chronic airway inflammation in guinea-pigs.
Topics: Acetates; Animals; Asthma; Chronic Disease; Cyclopropanes; Dexamethasone; Eosinophils; Glucocorticoids; Guinea Pigs; Leukocyte Count; Leukotriene Antagonists; Lung; Male; Quinolines; Sulfides | 2004 |
Increase in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitation.
Topics: Acetates; Acute Disease; Adolescent; Adult; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Forced Expiratory Volume; Humans; Infusions, Intravenous; Leukotriene Antagonists; Leukotriene E4; Middle Aged; Quinolines; Sulfides | 2004 |
Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adult; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Cohort Studies; Cyclopropanes; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluticasone; Health Maintenance Organizations; Humans; Male; Nebulizers and Vaporizers; Patient Compliance; Quinolines; Retrospective Studies; Salmeterol Xinafoate; Sulfides | 2004 |
Exhaled gas analysis and airway inflammation.
Topics: Acetates; Asthma; Breath Tests; Carbon Monoxide; Cyclopropanes; Glucocorticoids; Humans; Leukotriene Antagonists; Nitric Oxide; Quinolines; Respiratory Function Tests; Sulfides | 2004 |
Airway inflammation and asthma treatment modalities.
Topics: Acetates; Asthma; Bronchial Hyperreactivity; Child; Cyclopropanes; Humans; Immune System; Immunotherapy; Inflammation; Leukotriene Antagonists; Quinolines; Sulfides | 2004 |
Leukotriene modifier use and asthma severity: how is a new medication being used by adults with asthma?
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Female; Health Status Indicators; Hospitalization; Humans; Hydroxyurea; Leukotriene Antagonists; Logistic Models; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Quinolines; Sulfides | 2004 |
Exhaled nitric oxide.
Topics: Acetates; Albuterol; Asthma; Breath Tests; Bronchodilator Agents; Budesonide; Cyclopropanes; Exhalation; Humans; Nitric Oxide; Quinolines; Respiratory Function Tests; Salmeterol Xinafoate; Sulfides | 2004 |
Churg-Strauss syndrome associated with the leukotriene antagonist montelukast.
Topics: Acetates; Aged; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Electrophysiology; Female; Humans; Leukotriene Antagonists; Pain; Peripheral Nervous System Diseases; Quinolines; Sulfides | 2004 |
Montelukast-induced hepatitis.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Chemical and Drug Induced Liver Injury; Cyclopropanes; Female; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 2004 |
Churg Strauss syndrome during treatment of bronchial asthma with a leucotriene receptor antagonist presenting with polyneuropathy.
Topics: Acetates; Aged; Anti-Asthmatic Agents; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Humans; Leukotriene Antagonists; Male; Muscle, Skeletal; Quinolines; Sulfides; Sural Nerve | 2004 |
Effects of glucocorticoid and cysteinyl leukotriene 1 receptor antagonist on CD(34+) hematopoietic cells in bone marrow of asthmatic mice.
Topics: Acetates; Animals; Antigens, CD34; Asthma; Cell Count; Cyclopropanes; Hematopoietic Stem Cells; Immunohistochemistry; In Situ Hybridization; Interleukin-5; Male; Mice; Mice, Inbred BALB C; Prednisone; Quinolines; Sulfides | 2004 |
[The effects of anti-inflammatory and anti-asthmatic agents on CD34+ hematopoietic cells in bone marrow of asthmatic mice].
Topics: Acetates; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Antigens, CD34; Asthma; Bronchoalveolar Lavage Fluid; Cyclopropanes; Hematopoietic Stem Cells; Interleukin-5 Receptor alpha Subunit; Male; Mice; Mice, Inbred BALB C; Prednisone; Quinolines; Receptors, Interleukin; RNA, Messenger; Sulfides | 2004 |
Acquired thrombopathia related to montelukast therapy.
Topics: Acetates; Adult; Asthma; Blood Platelet Disorders; Cyclopropanes; Female; Hemorrhage; Humans; Leukotriene Antagonists; Platelet Function Tests; Quinolines; Sulfides | 2004 |
Evaluating the effectiveness of asthma treatment in real-life practice.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Evidence-Based Medicine; Humans; Pilot Projects; Quinolines; Randomized Controlled Trials as Topic; Sulfides; United Kingdom | 2004 |
Asthma hospitalization risk and costs for patients treated with fluticasone propionate vs montelukast.
Topics: Acetates; Adult; Androstadienes; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Female; Fluticasone; Health Care Costs; Hospitalization; Humans; Male; Quinolines; Retrospective Studies; Sulfides; Treatment Outcome | 2004 |
Reduced eosinophil pro-fibrogenic effect in severe childhood asthma compared to mild disease: an effect of corticosteroids?
Topics: Acetates; Adolescent; Albuterol; Androstadienes; Asthma; Child; Cyclopropanes; Dexamethasone; Eosinophils; Female; Fibroblasts; Fluticasone; Glucocorticoids; Humans; In Vitro Techniques; Male; Quinolines; Salmeterol Xinafoate; Sulfides | 2004 |
Cysteinyl leukotrienes and collagen type I synthesis in asthma.
Topics: Acetates; Adult; Androstadienes; Anti-Inflammatory Agents; Asthma; Collagen Type I; Cyclopropanes; Eosinophils; Female; Fluticasone; Humans; Leukotriene Antagonists; Male; Membrane Proteins; Middle Aged; Peptide Fragments; Pilot Projects; Procollagen; Quinolines; Receptors, Leukotriene; Sputum; Sulfides | 2004 |
Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adult; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Chronic Disease; Cost-Benefit Analysis; Cyclopropanes; Drug Therapy, Combination; Female; Fluticasone; Humans; Male; Nebulizers and Vaporizers; Prospective Studies; Quinolines; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Sulfides | 2004 |
Montelukast and Churg-Strauss syndrome.
Topics: Acetates; Asthma; Biopsy, Needle; Churg-Strauss Syndrome; Cyclopropanes; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunohistochemistry; Immunosuppressive Agents; Leukotriene Antagonists; Male; Middle Aged; Pulmonary Eosinophilia; Quinolines; Radiography, Thoracic; Risk Assessment; Severity of Illness Index; Sulfides; Switzerland; Treatment Outcome | 2004 |
[The effect of montelukast on airway remodeling and the expression of interleukins and transforming growth factor-beta2 mRNA].
Topics: Acetates; Animals; Asthma; Bronchi; Cyclopropanes; Disease Models, Animal; Eosinophils; Female; Interleukins; Leukotriene Antagonists; Mice; Mice, Inbred BALB C; Quinolines; Random Allocation; RNA, Messenger; Sulfides; Transforming Growth Factor beta; Transforming Growth Factor beta2 | 2004 |
Asthma update: Part II. Medical management.
Topics: Acetates; Adrenergic beta-Agonists; Anti-Bacterial Agents; Asthma; Child; Cyclopropanes; Drug Therapy, Combination; Glucocorticoids; Humans; Leukotriene Antagonists; Practice Guidelines as Topic; Quinolines; Respiratory Function Tests; Sulfides | 2004 |
Montelukast modulates lung CysLT(1) receptor expression and eosinophilic inflammation in asthmatic mice.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; Cyclopropanes; Eosinophils; Interleukin-5; Leukocyte Count; Leukotriene Antagonists; Lung; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Ovalbumin; Quinolines; Receptors, Leukotriene; RNA, Messenger; Sulfides; Up-Regulation | 2004 |
Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
Topics: Acetates; Airway Resistance; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bile; Bronchoalveolar Lavage Fluid; Cyclopropanes; Cysteine; Hypersensitivity; In Vitro Techniques; Leukocyte Count; Leukotriene A4; Leukotriene Antagonists; Leukotrienes; Lung; Methylprednisolone; Quinolines; Rats; Rats, Inbred BN; Receptors, Leukotriene; Sulfides | 2005 |
Novel inhibitory effect on 5-lipoxygenase activity by the anti-asthma drug montelukast.
Topics: Acetates; Allosteric Site; Animals; Anti-Asthmatic Agents; Asthma; Calcimycin; Calcium; Catalysis; Cell Line; Cell Line, Tumor; Cell Survival; Cells, Cultured; Chromatography, High Pressure Liquid; Cyclopropanes; Dexamethasone; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Inhibitory Concentration 50; Kinetics; Leukotriene B4; Leukotriene C4; Lipoxygenase Inhibitors; Mast Cells; Neutrophils; Protein Binding; Quinolines; Rats; Recombinant Proteins; Sulfides | 2004 |
Comparative cutoff points for adenosine monophosphate and methacholine challenge testing.
Topics: Acetates; Adenosine Monophosphate; Administration, Inhalation; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstrictor Agents; Cyclopropanes; Forced Expiratory Volume; Humans; Methacholine Chloride; Quinolines; Retrospective Studies; Sulfides | 2004 |
Observational study of the effects of using montelukast vs fluticasone in patients matched at baseline.
Topics: Acetates; Administration, Inhalation; Adolescent; Adult; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Child; Child, Preschool; Cohort Studies; Cyclopropanes; Female; Fluticasone; Hospitalization; Humans; Insurance Claim Review; Leukotriene Antagonists; Male; Managed Care Programs; Middle Aged; Quinolines; Retrospective Studies; Sulfides; Treatment Outcome | 2004 |
[Effect of montelukast on the apoptosis of lymphocytes in asthmatic rats and its molecular mechanism].
Topics: Acetates; Animals; Anti-Asthmatic Agents; Apoptosis; Asthma; CD4-Positive T-Lymphocytes; Cells, Cultured; Cyclopropanes; Male; Ovalbumin; Quinolines; Random Allocation; Rats; Rats, Sprague-Dawley; Sulfides | 2003 |
Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
Topics: Acetates; Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Clinical Trials as Topic; Cost of Illness; Cyclopropanes; Drug Combinations; Fluticasone; Humans; Middle Aged; Quinolines; Salmeterol Xinafoate; Sulfides | 2004 |
The national montelukast survey.
Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cross-Sectional Studies; Cyclopropanes; Demography; Female; Humans; Male; Middle Aged; Quinolines; Retrospective Studies; Sulfides; Surveys and Questionnaires; Treatment Outcome; United Kingdom | 2005 |
[Effect of the leukotriene receptor antagonist montelukast therapy on asthma in childhood].
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cyclopropanes; Drug Administration Schedule; Female; Humans; Leukotriene Antagonists; Male; Quinolines; Severity of Illness Index; Sulfides; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2004 |
[Value of leukotriene antagonists in bronchial asthma].
Topics: Acetates; Airway Obstruction; Asthma; Bronchial Hyperreactivity; Cyclopropanes; Eosinophilia; Humans; Leukotriene Antagonists; Quinolines; Respiratory Hypersensitivity; Sulfides; Treatment Outcome | 2004 |
[Effects of montelukast on apoptosis and Fas mRNA expression of eosinophils in airway of asthmatic guinea pigs].
Topics: Acetates; Animals; Anti-Asthmatic Agents; Apoptosis; Asthma; Cyclopropanes; Eosinophils; fas Receptor; Female; Guinea Pigs; Leukotriene Antagonists; Male; Ovalbumin; Quinolines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfides | 2004 |
The effect of montelukast on exhaled nitric oxide and lung function in asthmatic children 2 to 5 years old.
Topics: Acetates; Airway Resistance; Anti-Asthmatic Agents; Asthma; Breath Tests; Bronchodilator Agents; Child, Preschool; Cyclopropanes; Female; Genetic Predisposition to Disease; Humans; Leukotriene Antagonists; Male; Nitric Oxide; Quinolines; Radioallergosorbent Test; Respiratory Hypersensitivity; Sulfides; Terbutaline; Treatment Outcome | 2005 |
The effect of treatment with montelukast on in vitro interleukin-10 production of mononuclear cells of children with asthma.
Topics: Acetates; Adolescent; Analysis of Variance; Asthma; Child; Cyclopropanes; Eosinophils; Female; Forced Expiratory Volume; Humans; Hypersensitivity; Interleukin-10; Leukocyte Count; Leukocytes, Mononuclear; Leukotriene Antagonists; Lung; Male; Quinolines; Seasons; Sulfides; Treatment Outcome | 2005 |
Outcomes associated with initiation of different controller therapies in a Medicaid asthmatic population: a retrospective data analysis.
Topics: Acetates; Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Cohort Studies; Cyclopropanes; Drug Therapy, Combination; Female; Fluticasone; Health Care Costs; Humans; Leukotriene Antagonists; Male; Medicaid; Patient Compliance; Quinolines; Retrospective Studies; Salmeterol Xinafoate; Sulfides; Treatment Outcome | 2005 |
Salmeterol/fluticasone propionate versus fluticasone propionate plus montelukast: a cost-effective comparison for asthma.
Topics: Acetates; Adolescent; Adult; Aged; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Cost-Benefit Analysis; Cyclopropanes; Drug Combinations; Drug Therapy, Combination; Fluticasone; Fluticasone-Salmeterol Drug Combination; Humans; Middle Aged; Multicenter Studies as Topic; Netherlands; Quinolines; Randomized Controlled Trials as Topic; Sulfides | 2005 |
Leukotriene inhibitors in combination with steroids: potential role in the development of primary bacterial peritonitis.
Topics: Acetates; Aged; Anti-Inflammatory Agents; Asthma; Cyclopropanes; Drug Therapy, Combination; Escherichia coli Infections; Female; Humans; Leukotriene Antagonists; Peritoneal Lavage; Peritonitis; Prednisolone; Quinolines; Sulfides | 2005 |
Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the investigation of montelukast as a partner agent for complementary therapy [corrected].
Topics: Acetates; Administration, Inhalation; Adult; Albuterol; Androstadienes; Anti-Allergic Agents; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Cyclopropanes; Double-Blind Method; Emergencies; Female; Fluticasone; Humans; Male; Patient Acceptance of Health Care; Quinolines; Rhinitis, Allergic, Perennial; Risk Factors; Salmeterol Xinafoate; Sulfides | 2005 |
Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
Topics: Acetates; Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Anti-Asthmatic Agents; Asthma; Belgium; Cyclopropanes; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pilot Projects; Quinolines; Sulfides; Surveys and Questionnaires | 2005 |
Effects of montelukast in patients with persistent asthma using inhaled corticosteroids plus additional second-line therapy.
Topics: Acetates; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Humans; Nebulizers and Vaporizers; Quinolines; Sulfides; Treatment Outcome | 2005 |
[Churg-Strauss syndrome relapse when antileucotriene in taggered].
Topics: Acetates; Adrenal Cortex Hormones; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Humans; Leukotriene Antagonists; Male; Middle Aged; Quinolines; Radiography, Thoracic; Recurrence; Sulfides; Time Factors; Tomography, X-Ray Computed | 2005 |
Treatment of mild asthma.
Topics: Acetates; Adrenal Cortex Hormones; Adult; Albuterol; Anti-Asthmatic Agents; Asthma; Budesonide; Child; Cyclopropanes; Drug Administration Schedule; Humans; Quinolines; Sulfides | 2005 |
When an asthma drug has an inferiority complex: a noninferiority trial.
Topics: Acetates; Administration, Inhalation; Adolescent; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Child; Cyclopropanes; Fluticasone; Humans; Leukotriene Antagonists; Quinolines; Research Design; Sulfides | 2005 |
Bradykinin and tachykinin-induced leukotriene release in airway virus infections.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Bradykinin; Child, Preschool; Cyclopropanes; Humans; Leukotrienes; Quinolines; Sulfides; Tachykinins; Virus Diseases | 2005 |
Asthma rescue and allergy medication use among asthmatic children with prior allergy prescriptions who initiated asthma controller therapy.
Topics: Acetates; Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Child; Cohort Studies; Cyclopropanes; Drug Costs; Drug Prescriptions; Female; Humans; Longitudinal Studies; Male; Multivariate Analysis; Quinolines; Regression Analysis; Retrospective Studies; Rhinitis, Allergic, Perennial; Sulfides | 2005 |
Adherence to asthma controller medication regimens.
Topics: Acetates; Administration, Inhalation; Adult; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Cohort Studies; Cyclopropanes; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluticasone; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Patient Compliance; Quinolines; Retrospective Studies; Salmeterol Xinafoate; Sulfides | 2005 |
Montelukast for viral respiratory infection-induced exacerbations of asthma.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Humans; Quinolines; Respiratory Tract Infections; Sulfides; Virus Diseases | 2005 |
[Nose and lung breathe the same air].
Topics: Acetates; Asthma; Cyclopropanes; Desensitization, Immunologic; Diagnosis, Differential; Humans; Leukotrienes; Nursing Diagnosis; Quinolines; Rhinitis, Allergic, Seasonal; Sulfides | 2005 |
[One tablet daily against asthma and allergic rhinitis].
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Asthma; Clinical Trials as Topic; Cyclopropanes; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lung Volume Measurements; Quinolines; Rhinitis, Allergic, Seasonal; Sulfides | 2005 |
Isoquercitrin from Argemone platyceras inhibits carbachol and leukotriene D4-induced contraction in guinea-pig airways.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Argemone; Asthma; Bronchoconstriction; Carbachol; Chemical Fractionation; Dose-Response Relationship, Drug; Flowers; Guinea Pigs; Indomethacin; Leukotriene D4; Magnetic Resonance Spectroscopy; Male; Methanol; Molecular Structure; Muscle Contraction; Ovalbumin; Phytotherapy; Plant Leaves; Quercetin; Rutin; Time Factors; Trachea | 2005 |
Influence of leukotriene pathway polymorphisms on response to montelukast in asthma.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Female; Gene Frequency; Genotype; Humans; Leukotrienes; Male; Polymorphism, Genetic; Quinolines; Sulfides | 2006 |
Asthma-related health care resource use among patients starting fluticasone or montelukast therapy.
Topics: Acetates; Adolescent; Adult; Androstadienes; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cohort Studies; Cyclopropanes; Female; Fluticasone; Health Services; Humans; Male; Middle Aged; Quinolines; Retrospective Studies; Sulfides | 2005 |
Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade.
Topics: Acetates; Animals; Asthma; Cyclopropanes; Disease Models, Animal; Female; Follow-Up Studies; Glucocorticoids; Leukotriene Antagonists; Lung; Membrane Proteins; Mice; Mice, Inbred BALB C; Muscle, Smooth; Quinolines; Receptors, Leukotriene; Respiratory Mucosa; Sulfides; Treatment Outcome | 2006 |
"Inferiority complex" for a reason.
Topics: Acetates; Adolescent; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Child; Cyclopropanes; Fluticasone; Forced Expiratory Volume; Humans; Quinolines; Sulfides | 2006 |
Multimodality measurements of small airways disease.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Humans; Quinolines; Respiratory Function Tests; Sulfides; Tomography, X-Ray Computed | 2006 |
Invalid and irrelevant comparisons: apples or oranges?
Topics: Acetates; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Cost-Benefit Analysis; Cyclopropanes; Drug Combinations; Fluticasone-Salmeterol Drug Combination; Humans; Leukotriene Antagonists; Quinolines; Randomized Controlled Trials as Topic; Respiratory Function Tests; Sulfides | 2006 |
Comparing outcomes in patients with persistent asthma: a registry of two therapeutic alternatives.
Topics: Acetates; Adolescent; Adult; Aged; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Cyclopropanes; Drug Therapy, Combination; Emergency Service, Hospital; Female; Fluticasone; Humans; Male; Middle Aged; Multivariate Analysis; Patient Satisfaction; Prospective Studies; Quality of Life; Quinolines; Registries; Salmeterol Xinafoate; Sulfides; Surveys and Questionnaires; Treatment Outcome | 2006 |
Exhaled breath condensate cysteinyl leukotrienes and airway remodeling in childhood asthma: a pilot study.
Topics: Acetates; Adolescent; Asthma; Basement Membrane; Bronchi; Child; Child, Preschool; Cyclopropanes; Cysteine; Exhalation; Female; Humans; Leukotrienes; Male; Pilot Projects; Quinolines; Sulfides | 2006 |
[Airway diseases--leukotriene antagonist kills two flies with one fly-flap].
Topics: Acetates; Administration, Inhalation; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Budesonide; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Humans; Leukotriene Antagonists; Quinolines; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Seasonal; Sulfides; Time Factors | 2006 |
Montelukast in general pediatric practices.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Dermatitis, Atopic; Family Practice; Humans; Leukotriene Antagonists; Pediatrics; Quinolines; Rhinitis, Allergic, Seasonal; Sulfides | 2005 |
Suppressive effect of verproside isolated from Pseudolysimachion longifolium on airway inflammation in a mouse model of allergic asthma.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; Cyclopropanes; Disease Models, Animal; Female; Glucosides; Immunoglobulin E; Interleukin-13; Interleukin-4; Iridoid Glucosides; Iridoids; Lung; Methacholine Chloride; Mice; Mice, Inbred BALB C; Molecular Structure; Mucus; Ovalbumin; Plant Extracts; Pneumonia; Pulmonary Eosinophilia; Quinolines; Sulfides; Veronica | 2006 |
The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
Topics: Acetates; Airway Obstruction; Animals; Anti-Asthmatic Agents; Asthma; Collagen; Cyclopropanes; Cysteine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Goblet Cells; Hyperplasia; Hypertrophy; Leukotriene Antagonists; Leukotrienes; Lung; Mice; Mice, Inbred BALB C; Mucus; Muscle, Smooth; Pulmonary Fibrosis; Quinolines; Receptors, Leukotriene; Respiratory Mucosa; Sulfides | 2006 |
Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Budesonide; Cyclopropanes; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Lung; Male; Peak Expiratory Flow Rate; Quinolines; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sulfides | 2006 |
Administrative claims analysis of asthma-related health care utilization for patients who received inhaled corticosteroids with either montelukast or salmeterol as combination therapy.
Topics: Acetates; Administration, Inhalation; Adolescent; Adult; Albuterol; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cohort Studies; Cyclopropanes; Drug Therapy, Combination; Emergency Medical Services; Female; Glucocorticoids; Health Services; Hospitalization; Humans; Insurance Claim Review; Male; Middle Aged; Quinolines; Retrospective Studies; Salmeterol Xinafoate; Sulfides | 2006 |
PP-ICONS--another tool to help interpret asthma utilization studies.
Topics: Abstracting and Indexing; Acetates; Albuterol; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Drug Therapy, Combination; Glucocorticoids; Health Services; Humans; Quinolines; Retrospective Studies; Salmeterol Xinafoate; Sulfides | 2006 |
More evolution of the evidence in asthma disease management--SMART versus GOAL clinical trials debate the cost-benefit of LABA while the value of leukotriene modifiers, particularly montelukast, is uncertain.
Topics: Acetates; Adrenergic beta-Agonists; Asthma; Clinical Trials as Topic; Cost-Benefit Analysis; Cyclopropanes; Delayed-Action Preparations; Disease Management; Emergency Medical Services; Glucocorticoids; Hospitalization; Humans; Insurance Claim Review; Leukotriene Antagonists; Quinolines; Sulfides | 2006 |
Evaluating the effects of "triple therapy" with inhaled corticosteroids, long-acting beta2-agonists, and leukotriene modifiers in asthma.
Topics: Acetates; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Drug Therapy, Combination; Humans; Leukotriene Antagonists; Peak Expiratory Flow Rate; Quinolines; Sulfides | 2006 |
Patterns of asthma-related health care resource use in children treated with montelukast or fluticasone.
Topics: Acetates; Adolescent; Androstadienes; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cyclopropanes; Delivery of Health Care; Emergency Medical Services; Female; Fluticasone; Humans; Male; Medication Systems; Pharmaceutical Services; Quinolines; Retrospective Studies; Sulfides | 2006 |
Effects of long-term low-dose corticosteroid therapy on humoral immunity.
Topics: Acetates; Agammaglobulinemia; Albuterol; Anti-Asthmatic Agents; Antibodies, Bacterial; Antibody Formation; Asthma; B-Lymphocytes; Cyclopropanes; Drug Therapy, Combination; Female; Humans; Immunoglobulin G; Immunologic Memory; Lymphopenia; Methylprednisolone; Middle Aged; Nasal Polyps; Pneumococcal Vaccines; Quinolines; Sinusitis; Sulfides; T-Lymphocyte Subsets | 2006 |
Montelukast prevents the decrease of interleukin-10 and inhibits NF-kappaB activation in inflammatory airway of asthmatic guinea pigs.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; Cyclopropanes; Eosinophils; Guinea Pigs; Interleukin-10; Leukocyte Count; Leukotriene Antagonists; Lung; Male; NF-kappa B; Quinolines; Sulfides | 2006 |
Systemic reaction to omalizumab.
Topics: Acetates; Adrenal Cortex Hormones; Aged; Albuterol; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis; Asthma; Cyclopropanes; Depression; Drug Hypersensitivity; Drug Therapy, Combination; Epinephrine; Female; Humans; Hypersensitivity; Hypertension; Methylprednisolone; Omalizumab; Quinolines; Rhinitis; Salmeterol Xinafoate; Seizures; Sulfides; Syncope | 2006 |
Urine leukotriene E4 levels are associated with decreased pulmonary function in children with persistent airway obstruction.
Topics: Acetates; Adolescent; Airway Obstruction; Albuterol; Asthma; Child; Chronic Disease; Cyclopropanes; Disease Susceptibility; Female; Forced Expiratory Volume; Humans; Leukotriene E4; Male; Quinolines; Severity of Illness Index; Sulfides | 2006 |
Irrational combination of montelukast and bambuterol for management of childhood asthma.
Topics: Acetates; Asthma; Bronchodilator Agents; Child; Cyclopropanes; Drug Approval; Drug Combinations; Drug Industry; Humans; Leukotriene Antagonists; Quinolines; Sulfides; Terbutaline | 2006 |
Montelukast is an effective monotherapy for mild asthma and for asthma with co-morbid allergic rhinitis.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Child, Preschool; Clinical Trials as Topic; Cyclopropanes; Humans; Practice Guidelines as Topic; Quinolines; Sulfides | 2006 |
Adenosine A1 receptor antagonist versus montelukast on airway reactivity and inflammation.
Topics: Acetates; Adenosine A1 Receptor Antagonists; Animals; Anti-Asthmatic Agents; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoalveolar Lavage Fluid; Cyclopropanes; Disease Models, Animal; Eosinophils; Histamine; Inflammation; Leukotriene Antagonists; Lung Compliance; Lymphocytes; Macrophages, Alveolar; Neutrophils; Purines; Pyroglyphidae; Quinolines; Rabbits; Sulfides; Time Factors | 2006 |
Allergens induce enhanced bronchoconstriction and leukotriene production in C5 deficient mice.
Topics: Acetates; Allergens; Animals; Asthma; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Choline; Cockroaches; Complement C5; Cyclopropanes; Disease Models, Animal; Dust; Genetic Predisposition to Disease; Immunoglobulin E; Interleukin-12; Leukotriene Antagonists; Leukotrienes; Mice; Mice, Knockout; Quinolines; Respiratory Hypersensitivity; Sulfides | 2006 |
The use of rhinitis medications in children receiving initial controller therapy for asthma.
Topics: Acetates; Administration, Intranasal; Adolescent; Adrenal Cortex Hormones; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Child; Child, Preschool; Cyclopropanes; Drug Combinations; Drug Prescriptions; Fluticasone; Fluticasone-Salmeterol Drug Combination; Histamine H1 Antagonists, Non-Sedating; Humans; Hypersensitivity; Leukotriene Antagonists; Quinolines; Retrospective Studies; Rhinitis; Sulfides | 2006 |
Association between leukotriene C4 synthase A-444C polymorphism and asthma in Chinese Han population in Beijing.
Topics: Acetates; Adult; Alleles; Asian People; Asthma; China; Cyclopropanes; Female; Genotype; Glutathione Transferase; Humans; Male; Middle Aged; Polymorphism, Genetic; Quinolines; Sulfides | 2006 |
Treatment and outcomes in patients with asthma and allergic rhinitis in the United kingdom.
Topics: Acetates; Adolescent; Adrenergic beta-Agonists; Adult; Androstadienes; Anti-Asthmatic Agents; Asthma; Beclomethasone; Budesonide; Cohort Studies; Comorbidity; Cyclopropanes; Drug Therapy, Combination; Female; Fluticasone; Humans; Male; Middle Aged; Quinolines; Rhinitis; Sulfides; Treatment Outcome; United Kingdom | 2007 |
Novel selective orally active CRTH2 antagonists for allergic inflammation developed from in silico derived hits.
Topics: Acetates; Animals; Anti-Allergic Agents; Asthma; Binding, Competitive; Biological Availability; Eosinophils; Fluorescence Resonance Energy Transfer; Humans; In Vitro Techniques; Inflammation; Mice; Models, Molecular; Phenoxyacetates; Pyrazoles; Radioligand Assay; Rats; Receptors, Immunologic; Receptors, Prostaglandin; Stereoisomerism; Structure-Activity Relationship; Th2 Cells | 2006 |
Fatal liver failure following food supplements during chronic treatment with montelukast.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Chemical and Drug Induced Liver Injury; Cyclopropanes; Dietary Supplements; Drug Interactions; Fatal Outcome; Female; Humans; Liver Failure, Acute; Middle Aged; Quinolines; Sulfides | 2007 |
Comparative efficacy and cost of asthma care in children with asthma treated with fluticasone propionate and montelukast.
Topics: Acetates; Administration, Inhalation; Adolescent; Androstadienes; Asthma; Bronchodilator Agents; Child; Child, Preschool; Cohort Studies; Confidence Intervals; Cost-Benefit Analysis; Cyclopropanes; Female; Fluticasone; Follow-Up Studies; Humans; Male; Odds Ratio; Probability; Quinolines; Respiratory Function Tests; Retrospective Studies; Severity of Illness Index; Sulfides; Treatment Outcome | 2007 |
Effect of montelukast in a guinea pig model of cough variant asthma.
Topics: Acetates; Airway Resistance; Animals; Anti-Asthmatic Agents; Asthma; Bronchial Provocation Tests; Bronchoalveolar Lavage Fluid; Cough; Cyclopropanes; Disease Models, Animal; Guinea Pigs; Leukotrienes; Male; Ovalbumin; Quinolines; Sulfides | 2008 |
Asthma control in patients with asthma and allergic rhinitis receiving add-on montelukast therapy for 12 months: a retrospective observational study.
Topics: Acetates; Adolescent; Adult; Anti-Asthmatic Agents; Asthma; Chemotherapy, Adjuvant; Cyclopropanes; Female; Humans; Male; Middle Aged; Quinolines; Retrospective Studies; Rhinitis, Allergic, Seasonal; Sulfides; Treatment Outcome | 2007 |
Montelukast and theophylline: no use or some use in persistent asthma?
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Humans; Quinolines; Randomized Controlled Trials as Topic; Sulfides; Theophylline | 2007 |
Healthcare utilisation and costs associated with adding montelukast to current therapy in patients with mild to moderate asthma and co-morbid allergic rhinitis: PRAACTICAL study.
Topics: Acetates; Adolescent; Adult; Asthma; Cohort Studies; Cyclopropanes; Delivery of Health Care; Female; Health Care Costs; Humans; Leukotriene Antagonists; Male; Middle Aged; Quinolines; Retrospective Studies; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sulfides | 2007 |
Suppression of plasma matrix metalloproteinase-9 following montelukast treatment in childhood asthma.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Breath Tests; Child; Cyclopropanes; Female; Histamine H1 Antagonists; Humans; Ketotifen; Leukotriene Antagonists; Male; Matrix Metalloproteinase 9; Nitric Oxide; Peak Expiratory Flow Rate; Quinolines; Severity of Illness Index; Statistics, Nonparametric; Sulfides; Tissue Inhibitor of Metalloproteinase-1 | 2007 |
[A case of chest pain variant asthma].
Topics: Acetates; Asthma; Chest Pain; Cyclopropanes; Female; Humans; Leukotriene Antagonists; Middle Aged; Quinolines; Sulfides | 2007 |
[Biased about the treatment of asthma in children].
Topics: Acetates; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Child; Cyclopropanes; Fluticasone; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 2007 |
[Case of chest pain variant asthma].
Topics: Acetates; Adult; Androstadienes; Asthma; Chest Pain; Cyclopropanes; Drug Therapy, Combination; Fluticasone; Humans; Leukotriene Antagonists; Male; Membrane Proteins; Prednisolone; Procaterol; Quinolines; Receptors, Leukotriene; Sulfides | 2008 |
The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case-crossover study.
Topics: Acetates; Acute Disease; Anti-Asthmatic Agents; Antibodies, Antineutrophil Cytoplasmic; Asthma; Case-Control Studies; Churg-Strauss Syndrome; Cross-Over Studies; Cyclopropanes; Female; Humans; Leukotriene Antagonists; Male; Middle Aged; Quinolines; Sulfides | 2008 |
Extrapolating evidence beyond age groups.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Age Factors; Anti-Asthmatic Agents; Asthma; Budesonide; Child; Child, Preschool; Cyclopropanes; Female; Humans; Infant; Leukotriene Antagonists; Male; Quinolines; Randomized Controlled Trials as Topic; Research Design; Sulfides; Treatment Outcome | 2008 |
Seasonal allergic rhinitis: limited effectiveness of treatments.
Topics: Acetates; Adrenal Cortex Hormones; Adult; Allergens; Asthma; Beclomethasone; Child; Cost-Benefit Analysis; Cromolyn Sodium; Desensitization, Immunologic; Female; Histamine H1 Antagonists; Homeopathy; Humans; Ipratropium; Male; Pollen; Pregnancy; Quinolines; Rhinitis, Allergic, Seasonal; Steroids; Vasoconstrictor Agents | 2008 |
[Churg-Strauss syndrome in a patient with asthma treated with montelukast].
Topics: Acetates; Aged; Anti-Asthmatic Agents; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Eosinophilia; Female; Humans; Quinolines; Sulfides | 2008 |
[Asthma patients with allergic rhinitis, To treat airways as a whole!].
Topics: Acetates; Adolescent; Adult; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Budesonide; Cyclopropanes; Drug Therapy, Combination; Germany; Glucocorticoids; Humans; Leukotriene Antagonists; Multicenter Studies as Topic; Quinolines; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sulfides | 2005 |
[Therapy of bronchial asthma. To fight inflammation].
Topics: Acetates; Adolescent; Adult; Aged; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Budesonide; Cyclopropanes; Drug Therapy, Combination; Fluticasone; Glucocorticoids; Humans; Leukotriene Antagonists; Middle Aged; Multicenter Studies as Topic; Quinolines; Randomized Controlled Trials as Topic; Sulfides; Time Factors | 2005 |
Hemodialysis-associated asthma in a renal failure patient.
Topics: Acetates; Asthma; Chronic Disease; Glomerulonephritis; Humans; Kidney Diseases; Male; Middle Aged; Renal Dialysis | 1980 |
Neutrophil chemotactic activities in bronchoalveolar lavage fluid from patients with bronchial asthma.
Topics: Acetates; Adult; Asthma; Bronchoalveolar Lavage Fluid; Carbon Dioxide; Chemotactic Factors; Chemotaxis, Leukocyte; Ether; Female; Hot Temperature; Humans; Hypersensitivity, Immediate; Lipids; Male; Molecular Weight; Neutrophils; Respiratory Function Tests; Trypsin | 1995 |
Late asthmatic response to inhaled glacial acetic acid.
Topics: Acetates; Acetic Acid; Asthma; Bronchial Provocation Tests; Humans; Lung; Male; Middle Aged; Occupational Diseases; Occupational Exposure; Time Factors | 1994 |
Relationship between the acid-induced cough response and airway responsiveness and obstruction in children with asthma.
Topics: Acetates; Albuterol; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchodilator Agents; Child; Cough; Female; Forced Expiratory Volume; Histamine; Humans; Lung; Male | 1996 |
Montelukast (MK-0476)
Topics: Acetates; Anxiety; Asthma; Cyclopropanes; Headache; Humans; Leukotriene Antagonists; Quinolines; Sulfides; Vertigo | 1997 |
Montelukast approved for asthma management.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Drug Approval; Humans; Quinolines; Sulfides; United States; United States Food and Drug Administration | 1998 |
[Montelukast--a new building block in the therapy of bronchial asthma. Introductory Symposium, MSD Sharp & Dohme GMBH. Telfs (Austria) 6-8 March 1998].
Topics: Acetates; Asthma; Cyclopropanes; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 1998 |
Montelukast for persistent asthma.
Topics: Acetates; Administration, Inhalation; Adolescent; Adult; Anti-Asthmatic Agents; Asthma; Beclomethasone; Child; Clinical Trials as Topic; Cyclopropanes; Double-Blind Method; Drug Interactions; Fees, Pharmaceutical; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 1998 |
Montelukast for children with asthma.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 1998 |
Montelukast for mild and exercise-induced asthma.
Topics: Acetates; Adolescent; Adult; Anti-Asthmatic Agents; Asthma; Asthma, Exercise-Induced; Cyclopropanes; Double-Blind Method; Humans; Leukotriene Antagonists; Middle Aged; Multicenter Studies as Topic; Quinolines; Randomized Controlled Trials as Topic; Reproducibility of Results; Sulfides; Treatment Outcome | 1998 |
["Bronchial asthma--therapeutic advances due to leukotriene antagonists." Symposium: "Leukotriene antagonists: a therapeutic advance in the control of asthma." 30-31 October 1998, Copenhagen].
Topics: Acetates; Asthma; Cyclopropanes; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 1998 |
Drugs for asthma.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Bone Density; Bronchial Spasm; Bronchodilator Agents; Child; Child, Preschool; Choice Behavior; Cromolyn Sodium; Cyclopropanes; Exercise; Female; Growth; Humans; Hydroxyurea; Indoles; Infant, Newborn; Ipratropium; Lactation; Leukotriene Antagonists; Phenylcarbamates; Pregnancy; Pregnancy Complications; Quinolines; Salmeterol Xinafoate; Sulfides; Sulfonamides; Tachycardia; Theophylline; Tosyl Compounds | 1999 |
The emerging role of leukotriene antagonists in asthma therapy.
Topics: Acetates; Adrenergic beta-Agonists; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Glucocorticoids; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds; Treatment Outcome | 1999 |
Leukotriene modifiers: new drugs, old and new reactions.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Autoimmune Diseases; Chromones; Churg-Strauss Syndrome; Cyclopropanes; Drug Hypersensitivity; Eosinophilia; Humans; Indoles; Leukotriene Antagonists; Leukotrienes; Lupus Erythematosus, Systemic; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Th2 Cells; Tosyl Compounds | 1999 |
Pulmonary eosinophilia associated with montelukast.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Fever; Humans; Leukotriene Antagonists; Male; Pulmonary Eosinophilia; Quinolines; Respiratory Sounds; Sulfides | 1999 |
[The value of leukotriene receptor antagonists in the therapy of bronchial asthma one year following the introduction of Montelukast. Symposium at Munich, 6 March 1999].
Topics: Acetates; Asthma; Cyclopropanes; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 1999 |
[Asthma therapy in children and adults. Comment on the contribution by Wettengel R., et al. Recommendations of the German Respiratory League in the German Society of Pneumology].
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Humans; Leukotriene Antagonists; Leukotrienes; Quinolines; Sulfides | 1999 |
Leukotriene receptor antagonists versus inhaled steroids in asthma.
Topics: Acetates; Administration, Inhalation; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Beclomethasone; Chronic Disease; Cyclopropanes; Double-Blind Method; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Middle Aged; Quinolines; Randomized Controlled Trials as Topic; Reproducibility of Results; Sulfides; Treatment Outcome | 1999 |
Taking a look at new advances in asthma therapy.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Humans; Indoles; Leukotriene Antagonists; Nebulizers and Vaporizers; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 1999 |
Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal?
Topics: Acetates; Adrenal Cortex Hormones; Asthma; Chromones; Churg-Strauss Syndrome; Cyclopropanes; Eosinophils; Female; Humans; Indoles; Leukotriene Antagonists; Leukotrienes; Middle Aged; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 1999 |
Leukotriene receptor antagonist drugs for asthma.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Chronic Disease; Cyclopropanes; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 1999 |
Inhaled corticosteroids or antileukotrienes for asthma?
Topics: Acetates; Administration, Inhalation; Anti-Asthmatic Agents; Asthma; Beclomethasone; Cyclopropanes; Glucocorticoids; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 1999 |
[Successful and effective: Montelukast in clinical practice].
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Female; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfides; Treatment Outcome | 1999 |
Montelukast. No current use for asthma.
Topics: Acetates; Administration, Inhalation; Anti-Asthmatic Agents; Asthma; Chronic Disease; Cyclopropanes; Drug Costs; Humans; Quinolines; Steroids; Sulfides | 2000 |
Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma.
Topics: Acetates; Adrenal Cortex Hormones; Adult; Anti-Asthmatic Agents; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Leukotriene Antagonists; Male; Middle Aged; Quinolines; Risk Factors; Sulfides | 2000 |
Leukotriene receptor antagonists: useful in acute asthma?
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 2000 |
Successful outcome of montelukast overdosage in an asthmatic child.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Child, Preschool; Cyclopropanes; Drug Overdose; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfides; Treatment Outcome | 2000 |
Drugs for asthma.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchial Spasm; Child; Cromolyn Sodium; Cyclopropanes; Exercise; Female; Growth Disorders; Humans; Hydroxyurea; Indoles; Ipratropium; Lactation; Leukotriene Antagonists; Nebulizers and Vaporizers; Nedocromil; Phenylcarbamates; Pregnancy; Pregnancy Complications; Quinolines; Salmeterol Xinafoate; Sulfides; Sulfonamides; Theophylline; Tosyl Compounds | 2000 |
The use of newer asthma and allergy medications during pregnancy. The American College of Obstetricians and Gynecologists (ACOG) and The American College of Allergy, Asthma and Immunology (ACAAI).
Topics: Abnormalities, Drug-Induced; Acetates; Administration, Inhalation; Administration, Intranasal; Administration, Oral; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Animals; Anti-Allergic Agents; Anti-Asthmatic Agents; Asthma; Budesonide; Chlorpheniramine; Cyclopropanes; Ephedrine; Female; Histamine H1 Antagonists; Humans; Hydroxyurea; Hypersensitivity; Indoles; Ipratropium; Leukotriene Antagonists; Metaproterenol; Nasal Decongestants; Nebulizers and Vaporizers; Nedocromil; Phenylcarbamates; Pregnancy; Pregnancy Complications; Quinolines; Salmeterol Xinafoate; Sulfides; Sulfonamides; Terbutaline; Tosyl Compounds; Tripelennamine | 2000 |
Marked peripheral edema associated with montelukast and prednisone.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Cyclopropanes; Drug Interactions; Edema; Humans; Male; Prednisone; Quinolines; Sulfides | 2000 |
Recurrent panniculitis in a man with asthma receiving treatment with leukotriene-modifying agents.
Topics: Acetates; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Cyclopropanes; Diagnosis, Differential; Erythema Induratum; Humans; Hydroxyurea; Leukotriene Antagonists; Lipoxygenase Inhibitors; Male; Middle Aged; Panniculitis, Nodular Nonsuppurative; Quinolines; Sulfides | 2000 |
Montelukast added to inhaled beclomethasone in treatment of asthma.
Topics: Acetates; Administration, Inhalation; Anti-Asthmatic Agents; Asthma; Beclomethasone; Cyclopropanes; Drug Therapy, Combination; Humans; Quinolines; Sulfides | 2000 |
[Leukotriene antagonists against bronchial asthma. Not a replacement for steroids].
Topics: Acetates; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Drug Therapy, Combination; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 1999 |
Role of leukotriene receptor antagonists in pediatric asthma.
Topics: Acetates; Administration, Oral; Asthma; Asthma, Exercise-Induced; Child; Cyclopropanes; Humans; Leukotriene Antagonists; Quinolines; Respiratory Function Tests; Severity of Illness Index; Sulfides | 2000 |
Churg-Strauss syndrome associated with montelukast therapy.
Topics: Acetates; Aged; Anti-Asthmatic Agents; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Quinolines; Radiography; Sulfides; Vital Capacity | 2000 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 30-2000. A 25-year-old man with asthma, cardiac failure, diarrhea, and weakness of the right hand.
Topics: Acetates; Adult; Androstadienes; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Diagnosis, Differential; Diarrhea; Fluticasone; Glucocorticoids; Heart Failure; Humans; Leukotriene Antagonists; Lung; Male; Muscle Hypotonia; Prednisone; Quinolines; Radiography; Sulfides | 2000 |
Intravenous montelukast in acute asthma: expensive aminophylline?
Topics: Acetates; Acute Disease; Aminophylline; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Forced Expiratory Volume; Humans; Injections, Intravenous; Leukotriene Antagonists; Quinolines; Sulfides | 2000 |
Churg-Strauss syndrome: is there an association with leukotriene modifiers?
Topics: Acetates; Administration, Inhalation; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 2000 |
Montelukast in childhood asthma.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cyclopropanes; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 2000 |
[Leukotriene antagonism. Inhibiting inflammation plus bronchodilatation].
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 2000 |
Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics.
Topics: Acetates; Adult; Aged; Aspirin; Asthma; Bronchial Spasm; Cyclopropanes; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Quinolines; Sulfides | 2000 |
Non-parametric estimates of overlap.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Beclomethasone; Computer Simulation; Cyclopropanes; Data Interpretation, Statistical; Female; Hip; Humans; Models, Biological; Osteoporosis, Postmenopausal; Quinolines; Statistics, Nonparametric; Sulfides | 2001 |
Montelukast and Churg-Strauss syndrome.
Topics: Acetates; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 2001 |
Changes in asthma drug therapy costs for patients receiving chronic montelukast therapy in the U.K.
Topics: Acetates; Administration, Topical; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Cyclopropanes; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Middle Aged; Quinolines; Retrospective Studies; Salmeterol Xinafoate; Sulfides; United Kingdom | 2001 |
[Anti-inflammatory asthma therapy. Effectiveness depends on compliance].
Topics: Acetates; Administration, Oral; Adult; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Child; Cyclopropanes; Drug Therapy, Combination; Humans; Nebulizers and Vaporizers; Patient Compliance; Quinolines; Steroids; Sulfides | 2001 |
Montelukast and Churg-Strauss syndrome.
Topics: Acetates; Administration, Inhalation; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Dose-Response Relationship, Drug; Eosinophilia; Fluticasone; Humans; Nebulizers and Vaporizers; Prednisolone; Quinolines; Sulfides | 2001 |
Montelukast and Churg-Strauss syndrome.
Topics: Acetates; Administration, Inhalation; Aged; Anti-Asthmatic Agents; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Female; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfides | 2001 |
Montelukast sodium in cystic fibrosis.
Topics: Acetates; Adolescent; Adult; Asthma; Cyclopropanes; Cystic Fibrosis; Exercise Tolerance; Female; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfides; Treatment Outcome | 2001 |
Case 30-2000: Churg-Strauss syndrome.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Glucocorticoids; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfides | 2001 |
[Antileukotrienes in the prevention of postoperative recurrence of nasal polyposis in ASA syndrome].
Topics: Acetates; Adult; Aged; Aspirin; Asthma; Cyclopropanes; Drug Hypersensitivity; Female; Humans; Leukotriene Antagonists; Male; Middle Aged; Nasal Polyps; Neoplasm Recurrence, Local; Quinolines; Sulfides; Syndrome | 2000 |
Severe asthma attack in a patient with premenstrual asthma: hot pepper is the possible trigger.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Female; Humans; Leukotriene Antagonists; Menstrual Cycle; Quinolines; Sulfides; Vegetables | 2001 |
Correlation of airway obstruction and patient-reported endpoints in clinical studies.
Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Asthmatic Agents; Asthma; Clinical Trials as Topic; Cyclopropanes; Cysteine; Endpoint Determination; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Leukotrienes; Male; Middle Aged; Peak Expiratory Flow Rate; Pulmonary Ventilation; Quinolines; Sulfides; Treatment Outcome | 2001 |
Expedient liquid chromatographic method with fluorescence detection for montelukast sodium in micro-samples of plasma.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Chromatography, High Pressure Liquid; Cyclopropanes; Fluorescence; Humans; Light; Quality Control; Quinolines; Reference Standards; Sulfides | 2001 |
What is "more effective asthma control"?
Topics: Acetates; Albuterol; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Chronic Disease; Cyclopropanes; Humans; Peak Expiratory Flow Rate; Quinolines; Salmeterol Xinafoate; Sulfides | 2001 |
[Chewable leukotriene antagonist. New therapy option for asthmatic patients of preschool age].
Topics: Acetates; Administration, Oral; Asthma; Child, Preschool; Clinical Trials as Topic; Cyclopropanes; Dosage Forms; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 2001 |
Does leukotriene modulation of eosinophil function explain the therapeutic effectiveness of receptor antagonists in some patients with asthma?
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Endothelium, Vascular; Eosinophils; Humans; Leukotriene Antagonists; Leukotrienes; Quinolines; Sulfides; Treatment Outcome | 2001 |
Effect of a specific cysteinyl leukotriene-receptor 1-antagonist (montelukast) on the transmigration of eosinophils across human umbilical vein endothelial cells.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Cell Movement; Cell Survival; Chemotaxis, Leukocyte; Cyclopropanes; Endothelium, Vascular; Eosinophils; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-13; Leukotriene Antagonists; Male; Membrane Proteins; Platelet Activating Factor; Quinolines; Receptors, Leukotriene; RNA, Messenger; Sensitivity and Specificity; Sulfides; Umbilical Veins | 2001 |
Safety of antileukotriene agents in asthma management.
Topics: Acetates; Asthma; Churg-Strauss Syndrome; Clinical Trials as Topic; Cyclopropanes; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 2001 |
Leukotriene antagonists and symptom control in chronic persistent asthma.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Chronic Disease; Cyclopropanes; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 2001 |
[Pharma-clinics. Medication of the month. Montelukast (Singulair)].
Topics: Acetates; Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adult; Asthma; Child; Cyclopropanes; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 2001 |
Montelukast: new preparation. No current use in asthma.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Churg-Strauss Syndrome; Clinical Trials as Topic; Humans; Leukotriene Antagonists; Quinolones; Treatment Outcome | 1999 |
Effects of antileukotriene among asthmatic patients.
Topics: Acetates; Administration, Oral; Adult; Aged; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Humans; Leukotriene Antagonists; Middle Aged; Prospective Studies; Quinolines; Spirometry; Sulfides; Treatment Outcome | 2001 |
A comparison of asthma-related expenditures for patients started on montelukast versus fluticasone propionate as monotherapy.
Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Androstadienes; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cohort Studies; Cyclopropanes; Female; Fluticasone; Health Care Costs; Humans; Insurance Claim Review; Male; Middle Aged; Patient Compliance; Quinolines; Respiratory Function Tests; Retrospective Studies; Sulfides; Treatment Outcome | 2001 |
An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma.
Topics: Acetates; Adult; Aged; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Bleeding Time; Cyclopropanes; Female; Humans; Inspiratory Capacity; Leukotriene Antagonists; Male; Middle Aged; Nasal Polyps; Nitric Oxide; Peak Expiratory Flow Rate; Quinolines; Sensitivity and Specificity; Skin Tests; Sulfides | 2001 |
[Treatment of ASS-Associated Polyposis (ASSAP) with a cysteinyl leukotriene receptor antagonist - a prospective drug study on its antiinflammatory effects].
Topics: Acetates; Adult; Anti-Asthmatic Agents; Aspirin; Asthma; Cyclopropanes; Female; Humans; Leukotriene Antagonists; Male; Middle Aged; Nasal Polyps; Quinolines; Recurrence; Sulfides | 2001 |
Montelukast for persistent asthma.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Humans; Patient Selection; Quinolines; Randomized Controlled Trials as Topic; Reproducibility of Results; Sulfides | 2001 |
Montelukast for persistent asthma.
Topics: Acetates; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Humans; Polypharmacy; Quinolines; Reproducibility of Results; Sulfides | 2001 |
Montelukast for persistent asthma.
Topics: Acetates; Anti-Asthmatic Agents; Aspirin; Asthma; Cyclopropanes; Humans; Leukotriene E4; Prednisone; Quinolines; Sulfides | 2001 |
Interferon-gamma modulates cysteinyl leukotriene receptor-1 expression and function in human airway myocytes.
Topics: Acetates; Asthma; Bradykinin; Cells, Cultured; Constriction, Pathologic; Cyclopropanes; Cytoskeleton; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Interferon-gamma; Leukotriene Antagonists; Membrane Proteins; Muscle, Smooth; Pliability; Quinolines; Receptors, Leukotriene; Respiratory Muscles; Reverse Transcriptase Polymerase Chain Reaction; Sulfides; Up-Regulation | 2001 |
More about Churg-Strauss syndrome and montelukast treatment.
Topics: Acetates; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Duodenum; Female; Humans; Middle Aged; Pyloric Antrum; Quinolines; Sulfides | 2001 |
Adherence to oral montelukast and inhaled fluticasone in children with persistent asthma.
Topics: Acetates; Administration, Inhalation; Adolescent; Adult; Androstadienes; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Cyclopropanes; Fluticasone; Humans; Infant; Patient Compliance; Quinolines; Retrospective Studies; Sulfides | 2001 |
[Leukotrienes. Interlopers on trips to the park].
Topics: Acetates; Asthma; Cyclopropanes; Humans; Leukotriene Antagonists; Leukotrienes; Quinolines; Rhinitis, Allergic, Seasonal; Sulfides | 2001 |
A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model.
Topics: Acetates; Acute Disease; Allergens; Analysis of Variance; Animals; Asthma; Bronchoalveolar Lavage Fluid; Chronic Disease; Cyclopropanes; Disease Models, Animal; Drug Evaluation, Preclinical; Eosinophils; Fibrosis; Glycoproteins; Goblet Cells; Hyperplasia; Inflammation; Leukotriene Antagonists; Leukotrienes; Lysophospholipase; Macrophages, Alveolar; Mice; Ovalbumin; Quinolines; Respiratory Mechanics; Sulfides | 2002 |
[Churg-Strauss Syndrome associted with administration of Montelukast in an asthmatic patient withour underlying maintenance corticosteroid treatment].
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Female; Humans; Quinolines; Sulfides | 2002 |
Montelukast and Churg-Strauss syndrome.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Female; Humans; Leukotriene Antagonists; Male; Middle Aged; Quinolines; Sulfides | 2002 |
Pharmacoeconomic studies of asthma controller drugs: marketing gimmick or icing on the cake?
Topics: Acetates; Administration, Inhalation; Administration, Oral; Androstadienes; Anti-Inflammatory Agents; Asthma; Cohort Studies; Cyclopropanes; Economics, Pharmaceutical; Fluticasone; Humans; Indoles; Leukotriene Antagonists; Managed Care Programs; Marketing of Health Services; Phenylcarbamates; Quinolines; Randomized Controlled Trials as Topic; Sulfides; Sulfonamides; Tosyl Compounds | 2002 |
Economic impact of asthma therapy with fluticasone propionate, montelukast, or zafirlukast in a managed care population.
Topics: Acetates; Administration, Inhalation; Adolescent; Adult; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Child; Cohort Studies; Cyclopropanes; Female; Fluticasone; Humans; Indoles; Male; Managed Care Programs; Middle Aged; Phenylcarbamates; Quinolines; Retrospective Studies; Sulfides; Sulfonamides; Tosyl Compounds; United States | 2002 |
Asthma biomarkers and drug trials.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Clinical Trials as Topic; Cyclopropanes; Humans; Inflammation Mediators; Leukotriene Antagonists; Quinolines; Sulfides; Treatment Outcome | 2002 |
Inhaled corticosteroids plus salmeterol or montelukast: effects on resource utilization and costs.
Topics: Acetates; Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Adult; Albuterol; Asthma; Bronchodilator Agents; Child; Cyclopropanes; Drug Therapy, Combination; Female; Health Care Costs; Health Maintenance Organizations; Humans; Male; Quinolines; Salmeterol Xinafoate; Sulfides | 2002 |
[Interview with Dr. W. Wiebicke, Bremen. To treat early with anti-inflammatory drugs!].
Topics: Acetates; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Age Factors; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Drug Therapy, Combination; Humans; Leukotriene Antagonists; Lung; Patient Compliance; Phosphodiesterase Inhibitors; Quinolines; Radionuclide Imaging; Respiratory Therapy; Sulfides; Time Factors | 2002 |
High-dose montelukast exposures in a 3-year-old and a 5-year-old child.
Topics: Accidents; Acetates; Anti-Asthmatic Agents; Asthma; Child, Preschool; Cyclopropanes; Dose-Response Relationship, Drug; Emergency Medical Services; Humans; Male; Quinolines; Sulfides | 2002 |
Initial therapy in clinical asthma studies often does not equal therapy for mild, persistent asthma.
Topics: Acetates; Adrenergic beta-Agonists; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Drug Therapy, Combination; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 2002 |
Bronchodilator reversibility to albuterol predicts bronchodilator response to salmeterol.
Topics: Acetates; Administration, Inhalation; Airway Resistance; Albuterol; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Cyclopropanes; Drug Therapy, Combination; Forced Expiratory Volume; Humans; Peak Expiratory Flow Rate; Quinolines; Salmeterol Xinafoate; Sulfides; Treatment Outcome | 2002 |
[Churg-Strauss syndrome after treatment with Singulair (montelukast)].
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Female; Humans; Leukotriene Antagonists; Quinolines; Sulfides | 2002 |
New drug treatment for asthma: clinical versus statistical significance.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Forced Expiratory Volume; Humans; Quinolines; Sulfides; Treatment Outcome | 2002 |
Effect of montelukast, a once-daily leukotriene receptor antagonist, on peak expiratory flow variability.
Topics: Acetates; Adolescent; Adult; Aged; Anti-Asthmatic Agents; Asthma; Chronic Disease; Cyclopropanes; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Middle Aged; Multicenter Studies as Topic; Peak Expiratory Flow Rate; Quinolines; Randomized Controlled Trials as Topic; Respiratory Function Tests; Retrospective Studies; Sulfides | 2002 |
[Churg-Strauss syndrome in an asthmatic man treated with montelukast: continued controversy].
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Churg-Strauss Syndrome; Cyclopropanes; Humans; Leukotriene Antagonists; Male; Quinolines; Sulfides; Time Factors | 2002 |
Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.
Topics: Acetates; Administration, Inhalation; Adrenal Cortex Hormones; Albuterol; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Cyclopropanes; Drug Therapy, Combination; Humans; Powders; Quinolines; Salmeterol Xinafoate; Sulfides | 2002 |
5-Lipoxygenase polymorphism and in-vivo response to leukotriene receptor antagonists.
Topics: Acetates; Adult; Arachidonate 5-Lipoxygenase; Asthma; Cyclopropanes; Forced Expiratory Volume; Genotype; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Polymorphism, Genetic; Quinolines; Retrospective Studies; Sulfides; Sulfonamides; Tosyl Compounds | 2002 |
Effect of acetate upon arterial gases.
Topics: Acetates; Asthma; Bicarbonates; Carbon Dioxide; Female; Humans; Hydrogen-Ion Concentration; Hypoxia; Male; Oxygen; Renal Dialysis | 1979 |
Antiasthmatic effects of Picrorhiza kurroa: androsin prevents allergen- and PAF-induced bronchial obstruction in guinea pigs.
Topics: Acetates; Airway Obstruction; Allergens; Animals; Asthma; Bronchi; Bronchial Provocation Tests; Chloroform; Chromatography, Gel; Complement C5a; Dose-Response Relationship, Drug; Glycosides; Guinea Pigs; Histamine Release; Immunoglobulin E; Male; Neutrophils; Plants, Medicinal; Platelet Activating Factor; Plethysmography | 1991 |
Outbreak of the reactive airways dysfunction syndrome after a spill of glacial acetic acid.
Topics: Accidents, Occupational; Acetates; Acetic Acid; Adult; Asthma; Bronchial Provocation Tests; Disease Outbreaks; Female; Humans; Methacholine Chloride; Nuclear Medicine Department, Hospital; Occupational Diseases; Occupational Exposure; Rhode Island; Risk Factors; Surveys and Questionnaires; Syndrome | 1991 |
Increased rate of ethanol elimination and elevated blood acetate in asthmatics on corticosteroid, beta-2-sympathicomimetic and theophylline treatment.
Topics: Acetates; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Age Factors; Alcoholism; Asthma; Drug Therapy, Combination; Ethanol; Female; Humans; Male; Middle Aged; Theophylline | 1988 |
[Distilled water inhalation challenge in asthmatic children].
Topics: Acetates; Acetic Acid; Administration, Inhalation; Adolescent; Asthma; Bronchi; Bronchial Provocation Tests; Child; Female; Histamine; Humans; Male; Predictive Value of Tests; Water | 1988 |
Hyperresponsiveness of cough receptors in patients with bronchial asthma.
Topics: Acetates; Acetic Acid; Adolescent; Adult; Asthma; Bronchial Provocation Tests; Child; Child, Preschool; Cough; Differential Threshold; Female; Humans; Male; Methacholine Chloride; Methacholine Compounds | 1985 |
Histamine metabolism in asthma.
Topics: Acetates; Asthma; Child; Child, Preschool; Chromatography, Gas; Diet Therapy; Fluorometry; Histamine; Humans; Imidazoles; Methylation | 1974 |
[Use in pneumological therapy of a new injectable antibiotic: thiamphenicol glycinate].
Topics: Acetates; Adult; Anti-Bacterial Agents; Asthma; Bronchitis; Chronic Disease; Humans; Lung Diseases; Male; Middle Aged; Respiratory Insufficiency | 1967 |
Acetylation of human serum albumin by acetylsalicylic acid.
Topics: Acetates; Acetrizoic Acid; Alkylation; Animals; Aspirin; Asthma; Autoradiography; Carbon Isotopes; Chemical Phenomena; Chemistry; Dialysis; Drug Hypersensitivity; Humans; Hydrogen-Ion Concentration; Immunoelectrophoresis; Iodine Isotopes; Nasal Polyps; Rabbits; Rhinitis; Serum Albumin | 1968 |
[On the use of the association of acetylcysteine and thiamphenicol glycinate in some pediatric pulmonary diseases].
Topics: Acetates; Acetylcysteine; Asthma; Bronchopneumonia; Child; Child, Preschool; Drug Synergism; Female; Humans; Laryngitis; Male; Respiratory Tract Infections; Sinusitis; Tracheitis; Whooping Cough | 1968 |
[Quantitative determination of some degradation products of histidine and histamine in urine in allergic diseases].
Topics: Acetates; Asthma; Eczema; Histidine; Humans; Hypersensitivity; Imidazoles; Lactates; Rhinitis, Allergic, Seasonal | 1969 |